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Abstract 
Embryonic stem (ES) cells are a potential source of neural derivatives that can be used 
in stem cell-based therapies. To generate specific cell types in a predictable manner, a 
detailed understanding of cell fate specification is required. To address this, this study 
employed mouse ES cells as a model to explore how neural identity was acquired and how 
regional identities were specified in ES cell-derived neural progenitor cells (NPCs). 
Chemical inhibitors are more stable than recombinant proteins, hence they give more 
reproducible biological responses. This is crucial when generating specific cell types from ES 
cells for large-scale analysis. This study explored the effect of two newly discovered small 
molecule inhibitors of BMP signalling, dorsomorphin (DM) and LDN193189 (LDN) on the 
neural induction of ES cells, and compared their capabilities with those of recombinant 
noggin. Both DM and LDN treatments increased the expression of neural markers to levels 
that were comparable to that achieved by noggin treatment, suggesting that both LDN and 
DM can potentially substitute recombinant noggin in the generation of NPCs in vitro.  
Retinoic acid (RA) is an important regulator of regional specification in vivo, but the 
underlying mechanisms for giving region-specific response are unclear. Here, early and late 
NPCs were exposed to RA at specific periods and were analysed for neural and positional 
markers. Results showed that region-specific responses were produced by RA at specific 
periods, indicating that NPCs display temporal changes in patterning responsiveness to 
morphogenic cues.  
The ability of morphogens to impose positional response is lost in late cultures. Since 
Sox1 expression is associated with a naïve neural progenitor state and neural commitment, 
the expression of Sox1 was examined over time to test whether it was associated with the 
responsiveness to patterning cues. Both caudal and ventral markers were induced by RA and, 
because it plays an essential role in ventral patterning, Hedgehog (Hh) agonist 
purmorphamine respectively in early NPCs but not in late NPCs in both Sox1 positive and 
negative populations. This suggested that the expression of positional markers was not 
dependent on a temporally-defined Sox1 progenitor state. 
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1.1 Background of stem cells 
Recent decades have seen an upsurge in the field of stem cell research. It has captured 
the public imagination, awakening hopes of life-changing applications to previously 
untreatable medical conditions. Unsurprisingly, several definitions of stem cells have 
emerged. For the purposes of this thesis, however, stem cells are to be understood in broad 
terms as master cells which have yet to assume particular characteristics but which are 
capable of self-generation and of differentiation into a wide variety of cells as found in living 
organisms (McCulloch and Till, 2005, Friel et al., 2005). They are cells which, under suitable 
conditions, are able to play a part in generating more specific cell-types relevant, for 
example, to the healing or restoration of previously weakened or damaged tissue.  
Embryonic stem (ES) cells, the particular focus of this study, are key to the generation 
of other cell types found in adult organisms. As their name suggests, ES cells have great 
potential: they are at a point where development into more functionally-specific cell types 
has not yet taken place, whereas adult stem cells can only give rise to a limited range of cell 
types associated with organs from which they originated. It is for this reason that they have 
proved such an attractive and fruitful field of research. 
 
1.1.1 The discovery of embryonic stem cells 
The identification of mouse ES cells was one of the most critical discoveries of the 20th 
century (Evans and Kaufman, 1981, Martin, 1981). It was based on an important finding that 
teratocarcinomas (gonadal tumours) possess a unique type of stem cell, embryonic 
carcinoma (EC) cells, that can generate all cell types found in teratocarcinomas when grafted 
to extra-uterine sites (Stevens, 1970, Solter et al., 1970). EC cells were found to be 
pluripotent and able to generate all cell types found in the three germ layers (ectoderm, 
endoderm and mesoderm) (Kleinsmith and Pierce, 1964, Martin and Evans, 1975) and can be 
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propagated in cultures (Martin and Evans, 1975). However, most EC cells are aneuploid. 
They are unable to produce gametes and produce tumours when injected into the mouse 
blastocysts (Papaioannou et al., 1978, Rossant and McBurney, 1982). These limitations 
therefore led to the development of ES cells, which were derived from the inner cell mass of 
mouse blastocyst-stage embryos (E3.5) (Evans and Kaufman, 1981, Martin, 1981). Like EC 
cells, ES cells are pluripotent (Doetschman et al., 1985) and self-renew. This means that they 
remain pluripotent after prolonged propagation (Fig. 1.1). In contrast to EC cells, they 
maintain a diploid karyotype (Evans and Kaufman, 1981), able to produce gametes in 
chimaeras and to integrate into embryos, producing normal, fertile chimeras (Bradley et al., 
1984). The identification of these characteristics of ES cells was crucial: it formed the basis of 
our ability to genetically modify mice in order to study gene function. 
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Figure 1.1 Lineages derived from mouse ES cells  
The pluripotency of mouse ES cells means that they are responsive to the full range of 
developmental cues, giving rise to all cell types found in the three germ layers.  
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1.1.2 The use of mouse ES cells as a model to study neural development 
Mouse ES cells were maintained on layers of mitotically inactivated mouse fibroblasts 
(also known as ‘feeders’) in fetal bovine serum (FBS) to provide trophic factors for the 
growth of ES cells (Evans and Kaufman, 1981). More recently other factors (e.g. BMP, LIF, 2i) 
(Ying et al., 2008, Ying et al., 2003a, Williams et al., 1988) have been identified (see Section 
1.2) and have replaced these culturing conditions. In their absence, mouse ES cells 
differentiate into all the lineages that make up the adult animal (Solter, 2006). Primarily, ES 
cells will undergo neural specification in the absence of extrinsic factors (Smukler et al., 2006, 
Tropepe et al., 2001). The detection of this default neural pathway provided an important 
tool for our understanding of neural development in vivo through directing differentiation 
down specific neuronal lineages.  
The directed neural differentiation of mouse ES cells, then, is the subject of this thesis. It 
seeks to analyse the mechanisms governing the process of neural specification and how 
neural progenitors behave following neural specification. This has been done by addressing 
three questions. Firstly, what is the effect of two newly discovered inhibitors, dorsomorphin 
(DM) and LDN 193189 (LDN) on the generation of neural progenitors (Chapter 3)? Secondly, 
how is the developmental potential in neural progenitors changed temporally (Chapter 4)? 
And finally, how relevant is the expression of a particular gene, Sox1, in determining the 
ability of stem cells to respond to developmental cues (Chapter 5). The relevance of these 
three lines of inquiry to the question of neural specification is described in Section 1.8. 
The isolation of human ES cells from human blastocysts (Thomson et al., 1998) was 
another important step in stem cell history: it meant that the benefits of stem cell research 
were not limited to understanding embryonic development but could also be extended to 
therapeutic applications. They could be used to provide a source of cells that could be 
implanted into the nervous system to replace cells whose function is lost providing they 
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faithfully recapitulate the developmental programme that allows them to survive and fully 
integrate into the neural circuit (Price et al., 2011). Thus, they have opened up possibilities 
for tackling some currently incurable neurodegenerative diseases (e.g. Parkinson's disease) 
(Thomson et al., 1998). Furthermore, they can be directed to a particular phenotypes for 
disease modelling and for identifying new targets for drug screening (Eglen et al., 2008). 
To develop ES cells for replacement therapy, ultimately we need to understand neural 
development using human ES cells. However, as an initial step, mouse ES cells provide an 
important tool and possess many benefits over human ES cells. The protocols relating to the 
cultivation of mouse ES cells are well established and do not raise any of the ethical issues 
which, in the minds of some, remain, and which are not overcome even by the use of 
existing human ES cell lines. Some of these issues, and problems arising from the rejection of 
tissue are now being addressed by the use of induced pluripotent stem (iPS) cells, which are 
produced by reprogramming adult fibroblast cells to an embryonic-like state using Oct4, 
Sox2, Klf4 and c-Myc (Takahashi and Yamanaka, 2006, Takahashi et al., 2007), mouse 
cell-based research still has much to offer. In practical terms, while the difference between 
the doubling times for undifferentiated mouse and human ES cells cannot be ignored, it is 
nevertheless not substantial (～16 hours for mouse ES cells and ～36 hours for human ES 
cells (Buecker et al., 2010). On the other hand, the doubling times for ES cell-derived neural 
stem cells are on a bigger time scale (～24 hours for mouse ESC-derived NSC and 5-10 days 
for human ESC-derived NSC) (Conti et al., 2005). Again, on a practical level, mouse ES cells 
can be maintained more effectively as they can be passaged as single cells by trypsin digest. 
Most human ES cell lines cannot grow from a single cell, and therefore they have to be 
passaged as small clumps of cells (Buecker et al., 2010). In addition, because they come from 
diverse sources (Thomson et al., 1998), human ES cell lines vary in the efficiency of their 
differentiation into particular lineages (Silva and Smith, 2008). Additionally, at the present 
moment, mouse ES cell research provides a more fully documented basis for research in 
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comparison to human ES cell research. The ready availability of resources like knock-out and 
knock-in reporter mouse ES cell lines, for example, has made gene function study more 
practicable. Fundamental to all of this is the fact that, within a range of prescribed limits, 
research on mouse ES cells offers a high degree of transferability to work on human ES and 
iPS cells.    
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1.2 Self-renewal of mouse ES cells 
Once it was established that the use of mouse ES cells would provide a meaningful 
model for the analysis of neural specification, it became necessary to understand the 
interplay between extrinsic and intrinsic factors in the ES cells' capacity for self-renewal. It is 
on these factors that determine whether these cells remain self-renewing or undergo 
differentiation depends. 
 
1.2.1 Extrinsic factor 1: the role of LIF in maintaining pluripotency of ES cells  
Early ES cell work indicated that the undifferentiated state of ES cells was supported by 
a trophic factor produced by feeder cells. It was later discovered that the feeders could be 
replaced by conditioned media from buffalo-rat liver cells (Smith and Hooper, 1987). 
Subsequently, the critical factor that was found to be required for ES cells to remain 
undifferentiated was the leukaemia inhibitory factor (LIF) (Williams et al., 1988, Smith et al., 
1988). ES cells that are grown in feeders that lack a functional LIF gene are unable to 
propagate effectively (Stewart et al., 1992). The effect of LIF is primarily mediated through 
the Janus kinases / signal transducer and activator of transcription 3 pathway (JAK/STAT3 
pathway). Study has shown that LIF can also activate the phosphatidylinositol-3-ol kinase 
(PI3K)-Akt and mitogen-activated protein kinase (MAPK) pathways (Paling et al., 2004). For 
the JAK/STAT3 pathway, the binding of LIF with the receptor complex results in either the 
heterodimerisation of low-affinity LIF receptor (LIFRβ) and gp130 or the homodimerisation 
of the gp130 cell surface receptor complex (Nakamura et al., 1998). This then triggers the 
activation of Jaks and the subsequent tyrosine phosphorylation of LIFRβ and gp130, creating 
docking sites for Src homology 2 (SH2) domain-containing signalling molecules such as STAT1 
and STAT3 (Stahl et al., 1995). In ES cells, only STAT3 but not STAT1 has an effect on 
self-renewal. This is because co-expression of wild-type STAT3 but not STAT1 can restore 
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self-renewal in ES cells that express a dominant negative form of STAT3 (Niwa et al., 1998). 
The STAT proteins are then phosphorylated by JAKS on their tyrosine residues, which then 
leads to their dimerization and translocation to the nucleus to regulate specific gene 
transcription (Darnell, 1997).  
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1.2.2 Extrinsic factor 2: the role of BMP in maintaining pluripotency of ES cells  
Initially, it was thought that LIF alone can inhibit the differentiation of ES cells, but soon 
it was realised that culturing ES cells in LIF alone did not inhibit neural differentiation in 
serum-free conditions when ES cells were plated at high cell densities (Ying et al., 2003a). To 
prevent neural differentiation in such conditions, bone morphogenic protein 4 (BMP4) was 
introduced. Both BMP4 and serum acted through R-Smad to induce expression of the 
inhibitor of the differentiation gene (Id). It was found that the forced expression of Id genes 
enabled ES cells to self-renew in the absence of BMP or serum. Id proteins were seen to 
promote cell growth and prevent neural differentiation by inhibiting the action of basic 
helix-loop-helix (bHLH) transcription factors e.g. Neurogenin2 (Ngn2) (Miyazono and 
Miyazawa, 2002, Ying et al., 2003a). They had little or no effect on mesoderm and endoderm 
commitment. Therefore, it was deduced that BMP4 in isolation promoted the expression of 
endodermal and mesodermal genes, but that this expession was suppressed by LIF. This 
indicated that both STAT3 and the Id gene have to be activated to keep ES cells pluripotent. 
BMP4 did not increase STAT3 activity, and therefore there appeared to be no 
cross-regulation between the two pathways. The resultant activity seemed to be dependent 
on the existence of an appropriate balance between the input of both pathways (Ying et al., 
2003a).  
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1.2.3 Extrinsic factor 3: the role of Wnt in maintaining pluripotency of ES cells 
A further pathway was reported to facilitate pluripotency: Wnt signalling. Wnt proteins 
were observed to signal via the Frizzled receptor and destabilize the β-catenin degradation 
complex. This complex consists of Axin, adenomatous polyoposis coli (APC) and glycogen 
synthase kinase 3 (GSK3). The inhibition of GSK3 activity resulted in the translocation of 
β-catenin to the nucleus where it engages with DNA binding factors of the T-cell factor/ 
lymphocyte enhancer factor (Tcf/Lef) family to regulate the transcription of target genes 
(Reya and Clevers, 2005).  
Stimulation with Wnt3a (Sato et al., 2004) and the pharmacological inhibition of GSK3 
using BIO (Sato et al., 2004) or CHIRON99021 (Ying et al., 2008) were reported to maintain 
human and mouse ES cells in a pluripotent state. Furthermore, mouse ES cells responded to 
Wnt ligands (Wnt5a and Wnt6) produced by mouse feeder cells by upregulating STAT3 
expression. Such expression is a downstream effector of LIF (Niwa et al., 1998). This 
indicated that the anti-differentiation effect of Wnt is partly due to the synergistic effect of 
JAK/STAT3 and Wnt signalling (Hao et al., 2006).  
Further work was undertaken on the anti-differentiation effect of Wnt. It was seen to be 
explained by an upregulation of BMP4 expression - a result of the accumulation of active 
β-catenin in the nucleus. This accumulation had been induced by APC mutation or the 
overexpression of transgenic β-catenin. As a result, the number of ES cells committing to the 
neural lineage was reduced, as revealed by a decreased number of Sox1-expressing cells 
(Haegele et al., 2003). Conversely, inhibition of Wnt signalling by secreted Frizzled-related 
protein-2 (SFRP2) (Rattner et al., 1997) was shown to promote neural differentiation of ES 
cells (Aubert et al., 2002). Thus LIF, BMP4 and Wnts were all identified as being involved in 
regulating the pluripotency of ES cells.  
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1.2.4 Intrinsic factors: their role in determining pluripotency and lineage  
specification 
It was identified that the pluripotency of ES cells is regulated by a network of 
transcription factors. The three most-studied intrinsic regulatory factors are: 
octamer-binding protein 4 (Oct4), SRY (sex-determining region Y) HMG box 2 (Sox2) and 
Nanog (Chambers and Smith, 2004, Niwa, 2007). The expression of some regulatory factors 
was understood to be influenced by the presence of extrinsic factors (Loh and Lim, 2011). 
For instance, the expression of Sox2 and Nanog is indirectly regulated by LIF through the 
JAK/STAT3 pathway and PI3-Akt pathway respectively (Niwa et al., 2009). Oct4 is not a direct 
downstream target of LIF or STAT3 (Matsuda et al., 1999), but its expression was shown to 
be maintained by Sox2 (Masui et al., 2007). 
Customarily, it was held that each pluripotency factor inhibits ES cell differentiation by 
suppressing genes that are involved in cell differentiation (Silva and Smith, 2008). Although 
this model can explain how ES cells remain undifferentiated, it failed to account for the 
multilineage differentiating potential of ES cells (Loh and Lim, 2011). More recent findings 
showed that these intrinsic regulatory factors can also function as lineage specifiers in that 
they can direct the differentiation of pluripotent cells into specific lineages (Thomson et al., 
2011). Oct4 promoted mesodermal differentiation (Niwa et al., 2000, Thomson et al., 2011), 
while Sox2 promoted neuroectodermal differentiation (Kopp et al., 2008, Thomson et al., 
2011). Nanog directs endodermal differentiation in human ES cells by binding to and 
upregulating expression of the master gene that governs definitive endodermal 
differentiation, namely Eomesodermin (Eomes) (Teo et al., 2011). Nanog was found to block 
BMP-induced mesodermal differentiation by interacting with Smad1 (Suzuki et al., 2006). 
Since many different lineage specifiers with mutually exclusive lineages are expressed at the 
same time in ES cells, they have to inhibit each other's lineage-inducing activities in order to 
maintain pluripotency (Loh and Lim, 2011). For instance Oct4 represses neuroectodermal 
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differentiation by binding to a region of the promoter Sox2, and Sox2 represses the 
mesodermal lineage by binding to the promoter region of brachyury (Thomson et al., 2011). 
Therefore, the pluripotency of ES cells appeared to be safeguarded by maintaining 
equilibrium between the expression of pluripotency factors (Loh and Lim, 2011).  
 
1.2.5 Extrinsic factor 4: FGF signalling in regulating lineage specification 
Even when ES cells were undifferentiated, they continuously produced the 
differentiating signal fibroblast growth factor 4 (FGF4) (Kunath et al., 2007) under the 
influence of Oct4 and Sox2 (Yuan et al., 1995). This autocrine mechanism was seen to enable 
ES cells to respond to differentiating signals. FGF4-/- ES cells had a lower expression of early 
neural markers (Sox1 and nestin) and the neuronal marker β-III-tubulin than did wide-type 
ES cells (Kunath et al., 2007). Blocking FGFR using PD173074 (Mohammadi et al., 1998) 
inhibited the expression of the mesodermal marker Brachyury (Kunath et al., 2007). FGF4 
signalled via the mitogen-activated protein kinase (Erk1/2) (Stavridis et al., 2007), and similar 
results were obtained in Erk2-/- ES cells. This indicated that cells that are deficient in Erk1/2 
signalling are less effective in lineage commitment (Kunath et al., 2007). Therefore, 
inhibiting Erk1/2 signalling using 2i (SU5402 (Mohammadi et al., 1997) and PD184352 
(Davies et al., 2000)) enhanced the expression of Oct4 and Nanog. Because of this Ying et al. 
proposed that extrinsic signals are dispensable for maintaining self-renewal in ES cells (Ying 
et al., 2008). However, their model failed to take into account that ES cells are also 
continuously producing BMP4 to support their own self-renewal (Ying et al., 2003a). 
Therefore it seemed that suppressing differentiating signals in itself is not enough to 
maintain self-renewal in ES cells (Loh and Lim, 2011). 
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1.3 Generation of neural progenitors and neuronal cells from ES cells 
Section 1.2 has sought to outline what progress has been made in understanding the 
mechanisms which govern the pluripotency of ES cells. This provides an important context 
for considering advances made in developing new strategies for the generation of neural 
progenitors. There follows an account of a range of approaches which have come to play a 
part in these advances over the last two decades, later to be summarised as table 1.1.   
 
1.3.1 Differentiating ES cells as embryoid bodies  
The earliest method of initiating neural differentiation was to differentiate ES cells into 
what were known as either as floating spheres or, more commonly, embryoid bodies (EBs) 
(Doetschman et al., 1985). The central relevance of EBs to the study of the generation of 
neural progenitors lies, as their name implies, in the fact that they are capable of 
recapitulating embryonic development (ten Berge et al., 2008). Differentiating ES cells as EBs 
generated a variety of cell types (Zhuang et al., 1992). However, only a minority of cells 
showed neuron-like morphology. Later, it was discovered that the performance of EB cells in 
terms of producing neuron-characterised cells could be enhanced by treating EBs with 
retinoic acid (RA) (0.5 μM). Differentiated cells generated 38% of neuron-like cells in the 
presence of RA. They produced neuritic outgrowth, expressed β-III-tubulin and NF-M 
proteins and had voltage-gated K+, Na+ and Ca2+ channels (Bain et al., 1995). RA also 
suppressed the expression of mesodermal genes (brachyury, cardiac actin, and zeta-globin) 
(Bain et al., 1996).  
A recent study revealed that a dual mechanism is at work when RA induces neural 
differentiation in ES cell cultures. It works by first stimulating Erk activity through rapid FGF8 
induction while the expression of FGF4 is still high. At a point when cells acquire a primitive 
ectoderm-like state, RA inhibits Erk activity through the downregulation of FGF4. This was 
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confirmed by using a FGFR inhibitor (PD173074) (Mohammadi et al., 1998) which mimics the 
action of RA in promoting neural differentiation. Once ES cells have sufficient Erk signalling, 
it was noted that they cannot return to the undifferentiated ES state even when Erk 
signalling is inhibited (Stavridis et al., 2010).  
 
1.3.2 Differentiating ES cells by co-culturing with stromal cells  
Although differentiating ES cells as EBs using RA generated cells with neural character, 
it was difficult to analyse the regulatory steps involved in neural specification because EBs 
contain different kinds of cells including mesodermal and endormal cells (Maye et al., 2000). 
Additionally, RA itself is a strong teratogen (Soprano and Soprano, 1995), which might have 
unwanted side-effects when employed at non-physiological concentrations. Alternatives 
needed to be found. Other methods of differentiating ES cells in the absence of RA or serum 
were explored by co-culturing them on a monolayer of bone marrow-derived stromal cells 
(PA-6 cells). The active component of PA-6 cells is referred to as stromal cell-derived 
inducing activity (SDIA). Using this approach, neural progenitors were generated at over 90% 
efficiency, with no significant generation of mesodermal cells. A percentage of 30 ± 4% of 
TH-positive midbrain dopaminergic neurons was generated from β-III-tubulin positive 
neurons on day 12 by means of SDIA, while the percentage of neurons generated following 
the treatment of EBs with FGF8, Shh and ascorbate (33.9 ± 5.5%) was at a comparable level 
(Lee et al., 2000). Crucially, neurons induced by stromal cells were able to restore TH 
expression when transplanted into the mouse striatum treated with 6-hydroxydropamine 
(6-OHDA) for depleting dopaminergic projections (Kawasaki et al., 2000). It was also 
observed that SDIA only acts at an early stage of ES cell differentiation, because re-plating 
day 7-cultures which were Sox1-positive on laminin generated a number of TH positive 
neurons similar to that produced when cultures were plated on PA-6 cells (Parmar and Li, 
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2007). The disadvantage of this approach was that the molecular mechanisms involved in 
neurogenesis were unclear (Kawasaki et al., 2000). 
 
1.3.3 Differentiating ES cells as adherent monolayer culture  
Although differentiating ES cells as EBs had considerable value, nevertheless some 
limitations, especially in terms of heterogenicity and the reproducibility of results (Morshead 
et al., 2002) remained. These limitations, combined with the difficulties associated with 
co-culturing, as already described, underlined the desirability of an additional approach. 
Consequently, Ying and co-workers attempted to circumvent these problems by developing 
the adherent monolayer protocol (Ying et al., 2003b). In their approach, ES cells were 
differentiated on gelatin-coated plastic in the absence of serum and LIF in chemically 
defined medium (CDM) (N2B27). They generated 60% of Sox1-expressing cells, Sox1 being 
the earliest neural marker for neuroectoderm in mouse embryos (Pevny et al., 1998). The 
neurons generated were immunopositive for γ-aminobutyric acid (GABA) and TH from day 6 
to day 8 of differentiation after replating on fibronectin-coated plates. Differentiating cells 
as monolayer had the advantage of the easy visualization and manipulation of cell colonies. 
More homogenous cell colonies could also be achieved because colonies had better 
exposure to growth factors (Ying et al., 2003b). 
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1.3.4 Differentiating ES cells using chemically defined medium (CDM)  
Further steps to eliminate problems related to the consistency of results involved the 
use of chemcally defined medium (CDM). Early studies that had reported the use of RA in 
generating neurons with voltage-dependent channels were mainly performed in a 
serum-supplemented medium (Strubing et al., 1995, Fraichard et al., 1995). Although a 
serum-supplemented medium produced functional neurons, serum contains a variety of 
poorly-characterised factors that made it difficult to analyse the growth factors involved in 
the neural conversion process (Wiles and Johansson, 1999). In order to have full control over 
the generation of specific neurons it was necessary to develop protocols that could direct 
the neural differentiation of ES cells in a defined way. Differentiating ES cells in serum-free 
CDM proved to be a better alternative than serum-supplemented medium because all the 
components in CDM are defined (Bouhon et al., 2005).  
The first study on the use of CDM reported that cells differentiated as EBs showed a 
10-fold increase in the neuroectodermal marker Pax6 after 5 days and no expression of 
mesodermal marker brachury (Wiles and Johansson, 1999). Ying et al. used the first 
commercially available serum-free supplement B27 and developed a variant forumation 
(N2B27) to differentiate ES cells as adherent cultures and generated neuronal and glial cells 
(Ying et al., 2003b) (see section 1.3.3). After that, Bouhon et al. reported differentiating ES 
cells as EBs using a different formulation (DMEM/F12). This showed that cells expressed 
early neural markers (nestin, RC2 and Sox1) on day 4. Replating cells on laminin-coated 
coverslips on day 8 generated β-III-tubulin positive cells after 4 days of differentiation. Only 
a minority of cells expressed astrocyte marker (GFAP) and oligodendrocyte marker (NG2) on 
day 14. No non-neural lineage marker such as muscle marker desmin or epithelial marker 
pan-cytokeratin was detected which showed that cells were mostly directed towards the 
neural lineage (Bouhon et al., 2005).   
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Differentiation method Results Reference 
Embryoid bodies (EB) Differentiated cells generated 38 % 
of neuron-like cells in the presence 
of RA. They produced neuritic 
outgrowth, , expressed β-III-tubulin 
and NF-M proteins and had 
voltage-gated K+, Na+ and Ca2+ 
channels 
(Bain et al., 1995) 
Differentiation of EBs in 
CDM 
10-fold increase of Pax6 expression 
was observed on day 5 of 
differentation with undetectable 
Brachury expression 
(Wiles and Johansson, 
1999) 
Co-culturing ES cells with 
stromal cells 
30% of TH-positive midbrain 
dopaminergic neurons were 
generated from day 12 to day 14 
(Kawasaki et al., 2000) 
Adherent monoculture Cells generated 60% of Sox1 
positive cells on day 4 of 
differentiation, and were 
immunopositive for β-III-tubulin , 
γ-aminobutyric acid (GABA) and TH 
from day 6 to day 8 
(Ying et al., 2003b) 
Table 1.1 Strategies developed for directing neural differentiation of mouse ES cells.  
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1.4 Inhibition of BMP signalling in neural specification  
This development of CDM-based neural differentiation protocols was vital. It made 
possible the analysis of the signals involved in converting ES cells to neural progenitor cells. 
A central requirement in understanding this process has been the study of the role of BMP 
inhibition in neural induction. There follows an account of the stages involved in that study.  
 
1.4.1 Neural induction: the default model 
The investigation of what drives neural induction in vivo began in the 1920s through the 
work of Hans Spemann and his student Hilde Mangold. They discovered that when the 
dorsal lip of the bastopore (the opening formed during gastrulation by the invagination of 
cells to form the mesoderm and endoderm) was transplanted into the ventral mesoderm of 
a gastrula- stage Salamander embryo, then a second body axis is formed. This axis led to the 
generation of almost all of the central nervous system (except the floor plate) (Spemann and 
Mangold, 1924). Since the second body axis was derived from the host and not from the 
donor tissue, this led to a hypothesis that the dorsal lip of the blastopore (otherwise known 
as the ‘organizer’) is a region that releases neural inducing signals. Soon after, regions that 
have similar functions as the organizer were found in other vertebrates: Hensen's node in 
chicks (Waddington, 1933) and the node in mammals (Waddington, 1936). 
The discovery of organizer was followed by decades of research to identify the 
molecules responsible for inducing neural development. Further progress was made in the 
late 1980s. It was discovered that when the Xenopus gastrula animal cap explant was 
cultured in isolation, it gave rise to epidermis. However, if the animal cap was split up into 
into single cells, they became neural tissue (Grunz and Tacke, 1989). It was then observed 
that overexpressing a dominant negative transforming growth factor β (TGF-β) receptor 
(Activin receptor) in the animal cap generated ectopic neural tissue (Hemmati-Brivanlou and 
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Melton, 1994), indicating that a TGF-β-related signal is involved in inhibiting neural 
specification. Subsequently, this signal was identified as BMP, on the basis that even a very 
low dose of BMP4 can convert dispersed animal cap cells back into epidermis (Wilson and 
Hemmati-Brivanlou, 1995). Later, it was found that genes expressed in the organizer 
including noggin (Lamb et al., 1993, Smith and Harland, 1992, Smith et al., 1993), follistatin 
(Hemmati-Brivanlou and Melton, 1994) and chordin (Sasai et al., 1994) are BMP inhibitors 
and can convert ectoderm into neural tissue. These findings led to the development of what 
was known as the 'default model of neural induction'. This proposed that in the absence of 
BMP signalling. Uncommitted ectodermal cells acquire neural identity by default. On the 
other hand, If BMP signalling is active, ectodermal cells are prevented from forming 
neuroectoderm and instead become epidermis (Hemmati-Brivanlou and Melton, 1997).  
 
1.4.2 The use of BMP inhibitors in generating neural progenitors from ES cells  
Active BMP signalling does not only prevent neural specification in ecotodermal cells 
(see section 1.4.1). It also has the effect of maintaining self-renewal in ES cells by preventing 
neural differentiation (Ying et al., 2003a) (see section 1.2.2). Therefore, in order to initiate 
neural differentiation in ES cell cultures, BMP signalling would need to be inhibited.  
The generation of particular neural and neuronal subtypes from ES cells is influenced by 
the introduction of exogeneous factors. Historically, neural specification has been facilitated 
by using recombinant proteins. But they have disadvantages: a short shelf-life, high cost, and 
instability (Burton et al., 2010). Therefore, the potential for the use of modulators which are 
chemically based has attracted much attention. They are stable, cost-effective and 
consistent. They can therefore be used to generate large, homogenous populations of ES 
cell-derived neural progenitors for drug screening studies and cell-based therapy for 
neurodegenerative diseases (Hong and Yu, 2009).  
  Chapter 1       
 21 
 
Dorosmorphin (DM) (6- [4- (2-Piperidin-1-ylethoxy) phenyl] -3-pyridin-4-ylpyrazolo 
[1,5-a] pyrimidine), is also referred to as compound C. It acts as an inhibitor of AMP 
activated protein kinase (AMPK) (Zhou et al., 2001). It has been reported to inhibit PI3K and 
p38 MAPK phosphorylation and NFкB activity in human umbilical vein endothelial cells in an 
AMPK-independent manner (Kim et al., 2011). But, significantly, it has also been identified 
for its BMP inhibition function. It was recently found to be an inhibitor of the BMP signalling 
pathway when a phenotypic screen was used to identify compounds that disrupt the 
formation of the zebrafish dorsoventral axis. DM specifically inhibits BMP type I receptors 
and blocks BMP mediated Smad1/5/8 phosphorylation but not MAPK p38 phosphorylation. 
Noggin, conversely, blocks the activation of both pathways in cultured mouse pulmonary 
artery smooth muscle cells (Yu et al., 2008). The use of DM thus could provide a useful tool 
for studying the effect of BMP inhibition on neural induction in ES cell cultures.  
Because of the off-target effects observed in DM, it was necessary to design a more 
specific compound. LDN193189 (LDN) (4- (6- (4- (piperazin-1-yl) phenyl) pyrazolo [1,5-a] 
pyrimidin-3-yl) quinoline hydrochloride) is a more recently discovered small molecule for 
inhibiting the BMP pathway. It is produced by replacing the pendent-4-pyridine ring with 
4-quinoline (Cuny et al., 2008), and is a more effective tool than DM as it can be used more 
specifically in the precise study of BMP inhibition in ES cells (Vogt et al., 2011). 
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1.4.3 The activity of BMP inhibitors in the BMP signalling pathway 
The way in which BMPs can be controlled within the process of neural induction needs 
to be properly understood. BMPs comprise the largest group of the TGF superfamily of 
extracellular signalling molecules (Wozney and Rosen, 1998). During active BMP signalling, 
BMPs signal through type I and II receptors, each of which contains serine/threonine kinase 
at their C-termini. The binding of BMPs stabilises type I and type II receptor interaction and 
permits efficient transphophorylation of the type I receptor by the type II receptor. Active 
type I receptor kinase domain then phosphorylates cytoplasmically localised 
BMP-responsive effectors. Receptor- associated Smads (R-Smads) including Smads 1, Smad5 
and Smad8 then bind to Co-Smad (also known as Smad4). The co-Smad-R-smad protein 
complex then translocates to the nucleus and binds to DNA to regulate gene expressions 
(Chen et al., 2004, Blitz and Cho, 2009) 
The BMP antagonists, noggin and chordin, inhibit BMP signalling by binding to BMP 
ligands and prevent them from binding to their receptors (Sasai and DeRobertis, 1997). On 
the other hand, DM and LDN antagonise BMP signalling by inhibiting the function of BMP 
receptor type I. This findng is based on the evidence that the phosphorylation of Smad 1/5/8 
can be inhibited by DM in cells transfected with constitutively active forms of BMP type I 
receptors (Alk2, Alk3 and Alk6) (Yu et al., 2008). A schematic illustration of the BMP pathway 
can be found in Fig 1.2. 
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Figure 1.2 The BMP signalling pathway  
Binding of BMP ligand causes homomeric or heteromeric dimerization of BMP receptors, 
which then phosphorylates Smad 1/5/8. They bind to Smad4 (co-Smad) to form a complex, 
which then enters into the nucleus to activate transcription of target genes. This signalling 
pathway can be further modulated by BMP inhibitors (e.g. noggin and chordin) which prevent 
the BMP ligands from binding to the receptors or DM and LDN which inhibit BMP receptor I 
(Chen et al., 2004, Yu et al., 2008). 
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1.5 Regional specification in vivo 
This study is concerned with the question of the regulation of regional specification in 
ES cells. This section, therefore, offers an anatomically-related framework for the later 
discussion of how structures are developed. 
After neural induction, the ectodermal cells are committed to become neuroectoderm. 
The earliest neural tissue is believed to be anterior in character and is associated with the 
forebrain. This is based on evidence that the expression of Otx2 is observed throughout the 
epiblast (formed shortly after the mouse embryo implants into the mother) during 
pre-streak stage (E6.0) and is restricted to the anterior part of the embryo between early- 
and late-streak stages (E6.5 to E7.5) (Ang et al., 1994). The anterior character is maintained 
by signals released from four regions: the anterior visceral endoderm (AVE), the node, the 
gastrula organiser and the anterior mesendoderm (AME). The AVE expresses Lefty (a Nodal 
inhibitor) and Cerberus (a combined BMP and Wnt inhibitor) to inhibit posteriorizing signals 
(Belo et al., 1997, Meno et al., 1997). The node and the gastrula organiser (the predecessor 
of the node) release noggin and chordin (Bachiller et al., 2000, Kinder et al., 2001) to induce 
the development of anterior neural tissue. The posterior neural tissue is induced by 
posteriorizing signals such as RA which is synthesized by Raldh2 expressed in the node (Ribes 
et al., 2009) to form more posterior structures including midbrain, hindbrain and spinal cord 
(Durston et al., 1989). By E7.5, the neuroectoderm is thickened and forms the neural plate. 
The neural plate folds inward to form the neural groove, rolls up and joins dorsally to form 
the neural tube in a process of neurulation (E8.5). The AME (which is a derivative of the 
node) that lies underneath the neural tube releases chordin and noggin for the 
maintainenance of the forebrain character (Anderson et al., 2002). The overall body plan of 
an organism is illustrated in Fig 1.3. A summary of the development of the mouse nervous 
system from E6.0 to E8.5 is given in Fig. 1.4. 
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Figure 1.3 Anatomical terms used to describe locations in embryos 
Anatomical terms are used to describe how different parts of developing organisms are 
located relative to each other. The end of an embryo where the head is found is referred as 
anterior, and its opposite end is referred as posterior. Anterior can also be described as 
rostral and posterior can be described as caudal. The axis running through from the anterior 
end to the posterior end is referred as the anteroposterior (AP) axis. The axis that runs 
perpendicular to the AP axis is called the dorsoventral (DV) axis. It runs from the dorsal side 
(the back where the spinal cord develops) to the ventral side (the side towards the chest). The 
remaining axis runs from medial (towards the midline) to lateral (away from the midline) and 
is perpendicular to the AV and DV axes (Price et al., 2011). 
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Figure 1.4 Neural induction and regional specification in the mouse embryo from day 6.0 
to day 8.5 
The epiblast (grey) is formed shortly after the mouse embryo is implanted into the 
mother. It exists in a pre-anterior state from E6.0 to E6.5. The anterior visceral endoderm 
(AVE) (purple) is formed at the anterior region of the epiblast and releases signals that 
antagonise posterior signals. When gastrulation begins (E6.5), the posterior end of the 
embryo forms the primitive streak (brown) which expresses posteriorizing signals including 
Wnts, Nodal and FGFs. The early gastrular organiser (GO) (maroon) is formed at the anterior 
end of the primitive streak and is responsible for inducing anterior neural development. By 
mid-streak stage (E7.0), the anterior neural precursors (green) shift towards the anterior 
region and lie side-by-side with the AVE. The node formed at late-streak stage (E7.5) is 
responsible for releasing both anteriorising and posteriorizing signals. By E8.5, and the neural 
tube is now specified into the forebrain (FB), midbrain (MB), hindbrain (HB) and spinal cord. 
The anterior mesoendoderm (AME) is formed underneath the neural tissue for its 
maintenance. This diagram (Levine and Brivanlou, 2007) has been adapted and is not drawn 
to scale.  
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 Distinct neuronal subtypes are generated from discrete progenitor domains along the 
neural tube. The neural progenitor domains are characterized by restricted expression of 
transcription factors (Campbell, 2003). It is the unique combination of these transcription 
factors that determines the spatial organisation and specification of a neuronal subtype 
(Price et al., 2011, Allen, 2008). The expression domains of some of these transcription 
factors in the forebrain, hindbrain and spinal cord are described below. 
1.5.1 Organisation of telencephalic progenitors  
The telencephalon, the most rostral region of the forebrain, can be divided into the 
pallium (or dorsal telencephalon) and the subpallium (ventral telencephalon) (Wilson et al., 
2000). The pallium develops into cerebral cortex while the subpallium develops into basal 
ganglia which includes the striatum and the globus pallidus (Gerfen, 1992). Distinct 
populations of neurons of the basal ganglia come from ganglionic eminences of the 
subpallium including the medial ganglioinic eminence (MGE) and lateral ganglinoic eminence 
(LGE) (Sousa and Fishell, 2010).  
The expression of Foxg1 was found in the telencephalic epithelium (Xuan et al., 1995). 
The neuroepithelium of the cortex was observed to express Pax6 (Stoykova and Gruss, 1994), 
whereas that of the subpallium (especially in the LGE) expresses Gsh2 (Hsieh-Li et al., 1995, 
Toresson et al., 2000) . Nkx2.1 is specifically expressed in the MGE, but not in the LGE (Sussel 
et al., 1999). Early-born neurons derived from the pallium expressed Tbr1 (Bulfone et al., 
1995), whereas neurons derived from the subpallium express Dlx2 (Bulfone et al., 1993, 
Porteus et al., 1994, Anderson et al., 1997, Long et al., 2009). Ngn2 and Mash1 are bHLH 
transcription factors that regulate neurogenesis in the pallium and subpallium respectively 
(Nieto et al., 2001, Casarosa et al., 1999). The majority of subpallium-derived neurons are 
GABAergic (Stuhmer et al., 2002) whereas those derived from the pallium are glutamatergic 
(Hevner et al., 2001).  
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Figure 1.5 Schematic coronal section through the telencephalic vesicles at E14  
Expression domains of dorsal telencephalic progenitor (Emx1/2, Ngn1/2 and Pax6) and 
ventral telencehaplic subdomains (Mash1, Dlx1/2, Gsh1/2 and Nkx2.1) are shown. 
Morphologically defined structures in the pallium and subpallium were labelled in purple and 
blue respectively. dLGE, dorsal LGE; DP, dorsal pallium; LP, lateral pallium; MP, medial pallium; 
vLGE, ventral LGE; VP, ventral pallium. Figure has been adapted (Schuurmans and Guillemot, 
2002, Wilson and Rubenstein, 2000). 
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1.5.2 Specification of hindbrain rhombomeric progenitors 
As hindbrain structure differs from that of the forebrain, hindbrain patterning merits 
separate discussion. The vertebrate hindbrain is patterned via the generation of eight 
neuroepithelial compartments called ‘rhombomere’ (r). Distinct neuronal subtypes are 
generated from each rhombomere. The identity and patterning of rhombomere is mediated 
by the transcription factor of the Hox gene family, whose expression is under the control of 
RA (Glover et al., 2006) and will be described further in section 1.6. The Hox genes in turn 
are regulated by two transcription factors Krox20 (direct target for Hoxa2 and Hoxb2) 
(Nonchev et al., 1996) and Kreisler (direct target for Hoxa3 and Hoxb3) (Manzanares et al., 
1999). Some of the Hox genes are direct targets of RA because they contain RA response 
element (RARE) in their promoters and they include Hoxa1 (Frasch et al., 1995), Hoxb1 
(Marshall et al., 1992, Studer et al., 1998) and Hoxb4 (Gould et al., 1998) (Fig. 1.6). 
 
Figure 1.6 Expression pattern of Hox genes, Kreisler and Krox20 in the vertebrate 
hindbrain 
This diagram shows the expression patterns of genes involved in rhombomere 
specification. The figure has been adapted (Guthrie, 2007). 
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1.5.3 Specification of ventral progenitors 
The specification of neuronal subtypes in the spinal cord has been identified with the 
appearance of distinct cell types found at defined positions along the dorsoventral axis of 
the neural tube. From ventral to dorsal, there are p3, pMN, p2, p1 and p0 progenitors. The 
homeodomain proteins expressed by the progenitors can be subdivided into two groups on 
the basis of their mode of regulation by sonic hedgehog (Shh) signalling. The expression of 
class I proteins are repressed by Shh signalling whereas the expression class II proteins 
requires exposure to Shh (Jessell, 2000) (Fig. 1.7).  
 
 
Figure 1.7 Expression pattern of homeodomain transcription factors along the DV axis of 
the spinal cord 
Class I progenitor homeodomains are repressed by Shh whereas class II progenitor 
homeodomains are activated by Shh. FP, floorplate. Figure has been adapted (Wijgerde et al., 
2002). 
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1.5.4 Neurogenesis and gliogenesis 
 A further stage in neural development, following on from the establishment of the 
progenitor domains, comes when neurons are generated in a process called neurogenesis. 
Initially, new neural progenitors are generated from neuroectodermal cells through 
symmetrical division on the inner side of the neural tube closest to the lumen. In the brain, 
the proliferative zone for the neuroectodermal/neuroepithelial cells is found in the inner 
side of the neural tube and is known as the ventricular zone (VZ). During the onset of 
neurogenesis (E12), some of these neurepithelial cells downregulate certain epithelial 
features such as protein for the tight junction (occludin) (Aaku-Saraste et al., 1996) and 
generate radial glial cells through asymmetrical division. Radial glial cells are so called 
because they have cellular and molecular characteristics such as expression of 
astrocyte-specific glutamate transporter (GLAST) (Shibata et al., 1997) and brain lipid binding 
protein (BLBP) (Feng et al., 1994) that are similar to astroglia, but they also maintain 
neuroepithelial properties such as expression of nestin (Hartfuss et al., 2001). They divide 
asymmetrically to give rise to neurons and self-renewing radial glial cells. Radial glial cells are 
present throughout the whole process of neurogenesis and the remaining radial glial cells 
that are still present by the end of neurogensis are transformed into astrocytes (Noctor et al., 
2004). They also undergo molecular change such as downregulation of neurogenic factors 
such as Pax6 (Heins et al., 2002) and subsequently replace neuroepithelial cells (Gotz and 
Huttner, 2005). Besides radial glial cells, another cell type generated from neuroepithelial 
cells and radial glial cells through asymmetrical division during neurogenesis at VZ is called 
the basal progenitor cell. Basal progenitors are different from radial glial cells because they 
express Tbr2 but do not express Pax6 and GLAST (Englund et al., 2005, Malatesta et al., 
2003). These cells undergo symmetrical division to generate two daughter neurons 
(Haubensak et al., 2004). At a later stage of neurogenesis (E13 for ventral telencephalon, E15 
  Chapter 1       
 32 
 
for dorsal telencephalon), these basal progenitors are numerous enough to form a visible 
secondary proliferative layer that is basal to VZ. This layer is called the subventricular zone 
(SVZ) (Gotz and Huttner, 2005). In addition, a subpopulation of basal progenitors express 
epithermal growth factor receptors (EGFRs) that are asymmetrically distributed. This results 
in differing levels of EGFR expression in the daughter cells and the subsequent generation of 
astrocytes and oligodendrocytes (Sun et al., 2005). Thus early SVZ cells are mostly 
neurogenic whereas late SVZ cells are mostly gliogenic. The population of basal progenitors 
that are committed to be neurons exit the cell cycle and migrate towards the outside of the 
neural tube to a region called the mantle zone where they accumulate and differentiate into 
mature neurons (Gotz and Barde, 2005) (Fig. 1.8). 
 The decision whether to exit the cell cycle and undergo differentiation or to remain as 
progenitors is partly determined by negative regulator Hes genes and positive regulator 
proneural genes. Proneural genes (e.g. Ngn2 and Mash1) encode transcription factors of the 
bHLH class that initiates neurogenesis by directing the exit from the cell cycle and by 
promoting the expression of proteins that are found in post-mitotic neurons (Ma et al., 1996, 
Guillemot, 1999). Within the neural cells (i.e., those that are committed to undergoing 
neurogenesis), the proneural factor triggers the expression of those Notch ligands known as 
Delta genes (Kunisch et al., 1994). Delta molecules interact with the Notch receptors of the 
neighbouring progenitors. This leads to an activation of Notch signalling in the neighbouring 
progenitors. This in turn results in the production of Hes proteins including Hes1 and Hes5 
(Akazawa et al., 1992, Jarriault et al., 1995, Ohtsuka et al., 1999), which are transcriptional 
repressors. They inhibit neurogenesis by repressing the expression of the bHLH factors of 
the recipient cells (Ohtsuka et al., 1999), thus reducing their neural competence (Price et al., 
2011). Therefore, proneural genes serve to trigger neural commitment while Notch 
signalling maintains the population of progenitor cells. Proneural genes have also been 
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reported to direct neurogenesis by downregulating the expression of SoxB1 genes (Sox1-3), 
which are crucial for maintaining neural stem cell population (Bylund et al., 2003).  
 While SoxB1, Hes and proneural genes regulate the neural commitment of progenitor 
cells, different neuronal subtypes are generated from a common progenitor pool with 
specific temporal patterns (Mizutani and Gaiano, 2006). The temporal regulation of 
neurogenesis in the neocortex, for example, leads to the generation of six main layers of 
neurons. The neurons of each layer have distinct morphologies and functional identities 
(Mizutani and Gaiano, 2006). The preplate is generated first. The preplate is then separated 
into marginal and subplate layers by cortical neural progenitors. These are generated in the 
VZ and migrate outwards to create successive neuronal layers. Neurons destined for deep 
layers 6 and 5 are produced first, followed by those that were destined for more superficial 
layers 4, 3 and 2 (Price et al., 2011). (Fig. 1.9) Crucially, the sequential generation of neurons 
destined for different neocortical layers is programmed intrinsically (Shen et al., 2006). 
Isolated progenitor cells when grown at clonal density first generate Cajal-Retzius neurons 
(found at the marginal zone or layer 1) (Hevner et al., 2003b). These progenitor cells then 
express Foxp2 and Tle4 markers such as is found in layer 6 (Ferland et al., 2003, Yao et al., 
1998), then a marker such as is found in layer 5 (neuronal marker ERG81) (Hevner et al., 
2003a) and then eventually a marker such as found in layer 4 (neuronal marker Cux1) (Nieto 
et al., 2004). The order and timing of the generation of the neuronal subtype in vitro follows 
the order and timing of the generation of the neuronal subtype in vivo. In addition, the 
ability of late-stage progenitors to produce earlier neuronal subtypes is more restricted as 
this development progresses. Isolated progenitor cells first lose the capability to generate 
Cajal-Retzius neurons, followed by deep layer cortical neurons. This indicates that late-stage 
progenitors produce a narrower range of neuronal subtypes than early-stage progenitors. 
Although investigation has not ruled out the possibility that extrinsic factors might be 
involved, it has been observed that exposing developing clones to media conditioned by 
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high-density neocortical cultures of various ages or by co-culturing developing clones with 
neocortical progenitors which are of different ages did not significantly alter the neuronal 
composition. This indicated that the supposed extrinsic factors seemed to be overridden by 
the intrinsic factors programmed within each individual progenitor (Shen et al., 2006). 
Further discussion of these issues lies outside the scope of this study, it is nevertheless 
interesting to note that though the exact mechanism for the molecular regulation of the 
neuronal birth date is yet to be elucidated, it has been thought to be partly regulated by 
Foxg1 expression. For example, decreasing Foxg1 expression to about 50% of its normal level 
significantly enhanced the generation of Cajal-Retzius neurons from progenitors even at 
stages when such an increase would not normally be expected (Shen et al., 2006). 
 
 
Figure 1.8 Schematic coronal section through the telencephalic vesicles at E12.5 
Ventricular zone (VZ), subventricular zone (SVZ) and mantle zone in the telencephalon are 
shown. The VZ extends along the DV axis and contain proliferative radial glial cells. The SVZ 
zone contains intermediate progenitor cells that undergo symmetrical division. The mantle 
zone is the region where neural progenitor cells undergo neurogenesis. Figure adapted from 
(Toresson et al., 1999). 
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Figure 1.9 Layers in the developing cerebral cortex 
These panels show the cross-section of the cerebral cortex at different stages of 
development. During the early stages (left), progenitor cells undergo proliferation in the 
ventricular zone (VZ). At the beginning of corticogenesis (middle), postmitotic neurons 
migrate to the outer surface of the cerebral wall and become the preplate (PP). The 
intermediate zone (IZ) forms in between the PP and the VZ. At later stages (right), neurons 
generated from the VZ migrate outwards to create successive neuronal layers between the 
outer part, the marginal zone (MZ) and the lower part, the subplate (SP). The subventricular 
zone (SVZ), where most of the glial cells are generated, is formed at this stage. Figure has 
been adapted (Parnavelas, 2000).  
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1.6 Regulation of regional specification in vivo 
Successful manipulation of the cell fates of ES cell-derived NPCs, a basic requirement to 
the aims of this study, depends on an understanding of the regulation of fate specification in 
vivo.  
During vertebrate development, signals are generated in specific locations. Many of 
these signals act in a graded fashion and give positional information in such a way that the 
distance of a cell from the signal source determines the concentration of signal to which it is 
exposed, and in turn influences the fate of the responding cell. Signals that have direct 
concentration-dependent and distance-related effects are called morphogens (Wolpert, 
1996, Lawrence and Struhl, 1996). 
Several morphogens including the members of the hedgehog (Hh) and TGFβ families, 
have all been shown to play a role in specifying developing tissues (Lander, 2007). Much of 
our understanding of the effects of morphogens on regional specification in the CNS is based 
on studies of the effect of Hh signalling on the specification of progenitor domains in spinal 
cord tissue where partially overlapping patterns of transcription factors are found (Jessell, 
2000). Similar concepts can be applied to the development of other tissues. This thesis will 
focus on the patterning effects mediated by Hh and RA signalling.  
 
1.6.1 The establishment of progenitor homeodomains by graded signalling  
1.6.1.1 Effect of Shh on establishing progenitor domains In the spinal cord 
Shh is released from the floor plate and underlying notochord (Marti et al., 1995b, 
Echelard et al., 1993, Marti et al., 1995a). A gradient of Shh activity is known to exist in the 
ventral part of the spinal cord, with the highest Shh activity found at the ventral end 
(Echelard et al., 1993). The fact that the progenitor identities are governed by the Shh 
gradient is a significant finding. As mentioned in section 1.5.3, the expression of class I 
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proteins is repressed by Shh signalling (Ericson et al., 1997). The more ventral the boundary 
of progenitor domain, the higher the concentration of Shh required for the repression of 
protein expression (Ericson et al., 1997). For instance, the repression of Irx3 requires ～3 
nM of recombinant Shh, a concentration higher than that required for the repression of 
Pax7 (～2 nM) (Briscoe et al., 2000), but lower than that required for complete repression of 
Pax6 (～4 nM) (Ericson et al., 1997). The expression of class II proteins is induced by Shh 
signalling (Briscoe et al., 1999). Induction of Nkx6.1 requires ～0.25 nM of recombinant Shh 
whereas induction of Nkx2.2 requires 3-4 nM of Shh-N (Ericson et al., 1997, Briscoe et al., 
2000).  
1.6.1.2 Effect of RA on the development of hindbrain 
Much evidence suggest RA acts like a morphogen and regulates anteroposterior 
patterning in a concentration-dependent manner (White et al., 2007). The level and 
distribution of RA is determined by the availability of retinol, RA carrier proteins (CRABPs) 
which control the movement of RA from one cellular compartment to the other (Giguere et 
al., 1990, Smith et al., 1991), the local availability of RA receptors (RAR, ,  and RXR, , ) 
(Leroy et al., 1991, Kamei et al., 1993), and a combination of synthesis and degradation by 
two RA metabolic enzymes: Raldh2 which converts retinaldehyde into RA and Cyp26s which 
converts RA into inactive products (Fujii et al., 1997, Duester, 1998, White et al., 1996). Both 
metabolic enzymes have been suggested to be responsible for setting up the RA gradient 
along the AP axis (Swindell et al., 1999). A schematic illustration of the RA signalling diagram 
can be found in Fig. 1.10.  
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Figure 1.10 The RA signalling pathway 
Retinol circulates in blood and binds to cellular retinol-binding protein (CRBP) in the 
cytoplasm. It is then metabolized by retinol dehydrogenase (RoDH) to retinal, which is then 
converted to RA by retinaldehyde dehydrogenases (Raldhs). RA then enters the nucleus and 
binds to the RA receptors (RARs) and the retinoid X receptors (RXRs). RARs and RXRs 
heterodimerize and bind to DNA which contains the RA-response element (RARE) sequence 
and activates the transcription of target genes (Maden, 2002). Excess RA can then be 
metabolised into products such as 4-oxo-RA, 4-hydroxyl-RA by P450 cytochrome enzymes 
including CYP26A1, CYP26B1 and CYP26C1 to ensure appropriate RA signalling in specific 
tissues (Reijntjes et al., 2005).   
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One of the earliest experiments about the effect of RA gradient on regional specification 
conducted on Xenopus along the AP axis made it clear that RA treatment (10-5 M) inhibits 
the formation of anterior structures such as the forebrain and stimulates the formation of 
posterior structures such as the hindbrain. The higher the concentration of RA treatment, 
the more dramatic the effect of regional transformation (Durston et al., 1989). Consistent 
results were found in mouse study which confirm that RA treatment at mid-late streak stage 
downregulated expression of forebrain markers (Otx1, Otx2, Emx1, Emx2 and Dlx2) and 
induced rostral extension of the Hoxb1 domain (Simeone et al., 1995).  
More examples to demonstrate the effect of RA gradient can be found in hindbrain 
patterning. For instance, treating chick embryos with a decreasing concentration of RA 
receptor (RAR) antagonist (BMS493) (Wendling et al., 2000) resulted in the progressive 
establishment of more posterior rhombomeres (Dupe and Lumsden, 2001), and a similar 
observation was also found in Zebrafish embryos (Maves and Kimmel, 2005). Loss of 
function mutants in the RA synthetic enzyme Raldh2 in mice displayed anterior expansion as 
shown by the downregulation of the Kreisler gene in posterior rhombomeres (r5-r6) and an 
ectopic expression of Hoxb1 (normally expressed in r4) and Meis2 (normally expressed in 
r2-3) in r5-r6 (Niederreither et al., 2000). The opposite effect was found when there is loss of 
Cyp26a1 function mutants in mice: they displayed posterior transformation of r2-4, revealed 
by the ectopic expression of Hoxb1 in r2 (Abu-Abed et al., 2001, Sakai et al., 2001). 
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1.6.2 The defining of progenitor boundaries by cross-repressive interactions  
1.6.2.1 In the spinal cord 
The ventral to dorsal gradient of Shh activity establishes the progenitor domains in the 
spinal cord but the clear boundaries found between each progenitor domain require an 
additional mechanism to establish and maintain them. For example, misexpression of Nkx2.2 
in regions dorsal to the p3 domain resulted in the lack of expression of Pax6. Similarly, 
misexpression of Pax6 ventral to its normal limit resulted in the lack of expression of Nkx2.2, 
indicating that Pax6 acts by repressing the expression of Nkx2.2 in the p3 domain and 
sharpens the pMN/p3 boundary through cross-repressive interaction with Nkx2.2. Similar 
cross-repressive interaction exists between class I Dbx2 protein and class II Nkx6.1 protein, 
both proteins having complementary expression domains at the p1/p2 boundary (Briscoe et 
al., 2000) (see diagram 1.7).  
1.6.2.2. In the brain 
Similar examples of cross-repressive interactions can also be found within the 
telencephalon. There the pallio-subpallial boundary is maintained by cross-repressive 
interactions between dorsal Pax6 and ventral Gsh2 (Yun et al., 2001, Carney et al., 2009), 
and the complementary expression domains found between dorsal Ngn2 and ventral Mash1 
ensure that the correct neuronal subtypes are generated (Fode et al., 2000) (see diagram 
1.5). The interaction between Pax6 and Pax2, for example, defines the forebrain-midbrain 
boundary (Matsunaga et al., 2000), and the interaction between Otx2 and Gbx2 delineates 
the midbrain-hindbrain boundary (Simeone, 2000). 
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1.6.3 The temporal control of cell fate specification  
So far we have considered in what ways the establishing of progenitor homeodomains is 
affected by morphogen gradients and cross-repressive interactions. No discussion of 
regional specification, however, can fail to take into account the question of temporal 
control.  
 
1.6.3.1 Regulation of cell fates by changing Shh duration in the spinal cord 
Although more ventral cell types can be generated with increasing concentrations of 
recombinant Shh (see section 1.6.1), distinct neuronal subtypes cannot be generated by 
simply increasing the concentration of recombinant Shh. Exposing chick neural explants to 
0.05 nM to 0.4 nM of Shh produced a mixture of V0 to V2 neurons, indicating that 
incremental differences in Shh concentration were insufficient to generate distinct neuronal 
subtype from each progenitor homeodomain. If however chick explants were exposed to a 
fixed concentration of recombinant Shh (0.5 nM) but over lengthier time periods, distinct 
neuronal subtypes were generated progressively:  12 hours of Shh exposure generated V2 
neurons with a marked reduction in V0 neurons whereas 24 hours of Shh exposure 
generated pMN neurons with a reduction of V2 and V0 neurons. Accordingly, the expression 
of more ventral markers of the progenitor domains also can be induced by increasing the 
duration of Shh exposure from 0 hour to 24 hours. This led to the conclusion that in addition 
to the concentration of morphogens, the actual length of the duration of morphogen 
exposure was also important in specifying cell fates (Dessaud et al., 2010). Continued Shh 
signalling was necessary for maintaining the ventral identities of progenitors even after the 
progenitor identities were established. If Shh signalling was interrupted by administering 
Shh antagonist cycloplamine (Incardona et al., 1998) after all the progenitor domains were 
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established in chick embryos, some ventral markers are downregulated and cells adopted a 
more dorsal character (Dessaud et al., 2010).  
1.6.3.2 Regulation of cell fate by changing FGF8 duration at isthmic organiser 
Further experimentation has investigated cell fate regulation at the boundary between 
the midbrain and hindbrain border. This border, the isthmus, is a key organizing centre. FGF8 
is expressed in the isthmus (Crossley and Martin, 1995) and plays an important role in 
directing the development of the tectum (developed from dorsal midbrain) and cerebellum 
(developed from anterior hindbrain) (Chi et al., 2003). It was reported that the variation in 
the duration of FGF8 exposure influenced the development of the tectal-isthmo-cerebellum 
region in mouse. The formation of Isthmus requires the longest duration of FGF signalling. 
Progressively shorter durations of signalling are required for the development of more 
posterior tectal structures, and for regions from medial to lateral of the cerebellum (Sato 
and Joyner, 2009). 
 
1.6.3.3 Temporal change in RA levels by Cyp26s in hindbrain patterning 
More recent studies of Cyp26 genes have shed light on the temporal control of RA in 
hindbrain patterning. Based on the finding that RA generated by Raldh2 forms an anterior 
boundary r2/r3 (next to the r2 border of Cyp26a1 expression) at E7.5 and then at r4/5 (next 
to the r4 border of Cyp26c1 expression) at E8.5, Sirbu et al. suggested that the boundaries of 
expression of rhombomere-specific genes are determined by RA-catabolizing enzymes that 
shift over time. Furthermore, they showed that the duration of RA exposure is crucial for 
rhombomere specification because a longer period of RA activity was found in r5-r8 than in 
r3-r4 (Sirbu et al., 2005). Consistent results were found in an independent study carried out 
in zebrafish and therefore a model was proposed stating that the differential responsiveness 
to RA along the hindbrain AP axis is entirely determined by the dynamic expression of Cyp26 
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genes, and hence that rhombomeres can be specified in a 'gradient-free' manner. Their 
results placed temporal control at the centre of hindbrain patterning (Hernandez et al., 
2007). However, Maves and Kimmel argued that the expression of more posterior genes 
does not depend on the duration of RA exposure. They observed that when zebrafish 
embryos were treated with RALDH-inhibiting DEAB, a uniform concentration of RA (1 nM) 
was necessary for r5-r6 specification at a stage later than that needed for r7 specification 
(Russo et al.,1988). Therefore, they suggested that the sequential expression of more 
posterior genes required a higher level of RA than that of the anterior genes, and, deduced 
that this expression was achieved by gradually increasing the RA gradient over time (Maves 
and Kimmel, 2005). White et al. then reconciled these observations above by proposing that 
both RA and FGF act collaboratively in shaping the RA gradient. They showed that FGF 
signalling acts indirectly by inhibiting RA-mediated expression of Cyp26a1, thus explaining 
the anterior to posterior decline in the expression of Cyp26a1 when the level of RA could be 
expected to increase. These observations were further studied by computer analysis. This 
showed that RA gradients are shaped by interaction beween feedback (RA degradation 
induced by RA signalling) and feedforward (RA degradation repressed by FGF signalling). This 
integrated morphogen system enables RA gradients to be remain stable during fluctuations 
in RA synthesis and over an expanding field of cells (White et al., 2007).  
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1.6.4 The spatial control of responsiveness 
1.6.4.1 Spatial difference in RA responsiveness in the forebrain  
Within the forebrain, most sites of RA signalling (detected by examining RARE-lacZ 
reporter mice) and RA synthesis (detected by examining the expression of Raldh1, Raldh2 
and Raldh3) did not co-localise, suggesting that different regions of the forebrain can have 
different competences of RA signalling (Luo et al., 2004). Ventral telencephalon was 
reported to be more competent in retinoid signalling than dorsal telencephalon because the 
induction of RA responsive gene striatal-enriched tyrosine phosphatase (STEP) (Lombroso et 
al., 1991) in LGE and MGE explants was higher than that found in dorsal telencephalon. The 
induction was mediated by RARβ since the expression of STEP was reduced in RARβ-/- mutant 
mice. Hence it was suggested that RARβ plays a key role in regulating retinoid signalling 
competence in the developing telencephalon (Liao et al., 2005b). Furthermore, the various 
expression patterns of different isoforms of RARβ were detected at E13.5 LGE. RARβ1/3 
expression is found in the caudal and dorsolateral domains whereas expression of RARβ2 
mRNA was detected in the rostral and ventromedial domains. Interestingly, RARβ2 mRNA 
was expressed in a decreasing gradient in the developing striatum along the AP axis, but no 
such gradient was found for the other two isoforms of RARβ (RARβ1/3 and RARβ3). The 
authors suggested that the spatial arrangement of different isoforms in different domains is 
what in fact forms the basis of differential gene control regulated by RA signalling through 
RAR. (Liao et al., 2005a). It could probably also explain the expression of STEP when RARβ2 
(but not other isoforms of RARβ) was ectopically expressed in the dorsal telencephalon (Liao 
et al., 2005b). 
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1.6.5 The modulation of the signal transduction in response to morphogens  
1.6.5.1 Shh in the spinal cord 
Progress also has been made in understanding the molecular mechanisms of how cells 
respond to changes in the concentration and duration of Shh in the ventral neural tube. The 
binding of of Shh (a homolog of Hh) ligand to a transmembrane protein receptor Patch-1 
(Ptc1) results in the release of the repression of the transmembrane protein smoothened 
(Smo) (Stone et al., 1996, Taipale et al., 2002). This then transduces the Shh signal to the 
cytoplasm and subsequently regulates the expression of the glioma-associated oncogene 
homolog (Gli) family of zinc transcription factors (Gli1, Gli2 and Gli3) producing a net 
increase in their transcriptional activator function through proteolytic cleavage (Sasaki et al., 
1999) (Fig. 1.11).  
Studies of the chick neural explants revealed that Gli activity remains unchanged at a 
low concentration of recombinant Shh (1 nM) but decreases in response to a high 
concentration of Shh (≥4 nM) during the first 12 hours of exposure. This suggested that 
adjusting Gli activity allows cells to become desensitized to Shh in response to ongoing 
exposure to Shh. After 12 hours, Gli activity was sustained at high concentrations of Shh but 
was reduced rapidly at low concentrations. This adaptation mechanism appears to be 
important for the discrimination of Olig2 and Nkx6.1 expression and involves the regulation 
of Ptc1. If the expression of Ptc1 is silenced by small interfering RNA (siRNA), the expression 
of both Olig2 and Nkx6.1 was found even at a concentration that would normally only 
induce Olig2 (1 nM). This indicated that the upregulation of Ptc1 is involved in transforming 
extracellular concentrations of morphogen into time-limited periods of signal transduction. 
In the case of ventral tube patterning, this occurred through adjusting the period of Gli 
activity (Dessaud et al., 2007).  
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Figure 1.11 The Hh signalling pathway  
The cell surface receptor for Shh is a transmembrane protein receptor Patch-1 (Ptc1). In 
the absence of Hh, Ptc1 prevents the binding of another transmembrane protein 
Smoothened (Smo) from reaching the cell surface. Upon Hh binding, the Ptc1 receptor is 
downregulated, and allows Smo to move towards the cell surface. This prevents the protease 
from cleaving Gli protein, which acts as a repressor in cleaved form in the absence of Hh or 
Shh signal. The uncleaved form of Gli protein acts as an activator and enables the subsequent 
change in expression of target genes (Bai et al., 2004, Pan et al., 2006). 
 
 
  Chapter 1       
 47 
 
1.7 Cell fate specification of ES cell - derived NPCs 
This introduction has sought to indicate how temporal and spatial considerations, 
together with morphogen concentrations, can regulate regional specification in vivo. The 
strategies that manipulate the cell fates of ES cell-derived NPCs using morphogens involved 
altering one or a combination of the following parameters: the choice of morphogens, their 
concentration and the period of exposure (Irioka et al., 2005). By its very nature, a spatial 
perspective cannot be adopted in order to control cell fate: cell-cell interactions are changed 
each time when the cells are passaged. Despite this limitation to the parameters available 
for generating neural progenitors in vitro, studies have shown that neural progenitors with 
specific regional characters can nevertheless be generated. 
 
1.7.1 The influence of morphogen concentration on regional identities 
1.7.1.1 The effect of RA and Shh on the generation of pMN progenitors in the spinal cord  
Crucially, studies have demonstrated that those morphogens involved in generating 
neural progenitors with regional identities in animal studies can direct ES cells to form 
specific classes of neurons (Wichterle et al., 2002). This transferability, with its potential for 
the bio-medical application of findings to other spheres, provides a model for the 
investigation of the molecular processes involved in cell fate specification. Both RA and Shh 
are involved in spinal progenitor specification in vivo (Briscoe et al., 2000, Ericson et al., 1997, 
Pierani et al., 1999), and both signals have been shown to induce ES cells to generate spinal 
progenitor cells and subsequently differentiate into motoneurons (Wichterle et al., 2002). 
Cells exposed to the caudalising signal RA (2 μM) in isolation displayed characteristics of 
progenitor cells located in the dorsal and intermediate spinal cord as most cells expressed 
Pax7, Pax6, Irx3 and Dbx1 and few cells expressed Nkx6.1, Olig2 and Nkx2.2 (Wichterle et al., 
2002). Joint exposure of RA and a low concentration of Shh agonist, Hh-Ag1.3 (0.01 μM) 
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(Frank-Kamenetsky et al., 2002) ventralized neural progenitors. This was indicated by an 
increased number of Pax6- and Irx3- positive cells, and a reduction in the number of 
Dbx1-positive cells together with the induction of a few Nkx6.1- and Olig2-positive cells. 
Joint exposure of RA and a high concentration of Shh agonist, Hh-Ag1.3 (1 μM), resulted in 
the elimination of Dbx1 expression, the reduction of Pax6 and Irx3 expression and a marked 
increase in Nx6.1 and Olig2 expression (Wichterle et al., 2002). Both Nkx6.1 and Olig2 are 
closely linked with the generation of spinal motor neurons in vivo (Mizuguchi et al., 2001, 
Sander et al., 2000, Novitch et al., 2001). The dorsal-to-ventral shift in the expression profile 
of transcription factors in response to increasing levels of Hh signalling resembled the 
behaviours of neural tube progenitors in vivo (Briscoe et al., 2000, Ericson et al., 1997) (see 
Fig. 1.12). This indicated that signalling factors that operate along the DV axis of the neural 
tube in vivo can be made use of in vitro to direct the differentiation of ES cells into specific 
neural progenitors (Wichterle et al., 2002). 
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Figure 1.12 Specification of dorsoventral identities of ES cell- derived NPCs is 
dependent on the concentration of Shh 
ES cell-derived NPCs are ventralised by Shh in a concentration-dependent manner. Cells 
treated with caudalizing signal RA alone expressed markers that are found in the V0, V1 
domains (Pax7, Pax6, Irx3 and Dbx1); cells treated with a low concentration of Shh agonist 
expressed markers specific to the V1, V2 domains (Pax6, Irx3); cells treated with a high 
concentration of Shh agonist expressed markers specific to the MN domain (Nkx6.1 and 
Olig2).  This diagram has been adapted (Wichterle et al., 2002). 
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1.7.1.2 The use of recombinant Shh in the generation of region-specific telencephalic 
progenitors  
The way in which altering the concentration of Shh results in the generation of 
telencephalic progenitors is another example of the part played by concetration levels. In 
the absence of extrinsic Shh signal or when Hh signalling was inhibited by Hh antagonist 
cyclopamine, telencephalic progenitors (Foxg1 positive) preferentially gave rise to pallial 
progenitors and express Pax6 and Tbr1 (Danjo et al., 2011, Eiraku et al., 2008). A moderate 
dose of recombinant Shh (10 nM) strongly suppressed the expression of pallial markers and 
induced the expression of LGE marker Gsh2. A high dose of Shh (30 nM) results in the 
induction of the expression of MGE marker Nkx2.1 in neural progenitors on day 12 of 
differentiation (Danjo et al., 2011). This is further evidence that the regional specification of 
ES cells is influenced by the concentration of morphogens. 
 
1.7.1.3 The effect of changes in the concentration of RA on AP and DV patterning of NPCs 
The generation of spinal motor neurons from ES cells through systematic variation in the 
identity and concentration of patterning signals has provided a general strategy for 
generating other defined progenitors (Wichterle et al., 2002). Similarly, the anteroposterior 
identities of NPCs can be manipulated by changing the concentration of RA. In the absence 
of RA, EBs expressed genes that are specific to the forebrain but not the hindbrain or the 
spinal cord on both day 4 and day 6 of differentiation. A low concentration of RA (0.01 μM), 
on the other hand, induced the expression of midbrain-to-hindbrain markers but not the 
spinal cord markers. A high concentration of RA (1 μM) induced the expression of hindbrain 
and rostral spinal cord markers but reduced the expression of forebrain and midbrain 
markers (Okada et al., 2004, Okada et al., 2008) (Fig. 1.13). Consistent results were obtained 
in another independent study using SDIA-treated ES cells (Irioka et al., 2005), indicating that 
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the effect of changing RA concentration on regional specification is not restricted to EBs and 
can be transferable to other methods of inducing neural differentiation in ES cells. The 
concentration of RA also has an effect on the dorsoventral identities of NPCs. Both class I 
and class II genes were induced by low RA concentration (Okada et al., 2004), but only class I 
genes were induced by a high concentration of RA, indicating that high concentrations of RA 
promote dorsal specification and disrupt the ventral specification of NPCs (Okada et al., 
2004, Irioka et al., 2005).  
 
 
 
Figure 1.13 Specification of rostrocaudal identities of ES cell-derived NPCs is 
dependent on the concentration of RA 
ES cell-derived NPCs are caudalized by RA in a concentration-dependent manner. Cells 
that received no RA treatment expressed markers that are specific to the forebrain (Foxg1, 
Otx1). Cells treated with low concentrations of RA expressed midbrain to hindbrain markers 
(En2, HoxB1, HoxA2), and a reduced expression of forebrain markers. Cells treated with high 
concentrations of RA expressed spinal cord markers (HoxC4 and HoxC6), with reduced 
expression of forebrain and midbrain markers. 
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1.7.2 The temporal regulation of cell fate specifcation 
1.7.2.1 The use of recombinant Shh in the generation of subpallial progenitors  
The acquisition of cell fates in ES cell-derived NPCs is not influenced only by the 
concentration of the morphogens. The timing of morphogen treatment is equally important. 
For instance, the expression of subpallial markers Gsh2 and Dlx2 in telencephalic progenitors 
was strongly induced by Shh treatment on day 3 but not on day 7. Pallial markers Pax6 and 
Tbr1 expression was suppressed by Shh treatment between day 3 to day 4 but not on day 6.  
Furthermore, the temporal duration of Shh treatment also plays a critical role in 
specifying the identities of telencephalic progenitors. To direct telencephalic progenitors to 
a subpallial fate requires continuous Shh exposure (10 nM) until day 9. If, however, the 
period of exposure is between day 3 to day 8, telencephalic cells give rise to pallial fate. 
Interestingly, treating telencephalic progenitors with a high concentration of Shh (30 nM) 
from day 9 onwards inhibited LGE differentiation (Danjo et al., 2011). It can be observed, 
therefore, that the timing of morphogen treatment plays an important role in determining 
the identities of neural progenitors. 
 
1.7.2.2 The effect of RA exposure on AP patterning 
The period of RA exposure also has an impact of the specification of the regional 
identities of neural progenitors. Expression of caudal markers (Hoxb4 and Hoxb9) was found 
in SDIA-treated ES cells by a 1-day exposure of RA (2 μM) at any point between day 3 and 
day 8. On the other hand, the expression of forebrain markers (Foxg1 and Otx2) was strongly 
suppressed by 1-day or 2-day exposure of RA from day 3 to day 6, but the suppression was 
not found when RA was added after day 6. This indicated that different positional markers 
have different temporal windows of expression in response to RA treatment (Irioka et al., 
2005).  
  Chapter 1       
 53 
 
1.7.3 Temporal changes in responsiveness to morphogens 
The temporal control of the expression of regional markers in response to morphogens 
was further studied by Bouhon et al. They demonstrated that the ability of morphogens to 
impose regional identities is only found in early NPCs (from day 8 cultures). Late NPCs (from 
day 20 cultures) are refractory to RA and Shh signals and display constitutive expression of 
Olig2, Mash1, EGFR and vimentin, a phenotypic profile that is associated with putative 
gliogenic radial glia with lower neurogenic potential (Bouhon et al., 2006). The underlying 
mechanism for the change in responsiveness to morphogen is not clear. This indicates that 
although ES cells provide a valuable source for generating specific neuronal subtypes to be 
used for regenerative medicine and drug research, much remains to be clarified in terms of 
how time-related considerations govern their response to morphogens in acquiring specific 
regional identities, a process which can subsequently influence the generation of specific 
neuronal subtypes. 
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1.8 Aims and objectives of the study 
My interest lay in understanding the mechanisms governing the generation of neural 
progenitors from ES cells and in discovering to what extent the acquisition of positional 
identities of neural progenitors is influenced by a number of related factors: BMP inhibition, 
temporal changes in responsiveness and gene expression. 
BMP inhibition is essential for neural induction. Generating homogenous populations 
of NPCs using recombinant proteins for comparative studies or large-scale analyses has 
proved challenging: recombinant proteins, such as noggin, usually have a short shelf-life and 
there are batch-to-batch differences. Chemical alternatives have been developed in an 
attempt to find more stable and reliable inhibitors. Therefore, the first aim of this study is:  
-To examine to what extent the use of two newly discovered BMP chemical inhibitors, 
DM and its derivative LDN enhance neural induction in ES cell cultures and to discover 
whether they can be used to replace recombinant noggin (chapter 3). 
 
Much work has been carried out on the study of the caudalization of neural 
progenitors by RA at their early stages (Wichterle et al., 2002, Okada et al., 2004, Okada et 
al., 2008, Irioka et al., 2005). A later stage has also received attention (Bouhon et al., 2006). 
However, the temporal stage-specific effects of RA on regional specification of NPCs have 
not been established. Therefore this study also seeks:  
-To examine how temporal considerations influence the responsiveness of NPCs to RA 
thus determining the expression profile of different positional and neural markers in early 
and late neural cultures (chapter 4).  
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The ability of ES cell-derived NPCs to respond to morphogens in a predictable manner 
can only be found in early NPCs but not in late NPCs (Bouhon et al., 2006). The exact 
explanation for the change in responsiveness has not yet emerged. Therefore, since Sox1 
expression is associated with a naïve neural progenitor state and neural commitment, the 
final part of the study undertakes  
- To examine whether Sox1 expression is associated with the change in responsiveness 
to morphogens in late NPCs (chapter 5).  
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Figure 1.14 Diagram showing the major steps involved in neural differentiation of ES 
cells and showing the correspondence between the research chapters and 
the major steps involved in the neural differentiation of ES cells. 
 The specification of neuronal fate can be considered in three sequential steps:  
1) the neuralisation of ES cells to produce neural progenitors;  
2) the regional specification of neural progenitor cells and 
3) the generation of neurons from neural progenitors through cell cycle exit. 
    Chapter 3 investigates the effects of newly discovered BMP inhibitors LDN193189 (LDN) 
and dorsomorphin (DM) and compares the action of LDN and DM to that of recombinant 
noggin in order to assess the feasibility of using LDN and DM as substitutes for recombinant 
noggin.  
    NPCs can be specified regionally in response to morphogens. Since RA plays a major role 
in regulating regional identities in NPCs (Okada et al., 2008, Okada et al., 2004), the question 
of temporal responsiveness to RA in early and late NPCs is investigated in Chapter 4. 
    Chapter 5 investigates whether Sox1 expression is related to the responsiveness to 
patterning cues found in NPCs because Sox1 is associated with a naïve neural progenitor state 
and neural commitment. 
 
  Chapter 2   
 57 
 
 
 
 
CHAPTER 2: 
MATERIALS AND METHODS 
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2.1  In vitro methods 
2.1.1 Mouse embryonic stem cell lines 
Two mouse ES cell lines were used for most studies. The previously described Foxg1Z 
cell line was generated by replacing most of the coding sequence of Foxg1 with LacZ and a 
neomycin cassette (Xuan et al., 1995). The expression of β-galatosidase is therefore under 
the control of the Foxg1 promoter and this allows the expression of Foxg1 to be monitored 
by the expression of β-gatatosidase that can be measured using Beta-Glo assay (session 
2.1.4) and Xgal staining (session 2.1.9). Another previously described cell line was 46C. This 
was generated by replacing Sox1 with the coding sequence of GFP and also an internal 
ribosome entry site (IRES)-linked to the puromycin resistance gene (Ying et al., 2003b). This 
enables the expression of Sox1 in ES cells to be observed by fluorescence microscopy 
(session 2.1.10) and purified by fluorescence activated cell sorting (FACS) (session 2.1.5). 
Both cell lines were gifted historically to Nicholas Allen. 
 
2.1.2 General culture conditions 
2.1.2.1 ES media 
Mouse ES cells were maintained in ES cell culture medium which consisted of knockout 
Dulbecco’s modified eagle medium (D-MEM) (Gibco, Invitrogen, Paisley, Scotland, UK), 
supplemented with 15% knockout serum replacement (KSR) (Gibco), 1% 
penicillin/streptomycin (PS) (Gibco), non-essential amino acids (NEAA) (1 mM) (Gibco), 
L-glutamine (2 mM) (Gibco), β-mercaptoethanol (0.1 mM) (Sigma, Gillingham, Dorset, UK) 
and leukaemia inhibitory factor (LIF) (see section 2.1.3 for the preparation of LIF). 
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2.1.2.2 Chemically defined medium 
Chemically defined medium (CDM) was used to generate neural progenitors from ES 
cells. It consisted of advanced DMEM/F-12 (ADF) (Gibco), 1× lipid concentrate (Gibco), 1% PS, 
glutamine (2 mM), 18 μg/ml transferrin (Roche Applied Science, West Sussex, UK), 14 μg/ml 
insulin (Sigma). 
 
2.1.2.3 Splitting cells  
Culture medium was aspirated off and cells were washed with Ca2+ and Mg2+ free 
phosphate buffered saline (PBS) pH 7.2 (Gibco). They were then lifted off the plate by adding 
accutase (PAA laboratories, Farnborough, Hampshire, UK) and left at 37°C for 15 minutes. 
The enzymatic action of accutase was slowed down by adding an equal volume of PBS. Cells 
were harvested from the culture dishes by centrifugation at 1000 rpm for 3 minutes.  
 
2.1.2.4 Freezing cells 
Cells were split as described in section 2.1.2.3 and re-suspended in freezing media 
which was made up of 10% dimethyl sulfoxide (DMSO) (Sigma) in ES cell culture medium. 
Cells were aliquoted at 2 x 106 cells per ml in cryovials (Nunc) and placed into a cryochamber 
with isopropanol at -80°C. After 24 hours, cryovials of cells were removed from the 
isopropanol and stored at liquid nitrogen cell storage tank. 
 
2.1.2.5 Thawing cells 
Cells were removed from -80°C and thawed in a water-bath at 37°C for 2-3 minutes 
before being transferred to ES cell culture medium and centrifuged at 1000 rpm for 3 
minutes. The pellet was re-suspended in fresh ES cell culture medium and the cells were 
plated on gelatin-coated dishes. 
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2.1.2.6 Maintaining ES cells 
ES cells were maintained on petri-dishes (Nunc, Thermo Fisher Scientific, Loughborough, 
Leicestershire, UK) coated with 0.1% gelatin in Ultrapure water (Chemicon International, 
Walford, UK). The medium was changed daily and cultures were split every 2-3 days as 
described in section 2.1.2.3 when they reached sub-confluency. After centrifugation, the 
pellet was re-suspended in ES cell culture medium and re-plated at 1.5 x 106 cells per 10 cm 
plate. Cell counts were performed by transferring 10 μl of cell suspension to a 
haemocytometer and viewed under a microscope. The number of cells per milliliter was 
determined by the average number of cells in four different squares on the 
haemocytometer. 
 
2.1.2.7 Generating neural progenitors from ES cells 
Neural differentiation of ES cells was induced by splitting ES cells as described in 
section 2.1.2.3. After centrifugation, the resulting pellet was plated onto gelatin-coated 
petri-dish (Nunc) at 1.17 × 104 cells per cm3 in ES medium overnight. The following day, after 
2 washes of Ca2+ and Mg2+ free PBS, ES cell culture medium was replaced with chemically 
defined medium (CDM). Medium was changed every 2 days. When cells needed to be 
differentiated for 20 days, they were split on day 6, day 10, day 14 and day 18 as described 
in section 2.1.2.3. The resulting pellet was plated on poly-L-ornithine (PLO) (Sigma) coated 
plates (Nunc) at 7 x 104 cells per cm3 in CDM. Details of the growth factors and small 
molecules used for inducing neural differentiation in this study can be found in table 2.1.  
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Small molecules/growth factors Suppliers Stock solution 
All-trans-RA Sigma, UK absolute ethanol 
BMP4 Peprotech, ,USA 0.1% BSA 
Dorsomorphin (DM) Sigma, UK absolute ethanol 
FGF2 Peprotech, USA 0.1% BSA 
LDN193189 (LDN) Stemgent,, USA absolute ethanol 
Noggin Peprotech, USA 0.1% BSA 
Purmorphamine Calbiochem, UK DMSO 
Table 2.1 Suppliers and stock solutions of growth factors and small molecules  
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2.1.3 Preparation of LIF plasmid DNA for transfection 
The LIF expression vector was kindly donated by Prof Vladimir Buchman. The 
expression vector (ampicillin resistant) was transformed into TOP 10 E. coli chemically 
competent cells (Invitrogen) and left on ice for 20 minutes. It then underwent a heat shock 
at 42°C for 1 minute and was transferred to ice for a further 2 minutes before 1 ml 
cultivation medium (Invitrogen) was added. The bacterial suspension was then transferred 
to a bacteriological tube (Falcon, Becton Dickinson Labware, New Jersey, USA) and left to 
shake at 37°C for 30 minutes. Subsequently, 100 μl bacterial suspension was streaked onto a 
selective agar and left at 37°C overnight.  
An individual colony was selected using an inoculation loop, and transferred to a 
bacteriological tube containing 5 ml of Luria-Bertani (LB) media (DIFCO; Becton Dickinson) 
and ampicillin (150 μg/ml) (Sigma), and left to shake at 37°C overnight. A glycerol stock was 
made from the bacterial suspension by combining 600 μl of the bacterial suspension with 
400 μl LB media: glycerol (1:1). The remainder of the bacterial suspension was centrifuged 
and maxi prep was performed on the resulting pellet, following instructions using the Qiagen 
endofree plasmid Maxi kit (Qiagen, West Sussex, UK). A sample of the resulting DNA was run 
on a 0.8% agarose gel and visualised with Safeview. The DNA was stored at -20°C in 
Tris-EDTA (TE) at 200 ng/μl.  
For transfecting LIF plasmid DNA, COS (monkey renal epithelial) cells were used. Cells 
were maintained on T25 tissue culture treated flasks in COS culture medium which contains 
Glutamax DMEM (Gibco) supplemented with 10% fetal calf serum (FCS) (Invitrogen), 
L-glutamine (2 mM) and 1% PS. Medium was changed every 2-3 days and cells were 
passaged at 70-80% confluence. For passaging, medium was aspirated off, cells were washed 
in PBS, 0.1% trypsin-EDTA (Gibco) was added and cells were incubated at 37°C for 2-3 
minutes. Cells were harvested, resuspended in COS culture medium and centrifuged at 1000 
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rpm for 3 minutes. The pellet was resuspended in COS culture medium and replated 
according to the desired ratio for splitting, usually 1.5 x 106 cells per T25 flask. Cells were 
transfected at 70% confluence using Lipofectamine transfection reagent (Invitrogen). After 
24 hours, the transfection mix was removed and ES cell culture medium without LIF or PS 
was added and incubated at 37°C overnight. After a further 24 hours, the medium was 
collected into a 50 ml falcon tube and stored at 4°C. Another volume of ES cell culture 
medium without LIF or PS was added and incubated at 37°C overnight. After 24 hours, the 
medium was collected and combined with the medium collected 24 hours previously, the 
resulting ‘LIF-conditioned media was stored at -20°C.  
To determine the optimal concentration of LIF-conditioned medium for maintaining ES 
cell cultures. Cells were seeded at 2.5 x105 cells per cm3 and 5 x 104 cells per cm3 on 
gelatin-coated 6cm dishes (Nunc) with ES cell culture medium. LIF condition media at 
concentrations of 1:2000, 1:1000, 3:20000 and 1:500 were added into the ES cell culture 
medium. LIF prepared by Dr Sophie Precious was used as a positive control and medium with 
no LIF was used as a negative control. Medium was changed daily with replacement of the 
appropriate concentration of LIF conditioned medium. Each day, the cultures were checked 
microscopically and the concentration of LIF conditioned media that produced cells with 
comparable morphology with the positive control was chosen. 
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2.1.4 Beta-Glo assay 
This assay quantified the activity of beta-galatosidase based on the principle that 
β-galactosidase cleaves the luciferin-galactoside substrate (6-O-β-galactopyranosyl-luciferin) 
in the assay to form luciferin. This in turn reacts with luciferase which produces oxyluciferin. 
Oxyluciferin emits a luminescent signal measurable by a plate reader. Foxg1Z ES cells were 
plated on 96-well plate as 2000 cells per well on day 6, day 10, day 14 and day 18. On the 
day of analysis, cells were lysed with the addition of 30 μl of reporter lysis buffer (Promega, 
Southampton, UK) onto each well for 15 minutes at room temperature. The lysate was then 
mixed with 30 μl of Beta-Glo reagent (prepared as described by manufacturer's instructions) 
(Promega). After 30 minutes, the plate was scanned by a scanning multiwell plate reader 
(Fluro Optima, BMG labtech, Buckinghamshire, UK) at 420 nm. 46C cells were used as a 
control for negative background luminescence and the readings recorded from these cells 
were subtracted from all those from Foxg1Z cells. 
 
2.1.5 FACS analysis 
2.1.5.1 Principles of a flow cytometer 
Sox1/GFP expression of 46C cells was measured by a flow cytometer approach as this 
allowed rapid quantification of a large number of cells. When cell samples were introduced 
into a flow cytometer, they were ordered through a fluidic system, which consisted of a 
central channel containing the cell samples enclosed by an outer sheath fluid. The pressure 
of the flowing sheath fluid against the cells in the narrowing central channel created a 
velocity gradient in the flow front, forming a parabolic flow front and the greatest velocity 
was found at the centre while zero velocity was found at the wall. As a result, cells flowed in 
single file. This effect is called hydrodynamic focusing (Fig 2.1(a)). To obtain information on 
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the flowing cell samples, each single cell was analysed by lasers, which produced light at 
different frequencies. Light scattered in a forward direction is collected by a lens known as 
the forward scatter channel (FSC). This provided information about cell size as well as viable 
cells and cell debris. Light scattered perpendicular to the laser was collected by the side 
scatter channel (SSC), which provided information about granular content and cytoplasmic 
complexity of a cell (Fig. 2.1(b)). GFP was excited at 488 nm and detected by a number of 
fluorescence channels called photomultiplier. The specificity of detection was controlled by 
the use of optical filters which only permit passage of light with specific wavelengths (Carter 
and Ormerod, 2005). 
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Figure 2.1 Cell flow in a flow cytometer 
(a) Cell samples are focused hydrodynamically to produce a single stream of cell particles 
and are analysed by the 488 nm laser. Black arrows denote the direction of sheath flow.  
(b) Light scattered in a forward direction is detected by the forward scatter channel which 
provides information about cell size; light scattered perpendicular to the laser is detected 
by the side scatter channel which provides information about granularity and cytoplasmic 
complexity.  
 
2.1.5.2 Detection of fluorescence intensity  
Colonies were dissociated as described in section 2.1.2.3. The resulting pellet was 
re-suspended in 1 ml of Ca2+ and Mg2+ free PBS and all samples were stored at 4°C until 
required. To detect fluorescence intensity, cells were passed through 30 m filters (Celltrics, 
Partec, UK) into 12 mm FACS tubes (Falcon, Becton Dickinson (BD) Biosciences, Oxford, UK) 
and viewed on a BD FACS Canto flow cytometer (BD Biosciences). The BD FACS Canto is a 
dual laser bench top flow cytometer equipped with 633 nm and 488 nm lasers and BD FACS 
Diva software (v 5. 0. 3). Single colour analysis was performed on 46C cells that express GFP. 
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To control for GFP expression, undifferentiated 46C cells were used in chapter 3 and Foxg1Z 
cells were used in chapter 5. 
2.1.5.3 Cell sorting 
Cells were prepared as previously described for the flow cytometry analysis. Cells were 
analysed using a three-laser BD FACS Aria (BD Biosciences), equipped with 633 nm, 488 nm 
and 370 nm lasers and BD FACS Diva software (v 5. 0. 3) for FSC and SSC as described 
previously. Foxg1Z cells were used to set background fluorescent levels. Bimodal and 
trimodal distributions were observed in each case and the brightest subpopulation was 
denoted GFP positive. Cells that were less intensely fluorescent were denoted GFP negative. 
All data collected was analysed by FlowJo 7.6.4 software. Both populations were sorted and 
total RNA isolated using RNeasy Mini kit (Qiagen).  
 
2.1.6 Immunocytochemistry 
Immunochemistry was performed in order to detect specific protein antigens in cell 
cultures. On the day of analysis, medium was discarded, cells washed with PBS and fixed 
with 4% paraformaldehyde (PFA) at 4°C for 15 minutes followed by 3 washes with PBS. 
Information about the concentration of primary and secondary antibodies can be found in 
table 2.3.  
To prevent unspecific antibody binding, blocking solution which included 2% goat 
serum (Dako, Cambridgeshire, UK) and 3% BSA in PBS solution was added for 2 hours at 
room temperature. Cells were then incubated overnight at 4°C with primary antibody in 
blocking solution. If double staining was performed, both antibodies raised in different 
species were added at the same time. Primary antibodies were removed and after 3 washes 
in PBS, cells were incubated with secondary antibody in blocking solution for 1 hour at room 
temperature. Secondary antibodies were removed and 3 washes with PBS carried out. 
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Hoescht nuclear stain was applied for 1 hour at room temperature. After 3 washes of PBS, 
cover-slips were mounted onto glass microscope slides using PBS : glycerol (1:1) and sealed 
with clear nail varnish and stored at 4°C.  
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Fixative (4% paraformaldehyde)  
4 g PFA 
100 ml of 1X PBS 
Heat with addition of NaOH 
Titrate until pH7-8 
Table 2.2 Preparation of 4% paraformaldehyde 
 
 
Primary antibody Species Supplier Cat. No. Dilution 
Foxg1 Rabbit Abcam Ab18259 1:2000 
GFAP Rabbit Abcam Ab7260 1:2000 
HoxB4 Mouse DSHB CloneI12 1:5 
nestin Mouse DSHB Clone Rat-401 1:5 
p75 Rabbit Promega G3231 1:500 
Pax6 Mouse DSHB Clone 1-223 1:5 
β-galactosidase Mouse DSHB Clone 40-1a 1:5 
β-III-tubulin Rabbit Abcam Ab18207 1:1000 
 
 
Secondary antibody  Supplier Cat. No. Dilution 
anti-rabbit α 594 Invitrogen A11037 1:200 
anti-mouse α 594 Invitrogen A11032 1:200 
anti-mouse α 488 Invitrogen A10667 1:200 
Table 2.3 Information about antibodies used in fluorescence immunocytochemistry 
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2.1.7 Wst-1 mitochondrial activity assay 
Cell proliferation reagent WST-1 (Roche) was used to determine the relative number of 
metabolically active cells. The assay works by measuring the amount of formazan produced 
by metabolically active cells in the culture. The formazan produced is dark red in colour and 
can be measured at 450 nm. The readings obtained at 450 nm was normalised by 
absorbance at 590 nm. Cells were grown on a 24-well plate and Wst-1 reagent was added at 
1:25 dilution on day 6 of differentiation. After 3-4 hours of incubation at 37°C, 100 μl of each 
sample was transferred to a 96-well plate and scanned by a scanning multiwall 
spectrophotometer (Fluro Optima, BMG Labtech).  
 
2.1.8 Western blotting 
2.1.8.1 Protein extraction from cells in monolayer culture 
Western blotting was performed to detect phosphorylation of Smad1/5/8 and 
expression of β-actin. Confluent 6 cm dishes were washed with cold PBS and placed on ice. 
Ice-cold lysis buffer (300 μl) (RIPA buffer from Sigma) which contained phosphatase inhibitor 
(Sigma) and protease inhibitor (Roche) was added. Cells were incubated for 30 mins at 4°C 
with intermittent agitation after which they were centrifuged for 20 mins at 4 °C at 12,500 
rpm. The supernatant was transferred to a fresh tube and the pellet was discarded. Samples 
were stored as aliquots at -80 °C. 
2.1.8.2 Determination of protein concentration 
A standard was prepared using a dilution series of BSA ranging from 25 μg per ml to 2 
mg per ml, and 25 μl of each standard was triplicated, alongside 25 μl of the samples. The 
bicinchonnic acid (BCA) working reagent from the Pierce BCA Protein Assay kit (Cat No. 
23227, Thermo Scientific) was prepared as recommended by the manufacturer and 200 μl of 
working reagent was added to each sample and mixed thoroughly on a plate shaker for 30 
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seconds. The plate was incubated at 37°C for 30 minutes and cooled to room temperature. 
The absorbance was read at 590 nm using a scanning multiwall spectrophotometer (Fluro 
Optima, BMG Labtech). 
2.1.8.3 Western blot 
A polyacrylamide resolving gel (10%) was prepared and left to set with distilled water 
layered on the surface. The water was removed and replaced with a stacking gel and left to 
set with the correct comb size. Laemellis loading buffer (Sigma) was added to the protein at 
a 1:1 ratio and incubated at 95°C for 5 minutes to denature the protein samples. Samples 
were loaded alongside a full range rainbow ladder (GE Healthcare, UK) and run at 50 mA 
until the dye front reached the bottom of stacking gel followed by a current of 100 mA until 
the dye front reached the base of the resolving gel.   
The protein bands were then transferred to a membrane by electroblotting. To carry 
this out, Hybond ECL membrane (GE Healthcare) was soaked in distilled water briefly and 
then in transfer buffer (TBS) for 10 minutes. After that, the gel and the membrane were 
layered between two sponges and pieces of filter paper and soaked in transfer buffer. The 
transfer was carried out at 50mA for 1 hour at room temperature. The membrane was then 
carefully removed, rinsed in TBS-Tween (TBST) and blocked with 1% (w/v) milk (Marvel, UK) 
for 1 hour, followed by incubation with 1:1000 dilution of rabbit polyclonal Smad1/5/8 
antibody (Cell Signaling Technologies, Boston, USA) or 1:10000 dilution of rabbit monoclonal 
antibody (Cell Signaling Technologies) in 1% milk in TBST. The membrane was then washed 
three times with TBST at room temperature. This was then followed by incubation with a 
1:10000 dilution of goat anti-rabbit IgG, horseradish peroxidase-conjugated secondary 
antibody (Cell Signaling Technologies) in 1% (w/v) milk in TBST for 1 hour at room 
temperature. The membrane was then washed three times with TBST for 20 minutes each. 
Information about making polyacrylamide resolving gel and TBS can be found in table 2.4.  
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Detection was performed by placing the membrane in a developing cassette and 
coating the membrane with 0.5 ml of SuperSignal West Dura Stable peroxide buffer (Thermo 
Scientific, Massachusetts, USA) mixed as directed by manufacturer's instructions. The 
solution was poured off and Chemiluminescent film (Roche) was placed over the membrane 
and exposed for various time intervals. Band intensity was quantified by QuantiScan (Bio 
Soft, Cambridgeshire, UK).  
 
Polyacrylamide resolving gel Transfer buffer (TBS) 
Acrylamide   10% 
Tris pH 8.8   0.37 M 
SDS     0.1% 
Ammonium persulphate  0.1% 
 TEMED    0.6% 
Tris base   0.25 M 
Glycine   1.92 M 
 Methanol   20% 
Table 2.4 Preparation of polyacrylamide resolving gel and transfer buffer 
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2.1.9 X-gal staining 
5-Bromo-4-chloro-3-indolyl galactopyranoside (X-gal) staining was performed to 
visualize positive population of Foxg1/LacZ cells as β-galatosidase cleaves X-gal and yields a 
blue product. To perform the assay, cells were washed with PBS (with Ca2+ and Mg2+) (Gibco) 
and fixed with 1% formalin for 5 minutes at 4°C. Cells were then washed with PBS (with Ca2+ 
and Mg2+) and incubated with X-gal staining solution (5 μl of X-gal was used in every 1 ml of 
Ferro/Ferri-cyanide solution) at 37°C overnight in the dark. X-gal staining solution was 
removed and the cells were fixed in 4% formalin for 15 minutes after 3 PBS (with with Ca2+ 
and Mg2+) washes. Information about making X-gal and ferro/ferri-cyanide solution can be 
found in table 2.5. 
 
X-gal Ferro/Ferri-cyanide solution 
X-gal     0.5 g 
 N,N-dimethylformamide 0.5 ml 
Ferricyanide  0.825 g 
MgCl2   0.2 g 
 PBS    495 ml 
 (stored at 4°C in the dark) 
Table 2.5 Preparation of X-gal reagents 
 
2.1.10 Microscopy 
For immmunocytochemistry, cells were visualized under UV fluorescence using the 
Leitz microscope and Olympus BX61 microscopes at different wavelengths (560 nm-red; 494 
nm-green; 346 nm-blue). Images were processed using Optronics magnaFire Software and 
Adobe Photoshop. 
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2.2 Molecular methods 
2.2.1 RNA extraction  
Cells were washed with Ca2+ and Mg2+ free PBS and RNA was extracted using Qiagen 
RNeasy Mini Kit, RNase-free Dnase set and QiaShredder (all from Qiagen, West Sussex, UK). 
After RNA is extracted, the amount of RNA was measured by NanoDrop ND1000 
spectrophometer (Labtech International), which measures RNA concentration at 260 nm. 
Purity of RNA was assessed by the absorbance at 260 nm and 280 nm.  
 
2.2.2 cDNA synthesis  
For first strand synthesis, Dnase-treated RNA was incubated with random primers 
(Invitrogen) and 10 mM dNTP mix for 5 minutes at 65°C. After it had been ice-chilled, 5X first 
strand buffer, 0.1 M DTT and RNase Out Rnase Inhibitor (all from Invitrogen) were added 
and incubated for 2 minutes at 25°C. Superscript II (Invitrogen) was then added and 
incubated for 10 minutes at 25°C, followed by incubations at 42°C for 50 minutes and 70°C 
for 15 minutes. cDNA produced in this process was used for RT-PCR analysis.  
 
2.2.3 RT-PCR: Reverse Transcription-Polymerase Chain Reaction 
Reverse transcription-polymerase chain reaction (RT-PCR) was used to amplify DNA 
sequences. Each 50 μl reaction contained Go Taq DNA polymerase (Promega), 5X green flexi 
buffer (Promega), 25 mM MgCl2 solution (Promega), 10mM dNTP, oligo pairs at 10 pmol 
each and water (Qiagen). Each PCR cycle included an initial denaturation step at 94°C for 30 
seconds, an annealing step at 55°C for 30 seconds and an extension step at 72°C for 2 
minutes. PCR products were analysed by electrophoresis on a 1.8% agarose gel with 
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Safeview (NBS Biologicals, Cambridgeshire, UK) added to visualise the products. The gel was 
run at 80 V for 40 minutes in 1 mM TAE buffer which consisted of Tris base, acetic acid and 
ethylene diamine tetra acetic acid (EDTA). To normalize variations in the quantities of input 
cDNA, the amount of transcript was normalized against the level of GAPDH. Band intensity 
of the PCR products was measured by Gel Doc 2000 (Bio-Rad Laboratories, Hertfordshire, 
UK). 
 
2.2.4 Primer sequences 
Primer pairs were generated using Mouse Genome Informatics and Ensembl for 
sequence information, and Primer 3 Input for primer design. All primer sequences are listed 
in table 2.6. They are of 19-25 base pairs (bp) in length and generate transcripts of 200 to 
600 bp.  
 
primer forward sequence reverse sequence Product 
size (bp) 
CK18 agattgccagctctggattg gttctccaagttgatgttctgg 287  
Emx2 gacctcagacgattaaaagtcc gcatttgactgacagctcc 406  
En2 gactcggacagctctcaagc acactggccttttgttcacg 510  
Foxg1 gggcaacaaccactccttctccac gacccctgattttgatgtgtgaaa 396  
GAPDH accacagtccatgccatcac tccaccaccctgttgctgta 452  
HoxB3 tggaaaggaatccacagc gcagaaaaccaaccgtagg 407 
Mash1 cgtcctctccggaactgat tcctgcttccaaagtccatt 482  
Nestin agtcagagcaagtgaatgg agaaacaagatctcagcagg 600  
Ngn2 gatgccaagctcacgaagat ggagacgagagagggagacc 387 
Nkx2.1 gtcgatgagtccaaagcaca cgatgttccgcatggtgtc 320 
Oct4 cgcgttctctttggaaaggtgttc ctcgaaccacatccttctct 313 
Pax6 ctgtaccaacgataacatacc cccttcgattagaaaacc 455 
Ptc1 ctccgcacagagtatgacc agtcactgtcaaatgcatcc 598 
Table 2.6 Primer sequences used for RT-PCR analysis 
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2.3 Statistical analysis 
Statistical analyses were performed using Minitab 16 statistical software. Parametric 
data was analysed using a paired t-test, the two-sample t-test and the Tukey-Kramer test for 
post-hoc comparisons after one-factor analysis of variance (ANOVA) was performed. For 
non-parametric data, the Mann-Whitley U test was performed for paired comparisons and 
the Krustal-Wallis test was carried out.   
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CHAPTER 3: 
INVESTIGATION OF THE PHARMACOLOGICAL INHIBITION OF 
BONE MORPHOGENIC PROTEIN SIGNALLING IN EMBRYONIC 
AND NEURAL PROGENITOR CELLS
  Chapter 3   
 78 
 
3.1 Introduction 
This chapter examines whether two newly discovered BMP chemical inhibitors, 
Dorsomorphin (DM) and its derivative LDN193189 (LDN), can replace recombinant noggin in 
the neural induction of mouse ES cell cultures. Noggin inhibits the BMP signalling pathway 
by binding to the BMP ligands and preventing them from binding to their receptors (Sasai 
and DeRobertis, 1997). In vivo, noggin is released from the organiser (Lamb et al., 1993, 
Smith and Harland, 1992, Smith et al., 1993) in Xenopus or the node in mouse (Bachiller et 
al., 2000). It promotes neural specification of ectodermal cells (Hemmati-Brivanlou and 
Melton, 1994, Reversade et al., 2005), regulates the BMP levels during neural tube closure 
(Ybot-Gonzalez et al., 2007) and the development and patterning of the ventral neural tube 
(McMahon et al., 1998). 
In vitro, BMP inhibition has been demonstrated to enhance the neural induction of ES 
cells. Previous studies showed that the number of neural colonies generated from ES cell 
increased by at least 50% in the presence of noggin (Tropepe et al., 2001, Okada et al., 2008) 
or 3-4 folds from Smad4-/- ES cells (Tropepe et al., 2001). When Smad4-/- ES cells were 
encouraged to undergo neuronal differentiation by plating onto poly-L-orithine coated 
plates, they generated 13% more nestin positive cells and 16% more β-III-tubulin positive 
cells than wild-type control ES cells (Tropepe et al., 2001), and similar results were obtained 
with noggin treated-ES cells (Okada et al., 2004). Smad4-/- cells differentiated as embryoid 
bodies (EBs) gave a higher expression of tyrosine hydroxylase (TH), which is expressed in 
dopaminergic neurons (Sonntag et al., 2005) . This indicated that BMP inhibition can 
effectively enhance neural induction of ES cells.  
Since evidence has shown that BMP inhibition can enhance the generation of neural 
and neuronal cells, recombinant noggin was used in to promote differentiation of mouse ES 
cells towards the neural lineage to generate motoneurons (Wu et al., 2012) and GABAergic 
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neurons (Okada et al., 2008). However, recombinant proteins usually have a short shelf-life 
and batch-to-batch differences (Burton et al., 2010). This can affect the reproducibility of 
results. In order to reproducibly generate neural progenitor cells and also for scaling up 
cultures, replacing the expensive and unstable recombinant noggin with chemical inhibitors 
would provide a great advantage because of the potential for cost effectiveness, 
reproducibility and scalability (Burton et al., 2010).  
Dorsomorphin (DM) is the first reported chemical inhibitor that inhibits BMP signalling 
and caused severe dorsalization in zebrafish. DM specifically inhibits BMP type I receptors 
and blocks BMP mediated Smad 1/5/8 phosphorylation (Yu et al., 2008). Hence, this 
chemical compound can be used to study the effect of BMP inhibition on the neural 
induction of mouse ES cells. LDN193189 (LDN) was a more recently developed chemical 
compound for inhibiting the BMP pathway and was designed to be more stable and potent 
than DM by altering the pendent-4-pyridine ring to 4-quinoline (Cuny et al., 2008). The half 
maximal inhibitory concentration (IC50) of DM and LDN for BMP receptor type-I activin 
receptor-like kinase 2 (ALK2/BMPR1) is 148.1 nM and 40.7 nM respectively, indicating that 
the LDN is more potent than DM and has a greater specificity for BMPR1 (Hao et al., 2010).  
 The similarity in the inhibitory actions of DM, LDN and noggin found in in vivo models 
suggested that they could be used as substitutes for recombinant noggin in neural 
differentiation protocols. Hence, this chapter deals with the actions of DM and LDN on the 
neural differentiation of mouse ES cells and compared their actions with those of 
recombinant noggin. The ES cell line used in this study was 46C and is a Sox1 reporter cell 
line. The open reading frame of Sox1 of this cell line has been replaced with the coding 
sequence of green fluorescence protein (GFP) and an internal ribosome entry site 
(IRES)-linked puromycin resistance gene (Ying et al., 2003b), thus allowing easy 
measurement of Sox1 locus expression using flow cytometry and fluorescence microscopy. 
The 46C ES cell line was first used in Ying et al.'s study and they generated 60% of 
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Sox1-positive cells on day 4 of differentiation (Ying et al., 2003b). Sox1 expression represents 
the generation of neural progenitors because it is one of the earliest neural markers 
expressed when ES cells undergo neural differentiation (Ying et al., 2003b, Bouhon et al., 
2005). In mouse, Sox1 was reported to be involved in directing the acquisition of neural fate 
in the ectoderm (Pevny et al., 1998) and is important for maintaining stem cell character of 
neural progenitor cells (Bylund et al., 2003). To ensure cells had more uniform exposure to 
DM, LDN and noggin treatments, ES cells were differentiated as adherent monolayer, based 
on the adherent monolayer protocol developed by Ying and co-workers (Ying et al., 2003b). 
Modification of the adherent protocol was made by plating ES cells in ES medium with LIF 
overnight rather than plating them directly in CDM to allow for better plating efficiency. ES 
cells were differentiated in chemically defined media (CDM) described in Bouhon et al. 's 
study to minimize the influence of exogenous signals (Bouhon et al., 2005).  
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3.2 Results 
3.2.1 Phosphorylation of Smad 1/5/8 of undifferentiated ES cells treated with 
DM, LDN and noggin 
Before examining the effect of DM and LDN on the neural specification of ES cells, it 
was necessary to check whether DM and LDN acted as BMP inhibitors in undifferentiated ES 
cells and antagonised phosphorylation of Smad1/5/8. The pluripotency of undifferentiated 
mouse ES cells is maintained through active autocrine BMP signalling by the expression of 
both BMP4 and BMP receptors (Ying et al., 2003a, Bertacchi et al., 2013). The antagonism of 
Smad phosphorylation by LDN and DM could thus be tested directly. Strong Smad 1/5/8 
phosphorylation was found in untreated ES cells, confirming that BMP signalling was active 
in the undifferentiated ES cells (Lane 7 in Fig. 3.1(a) and Lane 1, Fig. 3.2(a)). To test the 
effects of DM and LDN, cells were treated with increasing doses of LDN and DM for 24 hours 
maintained in the presence of LIF. The results showed that phosphorylation of Smad1/5/8 
was reduced in LDN-treated samples and DM-treated samples in a dose-dependent manner. 
LDN was more potent than DM in antagonising BMP signalling in undifferentiated ES cells, 
because higher doses of DM were required to reduce phosphorylation to a level comparable 
with that observed in noggin treatment (Figs. 3.1 and 3.2). 
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(a) 
 
 
 (b) 
 
Figure 3.1 Western blotting of undifferentiated 46C ES cells treated with DM and 
noggin 
(a) Undifferentiated 46C ES cells were treated with DM (0.25 μM, 0.5μM, 0.75μM, 1μM) 
for 24 hours in CDM in the presence of LIF. Protein was extracted and 
phosphorylation of Smad 1/5/8 was detected by Western blotting. Ethanol (0.1 %) 
was used as a vehicle control for DM. Noggin (150 ng/ml) was used as a positive 
control for phosphorylated Smad1/5/8 inhibition. Equal loading was confirmed by 
β-actin. 
(b) Band intensity of phosporylated Smad1/5/8 was quantified by QuantiScan and was 
expressed as a value relative to β-actin expression (n=1). 
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(a) 
 
 
(b) 
 
Figure 3.2 Western blotting of undifferentiated 46C ES cells treated with LDN and 
noggin 
(a) Undifferentiated 46C ES cells were treated with LDN (0.01 μM, 0.1 μM, 0.25 μM) for 
24 hours in CDM in the presence of LIF. Protein was extracted and phosphorylation 
of Smad 1/5/8 was detected by Western blotting. Ethanol (0.1 %) was used as a 
vehicle control for LDN. Noggin (150 ng/ml) was used as a positive control for 
phosphorylated Smad1/5/8 inhibition. Equal loading was confirmed by β-actin. 
(b) Band intensity of phosporylated Smad1/5/8 was quantified by QuantiScan and was 
expressed as a value relative to β-actin expression (n=1). 
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3.2.2 Effect of cell plating density on neural differentiation 
Studies in the past have shown that ES cells undergo neural differentiation at optimal 
cell plating densities. For instance, Tropepe et al. found that if the cell plating density was 
increased from 10 cells/μl to 50 cells/μl, the percentage of nestin immolabelled cells would 
be decreased from 82% to 40% after 24 hours of plating (Tropepe et al., 2001). In another 
study, Watanabe et al. showed that the percentage of Sox1 positive cells increased from 
60% to 85% when the cell plating density was increased from 0.5 x 104 cells/ml to 5 x 104 
cells/ml, and the percentage of Sox1 positive cells decreased from 85% to 55% when the cell 
plating density was decreased from 5 x 104 cells/ml to 50 x 104 cells/ml after 2 days of 
plating (Watanabe et al., 2005). In view of this, it was necessary to find out what is a suitable 
plating density for ES cells for generating neural progenitors.  
To determine the effect of cell plating densities on the generation of neural progenitors, 
ES cells were plated from 500 cells/cm2 up to 5000 cells/cm2 and differentiated in CDM. On 
day 6 of the differentiation, cells were dissociated into single cell suspension and the 
percentage and intensity of Sox1/GFP-expressing cells were analysed by flow cytometry.  
Cells introduced in a flow cytometer were analysed for forward scatter (FSC) and side 
scatter (SCC). FSC is a measure of relative cell size while SSC is a measure of relative cellular 
granularity. Density dotplots of SSC against FSC were generated, and voltages for SSC and 
FSC were adjusted so that all the recorded cell events were shown on the density plots. A 
gate (G1) was generated to exclude cell debris (which usually has low SSC and low FSC values) 
and cell aggregates (which usually have high SSC and high FSC values) (Fig. 3.3 (a)). The 
subpopulation that was included in the G1 gate was analysed for Sox1/GFP expression. 
Single parameter histograms were generated to show the relative fluorescence intensity on 
the x-axis and cell count on the y-axis, and the voltage was adjusted so that the negative 
control sample for GFP expression (i.e. undifferentiated 46C ES cells) was set to the second 
logarithmic decade (Fig 3.3 (b)).  
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For each analysis, a histogram of undifferentiated ES cell samples was overlaid with 
histogram of the treated cell samples. Sox1/GFP expression for each treated sample was 
assessed according to fluorescence intensity and the percentage of expressing cells. If the 
treated sample displayed a unimodal distribution of fluorescence intensity, the intensity of 
Sox1/GFP expression was determined by comparing the geometric mean fluorescence 
intensity (MFI) of the treated cells with that of undifferentiated ES cells. The percentage of 
Sox1/GFP expression was considered to be 100% if the entire population of the treated 
samples shifted and had higher GFP intensity than undifferentiated samples (Fig. 3.3 (c)). If 
the treated sample displayed a bimodal distribution of fluorescence intensity, the population 
was divided into positive and negative subpopulations, and was defined by placing a 
delineator at the limit of the undifferentiated sample (between 0.5% to 1%). Cells that were 
found above this level were considered to be positive. The fluorescence intensity of 
Sox1/GFP was determined by comparing the MFI of positive subpopulation with that of 
negative subpopulation. The percentage Sox1/GFP expression was determined by the 
positive subpopulation (Fig. 3.3 (d)) (Richardson, 2011). 
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Figure 3.3 Gating strategies for flow cytometry analysis  
(a) A density dotplot of side scatter (SSC) against forward scatter (FSC) illustrating cell 
population included in gate (G1) for Sox1/GFP expression analysis. Cell debris (low SSC 
and low FSC) and cell aggregates (high SSC and high FSC) were not included in the G1 gate. 
Red pixels represent the population with the highest cell density and blue pixels 
represent the population with the lowest cell density. 
(b) A histogram showing cell count against fluorescent intensity for the negative control 
sample (undifferentiated 46C ES cells) for GFP expression. Voltages were adjusted so that 
the median fluorescence was close to the second logarithmic decade. 
  Chapter 3   
 87 
 
(c) A histogram showing the fluorescence intensity of the negative control sample (red line) 
and treated sample that displays unimodal distribution (blue line). Geometric mean (Geo. 
mean) fluorescence value, MFI ratio and percentage of GFP expression of the 
corresponding sample are shown on the table.  
(d) A histogram showing the fluorescence intensity of a negative control sample (red line) 
and a treated sample that displays bimodal distribution (blue line). Geo. mean 
fluorescence value, MFI ratio and percentage of GFP expression of the corresponding 
sample are shown in the tables. 
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The MFI values of Sox1/GFP expressing cells plated at different cell densities were 
normally-distributed and displayed equal variance, hence parametric one-way ANOVA 
statistical analysis was performed. The effect of cell plating density on MFI was significant 
overall (one-way ANOVA, F3,8 = 5.21, P = 0.028). A significant difference was found between 
the lowest and the highest cell plating densities (500 cells/cm2 and 5000 cells/cm2) when the 
Tukey-Kamer test was performed (P < 0.05). The Tukey-Kamer test is a post-hoc statistical 
test for determining individual significance between samples after performing an ANOVA 
test. Cells plated at 2500 cells/cm2 and 5000 cells/cm2 that were Sox1/GFP negative, and 
hence neither of these cell plating densities were used in subsequent differentiation 
experiments. Cells plated at 500 cells/cm2 and 1250 cells/cm2 generated 100% of Sox1/GFP 
positive cells. Although the mean MFI value was higher at 500 cells/cm2, very few colonies 
were found at this plating density, which could be a problem if cells were subjected to 
further treatments. Therefore, the second lowest cell plating density of 1250 cells/cm2 was 
used in the subsequent experiments (Fig. 3.4).  
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(a) 
 
Figure 3.4 Mean fluorescence intensity (MFI) and percentage of Sox1/GFP expression 
of 46C cells plated at different cell densities 
(a) 46C ES cells were plated at different cell plating densities (500 cells/cm2, 1250 cells/cm2, 
2500 cells/cm2, 5000 cells/cm2) and differentiated in CDM for 6 days. Cells were 
dissociated and analysed by flow cytometry. Cells were gated in G1, excluding clumped 
cells and debris. The percentage of cells included in the G1 gate is shown on the SSC/FSC 
plots. The fluorescent intensity of undifferentiated 46C ES cells (red line) and 
differentiated 46C cells (blue line) is shown on the histograms. The bimodal distribution is 
divided into +ve and -ve cell populations. Tables show the percentage of Sox1/GFP 
expressing cells, the geometric mean (geo. mean) fluorescence value and MFI ratio of 
each sample acquired. The highlighted regions (in green) indicate the samples 
represented in the SSC/FSC plots and the histograms. 
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(b) 
 
(c) 
 
(b) The graph illustrates the mean percentage of Sox1/GFP expressing cells on day 6 of 
neural differentiation for each plating cell density. Bars represent the mean ± standard 
deviation (S.D.) of three independent experiments. (Krustal-Wallis test, P = 0.273) 
(c) The graph illustrates the mean MFI ratio of Sox1/GFP expressing cells on day 6 of neural 
differentiation for each plating cell density. Bars represent the mean ± S.D. of three 
independent experiments. Significant post-hoc difference is indicated with bracket. 
(Tukey-Kramer test, *P < 0.05) 
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3.2.3 Effect of DM and LDN treatments of Sox1/GFP expression  
Next, the effect of two doses of DM and LDN on Sox1/GFP expression in cultures was 
investigated. Cells were differentiated in CDM with LDN (0.1 μM and 0.25 μM) or DM (0.25 
μM and 0.5 μM) for 6 days. DM and LDN can be dissolved in ethanol (0.1%) therefore it was 
used as the vehicle control for LDN and DM treatments. All treatments except that of BMP4 
induced over 90% of Sox1/expression (Fig. 3.6 (b)). Both LDN and DM treatments produced 
higher mean MFI values than those in CDM control cultures. Although LDN produced higher 
mean MFI values than DM, the differences between the tested doses were not significant 
when a non-parametric Mann-Whitney U test was performed (Mann-Whitley U test, P > 
0.05). A Mann-Whitney U test was performed because the data were normally-distributed 
but did not display equal variance, hence the data did not satisfy the requirements for 
performing parametric statistical analysis (Fig. 3.6 (c)).  
Because Sox1/GFP expression was too high on day 6 and the differences between the 
tested doses of LDN and DM treatments were small and insignificant, additional flow 
cytometry analysis was carried out on day 4. Similarly, all treatments induced over 90% of 
Sox1/GFP expression on day 4 as determined by the unimodal right-shift in the FACS analysis 
(Fig. 3.5 (b)). Similar to day 6, treatments with LDN produced higher MFI values than 
treatments with DM but the differences between the tested doses were not obvious. This 
might suggest that undifferentiated cells exhibit a high background of Sox1/GFP expression 
or that differentiated cells were unable to respond to BMP modulators. The second 
possibility was unlikely because differentiated cells responded to BMP4 treatment by 
reducing Sox1/GFP expression substantially from over 90% to 0% by comparing CDM 
treatment with BMP4 treatment (Fig. 3.5 (b)) 
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(a) 
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(b) 
 
(c) 
 
Figure 3.5 Flow cytometry analysis for Sox1/GFP expression of 46C cells treated with 
LDN, DM and BMP4 on day 4 
(a) 46C cells were treated with LDN (0.1 μM and 0.25 μM), DM (0.25 μM and 0.5 μM) 
and BMP4 (2 ng/ml) for 4 days. Cells were dissociated and analysed by flow 
cytometry for Sox1/GFP expression. Ethanol (0.1%) was used as a vehicle control for 
LDN and DM. Cells were gated in G1, excluding clumped cells and debris. The 
percentage of cells included in the G1 gate is shown on the SSC/FSC plots. The 
fluorescent intensity of gated control samples (undifferentiated 46C ES cells) (red line) 
and gated treated samples (blue line) is shown on the histograms. The bimodal 
distribution is divided into +ve and -ve cell populations. Tables show the percentage 
of Sox1/GFP expressing cells, the geometric mean (geo. mean) fluorescence value 
and MFI ratio of each sample acquired. The highlighted regions (in green) indicate the 
samples represented in the SSC/FSC plots and the histograms. 
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(b) The graph illustrates the mean percentage of Sox1/GFP expressing cells on day 4 of 
neural differentiation for each treatment. Bars represent the mean ± S.D. of three 
independent experiments. 
(c) The graph illustrates the mean MFI ratio of Sox1/GFP expressing cells on day 4 of 
neural differentiation for each treatment. Bars represent the mean ± S.D. of three 
independent experiments. (Mann-Whitley U test for all comparisons, P > 0.05)
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(a) 
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(b) 
 
(c) 
 
Figure 3.6 Flow cytometry analysis for Sox1/GFP expression of 46C cells treated with 
DM, LDN, noggin and BMP4 on day 6 
(a) 46C cells were treated with LDN (0.1 μM and 0.25 μM), DM (0.25 μM and 0.5 μM) 
and BMP4 (2 ng/ml) for 6 days. Cells were dissociated and measured by flow 
cytometry for Sox1/GFP expression. Ethanol (0.1%) was used as a vehicle control for 
LDN and DM. Cells were gated in G1, excluding clumped cells and debris. The 
percentage of cells included in the G1 gate is shown on the SSC/FSC plots. The 
fluorescent intensity of gated control samples (undifferentiated 46C ES cells) (red line) 
and gated treated samples (blue line) is shown on the histograms. The bimodal 
distribution is divided into +ve and -ve cell populations. Tables show the percentage 
of Sox1/GFP expressing cells, the geometric mean (geo. mean) fluorescence value 
and MFI ratio of each sample acquired. The highlighted regions (in green) indicate the 
samples represented in the SSC/FSC plots and the histograms. 
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(b) The graph illustrates the mean percentage of Sox1/GFP expressing cells on day 6 of 
neural differentiation for each treatment. (Krustal-Wallis test, P = 0.217) 
(c) The graph illustrates the mean MFI ratio of Sox1/GFP expressing cells on day 6 of 
neural differentiation for each treatment. Bars represent the mean ± S.D. of three 
independent experiments. (Krustal-Wallis test, P = 0.055) 
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3.2.4 Effect of BMP4 on Sox1/GFP expression  
CDM alone seemed to have produced a 'ceiling effect' on the percentage of Sox1/GFP 
expressing cells on day 4 and day 6, and LDN and DM treatments appeared to have little or 
no further effect on the percentage of Sox1/GFP expressing cells. Therefore, it was 
necessary to bring down the Sox1/GFP level before the effect of LDN and DM could be 
determined and compared. BMP4 has been shown to suppress neural cell fate specification 
and direct cells towards epidermal cell fate (Ying et al., 2003b, Kunath et al., 2007). BMP4 
was therefore added to reduce the Sox1/GFP expression. Because the previous experiment 
has shown that 2 ng/ml BMP4 reduced Sox1/GFP expression from 90% to 0% (Fig. 3.5 (b), Fig. 
3.6 (b)), a BMP4 dose that would yield a percentage that reduced Sox1/GFP expression but 
not did not completely abrogate Sox1/GFP expression was decided upon. To examine the 
dose response of BMP4, cells were treated with BMP4 ranging from 0 ng/ml to 2 ng/ml. As 
shown by Fig. 3.7(b), the percentage of Sox1/GFP expressing cells was reduced by BMP4 in a 
dose-dependent manner, indicating that cells were responsive to BMP4 treatment.  
BMP4 at 0.5 ng/ml was chosen for subsequent comparison of the effect of selected 
LDN and DM doses. The lowest dose of BMP4 (0.1 ng/ml) was not chosen because LDN and 
DM would probably overcome the effect of BMP4 completely; likewise, higher doses of 
BMP4 (1 ng/ml, 1.5 ng/ml and 2 ng/ml) were not chosen because the effect of LDN and DM 
antagonism might not be obvious enough to detect. The percentage of Sox1/GFP expression 
was 37.33 % at 0.5 ng/ml of BMP4 treatment (Fig 3.7 (b)), and this concentration of BMP4 
was used for the next experiment to compare the effect of BMP antagonism on treatments 
with LDN and DM. 
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 (a) 
 
Figure 3.7 Flow cytometry analysis of 46C cells treated with BMP4 
(a) 46C cells were treated with BMP4 (0.1 ng/ml, 0.5 ng/ml, 1 ng/ml, 1.5 ng/ml and 2 ng/ml) 
for 6 days. Cells were dissociated and analysed by flow cytometry for Sox1/GFP 
expression. Cells were gated in G1, excluding clumped cells and debris. The percentage of 
cells included in the G1 gate is shown on the SSC/FSC plots. The fluorescent intensity of 
gated control samples (undifferentiated 46C ES cells) (red line) and gated treated samples 
(blue line) is shown on the histograms. The bimodal distribution is divided into +ve and 
-ve cell populations. Tables show the percentage of Sox1/GFP expression, the geometric 
mean (geo. mean) fluorescence value and MFI ratio of each sample acquired. The 
highlighted regions (in green) indicate the samples represented in the SSC/FSC plots and 
the histograms.
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(b) 
 
(c) 
 
(b) The graph illustrates the mean MFI ratio of Sox1/GFP expressing cells on day 6 of neural 
differentiation for each BMP4 concentration. Bars represent the mean ± S.D. of three 
independent experiments. (Mann-Whitley U test for all comparisions, P > 0.05) 
(c) The graph illustrates the mean MFI ratio of Sox1/GFP expressing cells on day 6 of neural 
differentiation for each BMP4 concentration. Bars represent the mean ± S.D. of three 
independent experiments. (Mann-Whitley U test for all comparisons, P > 0.05) 
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3.2.5 Effects of DM and LDN on Sox1/GFP expression in the presence of BMP4 
The high percentage of Sox1/GFP expressing cells found in CDM alone in cultures 
makes it difficult to compare the effect of DM, LDN (Figs. 3.5 and 3.6). Therefore 0.5 ng/ml 
of BMP4 was added into the cultures in order to determine the ability of LDN and DM to 
induce neural differentiation.  
In analysing the MFI values on day 4, significant differences were found across all 
samples (one-way ANOVA test, F6,14 = 64.11, P < 0.0001) (Fig. 3.8 (c)). LDN (0.1 μM and 0.25 
μM) had significantly higher MFI values than vehicle control (ethanol 0.1%), DM (0.25 μM 
and 0.5 μM) and BMP4 treatments (Tukey-Kramer test, P < 0.05). The difference in MFI value 
between DM treatments and the vehicle control was not significant, suggesting that LDN 
was more effective than DM in antagonising BMP4 to induce Sox1/GFP expression. No 
significance difference was found in the percentage of Sox1/GFP expression for all 
treatments (Fig. 3.8 (b)). 
 On day 6, no significant difference was found in MFI values and the percentage of 
Sox1/GFP expression between individual samples (Mann-Whitney U test, P > 0.05) (Fig. 
3.9(b), (c)). LDN treatments induced a higher percentage and mean MFI values of Sox1/GFP 
expression on day 6 than day 4. In contrast, it appeared that the mean MFI values of DM 
treatments only started to increase on day 6 (compare Fig 3.8 (c) and Fig. 3.9 (c)). The reason 
for the slight delay before the differentiation of ES cells becomes positive for Sox1/GFP 
expression in response to treatment with DM compared to LDN is not clear. Although the 
percentage of Sox1/GFP positive cells was much lower in DM treatments than LDN 
treatments on day 4 and 6, it was still higher than vehicle control (ethanol 0.1%) which 
contains BMP4 (0.5 ng/ml) (compare Fig 3.7(b) and Fig. 3.8 (b)).  
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Combining the data collected on day 4 and day 6, it appeared that LDN and DM were 
both able to overcome BMP4-induced suppression of neural differentiation. LDN was more 
potent than DM because higher percentage and mean MFI values of GFP expression were 
found. In the absence of BMP4, DM treatments induced strong expression of Sox1/GFP, 
though not as strong as LDN treatments (compare Fig 3.6 (b), (c) and Fig. 3.9 (b), (c)), 
suggesting that the induction of Sox1/GFP in DM treatments might require other 
mechanisms in the absence of BMP4.
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(a) 
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(b) 
 
(c) 
 
Figure 3.8  Flow cytometry analysis of 46C cells treated with LDN, DM in the presence 
of    BMP4 on day 4 of neural differentiation 
(a) 46C cells were treated with LDN (0.1 μM and 0.2 5μM), DM (0.25 μM and 0.5 μM) in 
addition to BMP4 (0.5 ng/ml) for 4 days. Cells were dissociated and analysed by flow 
cytometry for Sox1/GFP expression. Ethanol (0.1%) was used as a vehicle control for 
LDN and DM. Cells were gated in G1, excluding clumped cells and debris. The 
percentage of cells included in the G1 gate is shown on the SSC/FSC plots. The 
fluorescent intensity of gated control samples (undifferentiated 46C ES cells) (red 
line) and gated treated samples (blue line) is shown on the histograms. The bimodal 
distribution is divided into +ve and -ve cell populations. Tables show the percentage 
of Sox1/GFP expression, the geometric mean (geo. mean) fluorescence value and 
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MFI ratio of each sample acquired. The highlighted regions (in green) indicate the 
samples represented in the SSC/FSC plots and the histograms. 
(b) The graph illustrates the mean percentage of Sox1/GFP expressing cells on day 4 of 
neural differentiation for each treatment. Bars represent the mean ± S.D. of three 
independent experiments. (Mann-Whitley U test for all comparisons, P > 0.05) 
(c) The graph illustrates the mean MFI ratio of Sox1/GFP expressing cells on day 4 of 
neural differentiation for each treatment. Bars represent the mean ± S.D. of three 
independent experiments. Significant post-hoc differences are indicated with 
brackets. (Tukey-Kramer test, *P < 0.05) 
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(a) 
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(b)  
 
(c) 
 
Figure 3.9 Flow cytometry analysis of 46C cells treated with LDN, DM in the presence 
of BMP4 on day 6 of neural differentiation 
(a) 46C cells were treated with LDN (0.1 μM and 0.25 μM), DM (0.25 μM and 0.5 μM) in 
addition to BMP4 (0.5 ng/ml) for 6 days. Cells were dissociated and analysed by flow 
cytometry for Sox1/GFP expression. Ethanol (0.1%) was used as a vehicle control for LDN 
and DM. Cells were gated in G1, excluding clumped cells and debris. The percentage of 
cells included in the G1 gate is shown on the SSC/FSC plots. The fluorescent intensity of 
gated control samples (undifferentiated 46C ES cells) (red line) and gated treated samples 
(blue line) is shown on the histograms. The bimodal distribution is divided into +ve and 
-ve cell populations. Tables show the percentage of Sox1/GFP expression, the geometric 
mean (geo. mean) fluorescence value and MFI ratio of each sample acquired. The 
highlighted regions (in green) indicate the samples represented in the SSC/FSC plots and 
the histograms. 
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(b) The graph illustrates the mean percentage of Sox1/GFP expressing cells on day 6 of 
neural differentiation for each treatment. Bars represent the mean ± S.D. of three 
independent experiments. (Mann-Whitley U test for all comparisons, P > 0.05) 
(c) The graph illustrates the mean MFI ratio of Sox1/GFP expressing cells on day 6 of neural 
differentiation for each treatment. Bars represent the mean ± S.D. of three independent 
experiments. (Mann-Whitley U test for all comparisons, P > 0.05) 
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3.2.6 Comparing the effect of LDN and DM with noggin on Sox1/GFP 
expression 
The effect of two doses of LDN and DM on Sox1/GFP expression was examined in the 
previous section. This section looked at whether the effect of LDN and DM was comparable 
to recombinant noggin. Cells were treated with LDN (0.25 μM), DM (0.5 μM) and noggin 
(150 ng/ml). Significant differences were found in the percentage of Sox1/GFP expressing 
cells across all samples on day 4 (one-way ANOVA test, F6,14 = 74.91, P < 0.0001). Both LDN 
and DM treatments induced a significantly higher expression of Sox1/GFP than the vehicle 
control (Tukey-Kamer test, P < 0.05). The difference in the percentage of Sox1/GFP 
expression of LDN and DM was not significant when compared to noggin treatment (Fig. 
3.10 (b)). Although DM treatment produced lower mean MFI value, it induced Sox1/GFP 
expression in 100% of cells, an effect that was also found in LDN and noggin treatments (Fig. 
3.10 (b)). Interestingly, both LDN and DM had a lower percentage of Sox1/GFP expressing 
cells on day 6 than day 4. Whether the decrease was due to the way cells were gated or 
whether cells had undergone phenotypic changes will require further studies to confirm. DM 
treatment induced much higher mean MFI value on day 6 than day 4 (Fig. 3.11 (c)). A similar 
observation was also found in the flow cytometry analyses shown in Figs. 3.8 and 3.9. 
 Cells displayed different levels of responsiveness to recombinant BMP4. In the 
previous experiment, 0.5 ng/ml of BMP4 reduced the percentage of Sox1/GFP-expressing 
cells to 0% whereas in this experiment, 0.5 ng/ml of BMP4 only reduced this percentage to 
40-60% of Sox1/GFP -expressing cells on day 4 and 6 (compare Figs. 3.8 and 3.10 or Figs 3.9 
and 3.11). This difference could be due to batch-to-batch differences in recombinant BMP4 
or to different response mechanisms found in different batches of 46C cells.  
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(a) 
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 (b) 
 
(c) 
 
Figure 3.10 Flow cyotmetric analysis of 46C cells treated with LDN, DM and noggin  
   in the presence of BMP4 on day 4 of neural differentiation 
(a) 46C cells were treated with LDN (0.25 μM), DM (0.5 μM) and noggin (150 ng/ml) in 
addition to BMP4 (0.5 ng/ml) for 4 days. Cells were dissociated and analysed by flow 
cytometry for Sox1/GFP expression. Ethanol (0.1%) was used as a vehicle control for 
LDN and DM. Cells were gated in G1, excluding clumped cells and debris. The 
percentage of cells included in the G1 gate is shown on the SSC/FSC plots. The 
fluorescent intensity of gated control samples (undifferentiated 46C ES cells) (red 
line) and gated treated samples (blue line) is shown on the histograms. The bimodal 
distribution is divided into +ve and -ve cell populations. Tables contain the 
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percentage of Sox1/GFP expression, the geometric mean (geo. mean) fluorescence 
value and MFI ratio of each sample acquired. The highlighted regions (in green) 
indicate the samples represented in the SSC/FSC plots and the histograms. 
(b) The graph illustrates the mean percentage of Sox1/GFP expression on day 4 of 
neural differentiation for each treatment. Bars represent the mean ± S.D. of three 
independent experiments. (Tukey-Kramer test, *P < 0.05) 
(c) The graph illustrates the mean MFI ratio of Sox1/GFP expression on day 4 of neural 
differentiation for each treatment. Bars represent the mean ± S.D. of three 
independent experiments. Significant post-hoc differences are indicated with 
brackets. (Mann-Whitley U test for all comparisons, P > 0.05) 
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(a) 
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 (b) 
 
(c) 
 
Figure 3.11 Flow cytometry analysis of 46C cells treated with LDN, DM and noggin  
   in the presence of BMP4 on day 6 of neural differentiation 
(a) 46C cells were treated with LDN (0.25 μM), DM (0.5 μM) and noggin (150 ng/ml) in 
addition to BMP4 (0.5 ng/ml) for 6 days. Cells were dissociated and analysed by flow 
cytometry for Sox1/GFP expression. Ethanol (0.1%) was used as a vehicle control for 
LDN and DM. Cells were gated in G1, excluding clumped cells and debris. The 
percentage of cells included in the G1 gate is shown on the SSC/FSC plots. The 
fluorescent intensity of gated control samples (undifferentiated 46C ES cells) (red line) 
and gated treated samples (blue line) is shown on the histograms. The bimodal 
distribution is divided into +ve and -ve cell populations. Tables contain the 
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percentage of Sox1/GFP expression, the geometric mean (geo. mean) fluorescence 
value and MFI ratio of each sample acquired. The highlighted regions (in green) 
indicate the samples represented in the SSC/FSC plots and the histograms. 
(b) The graph illustrates the mean percentage of Sox1/GFP expression on day 6 of neural 
differentiation for each treatment. Bars represent the mean ± S.D. of three 
independent experiments. (Mann-Whitley U test for all comparisons, P > 0.05) 
(c) The graph illustrates the mean MFI ratio of Sox1/GFP expression on day 4 of neural 
differentiation for each treatment. Bars represent the mean ± S.D. of three 
independent experiments. (Mann-Whitley U test for all comparisons, P > 0.05) 
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3.2.7 Effect of LDN and DM on cell lineage marker expression 
Besides examining the expression of Sox1, it was necessary to examine the expression 
of other neural and non-neural lineage markers after treatment with LDN, DM and noggin in 
order to determine the extent they can be used as substitutes for noggin. Cells were 
subjected to immunocytochemistry analysis for neural and neural crest expression. 
Background staining was detected by treating the samples following the 
immunocytochemistry protocol described in section 2.1.8, omitting primary antibodies and 
incubating cells with appropriate secondary antibodies. Immunostaining for control samples 
in Fig. 3.12 which shows that the background staining was almost undetectable. 
  
Figure 3.12 Fluorescent immunocytochemistry analysis of control samples  
 Background staining from the secondary antibodies used for the immunocytochemistry 
analysis was detected by treating samples without adding primary antibody. The primary 
antibodies used in this study were either raised in mouse or rabbit. Cells were fixed and also 
stained with Hoechst nuclear stain to identify cell nuclei (blue). Scale bars = 100 μm. 
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Nestin is a marker of neural precursor cells in embryonic CNS tissue as it is expressed 
from E7.5 within the neuroepithelium of the neural plate (Lendahl et al., 1990). On day 6 of 
neural differentiation, LDN appeared to induce a marginally higher percentage of nestin 
expression than all other treatments (Fig 3.13).  
All treatments appeared to have a similar percentage (between 75% to 90%) of Pax6 
expression. In vivo, Pax6 expression is found in the ventricular zone of the pallium in mouse 
embryos (Hill et al., 1991) and is important for establishing and maintaining neural 
progenitor cell population (Gotz et al., 1998, Quinn et al., 2007). Interestingly, the vehicle 
control induced strong expression of Pax6 (Fig 3.14). 
Examination of the expression of low-affinity neurotrophin receptor p75, a marker for 
self-renewing neural crest cells (Stemple and Anderson, 1992), shows that it was strongly 
induced by noggin but not by DM and LDN, suggesting noggin might have an effect on neural 
crest expression. Neural crest cells are a transient migratory population originating from 
cells in the dorsal neural folds at the border of the neural plate and epidermal ectoderm and 
giving rise to neurons and glia of the peripheral nervous system, as well as 
pigment-producing melanocytes of the skin (Knecht and Bronner-Fraser, 2002, Nieto, 2001) 
(Fig 3.15). 
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(a) 
 
 (b) 
 
Figure 3.13 Immunocytochemistry analysis of nestin expression 
(a) Nestin expression was analysed by fluorescent immunocytochemistry. 46C cells were 
treated with LDN (0.25 μM), DM (0.5 μM) and noggin (150 ng/ml) for 6 days. Cells were 
fixed and double-labelled for nestin (red) and Hoechst nuclear stain (blue). Scale bars = 
100 μm. 
(b) Nestin immuno-positive cells on day 6 were counted and were represented as percentage 
of total Hoechst cells. Bars represent the mean of the numbers obtained by counting two 
random fields of one coverslip from one experiment.  
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(a)  
 
 (b)  
 
Figure 3.14 Immunocytochemistry analysis of Pax6 expression 
(a) Pax6 expression was analysed by fluorescent immunocytochemistry. 46C cells were 
treated with LDN (0.25 μM), DM (0.5 μM) and noggin (150 ng/ml) for 6 days. Cells were 
fixed and double-labelled for Pax6 (red) and Hoechst nuclear stain (blue). Scale bars = 100 
μm. 
(b) Pax6 immuno-positive cells on day 6 were counted and were represented as percentage 
of total Hoechst cells. Bars represent the mean of the numbers obtained by counting two 
random fields of one coverslip from one experiment.  
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(a)  
 
(b)  
 
Figure 3.15 Immunocytochemistry analysis of p75 expression 
(a) p75 expression was analysed using fluorescent immunocytochemistry. 46C cells were 
treated with LDN (0.25 μM), DM (0.5 μM) and noggin (150 ng/ml) for 6 days. Cells were 
fixed and double-labelled for p75 (red) and Hoechst nuclear stain (blue). Scale bars = 100 
μm. 
(b) p75 immuno-positive cells on day 6 were counted and were represented as percentage 
of total Hoechst cells. Bars represent the mean of the numbers obtained by counting two 
random fields of one coverslip from one experiment.  
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To further examine the lineage commitment of the ES cell-derived neural progenitors, 
the expression of genes restricted to neural and non-neural lineages was analysed by RT-PCR. 
It has been shown that Oct4 is essential for the maintenance of pluripotency and is 
expressed in early pluripotent cells (Niwa et al., 2000) and downregulated upon LIF 
withdrawal (Faherty et al., 2005). Most cells treated with BMP modulators were committed 
to other lineages by day 6 of differentiation as strong expression of Oct4 was only found in 
the undifferentiated ES cells and was lost following differentiation after LIF withdrawal and 
treatment with either DM, LDN and noggin(Fig. 3.16).  
The difference in nestin expression between LDN or DM treatments and the vehicle 
control (ethanol 0.1%) is small but it appeared that noggin, LDN (0.25 μM) and DM (0.5 μM) 
-treated cells induced higher Pax6 and nestin expression than CDM control (Fig. 3.16). 
The expression of Sox9 was relatively low compared to the expression of Pax6 and 
nestin. Sox9 is expressed in the dorsal tip of the neural fold and is responsible for specifying 
neural crest character (Stuhlmiller and Garcia-Castro, 2012, Zhao et al., 1997). The 
expression of CK18 was also relatively weak across all samples. CK18 is an intermediate 
filament protein that is expressed in the epithelia (Baribault et al., 1993), indicating that 
most cells were not directed to the epithelial lineage even in the absence of BMP inhibitors 
(Fig. 3.16). 
The results obtained from RT-PCR and immunocytochemistry analysis showed that the 
expression of neural markers (Pax6 and nestin) were relatively strong in LDN, DM and noggin 
treatments, while the expression of neural crest and epithelial markers (p75, Sox and CK18) 
were relatively weak compared to the expression of neural markers (Pax6 and nestin) for all 
treatments: this indicated that most cells when differentiated up to day 6, in the presence or 
absence of LDN or DM, gave rise to cells that have the characteristics of neural progenitor 
cells. 
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(a) 
 
 (b) 
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Figure 3.16 RT-PCR analysis of LDN, DM and noggin treated 46C cells on day 6 of neural 
differentiation 
(a) Gene expression of Oct4, Pax6, nestin, Sox9 and CK18 was determined by RT-PCR analysis 
on day 6 of neural differentiation. 46C cells were treated with LDN (0.01 μM, 0.1 μM, 
0.25 μM), DM (0.25 μM, 0.5 μM). No BMP4 was added in any treatment. Noggin (150 
ng/ml) was used as a positive control. Ethanol (0.1%) was used as a vehicle control for 
LDN and DM. 
(b) Band intensity of the PCR products of Oct4, Pax6, nestin, Sox9 and CK18 was quantified 
by Gel Doc 2000 and was expressed as arbitrary values relative to those obtained for 
GAPDH. 
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3.2.8 Phosphorylation of Smad 1/5/8 of neural progenitor cells treated with 
DM, LDN and noggin 
Results obtained from flow cytometry analysis showed that expression of Sox1/GFP 
was induced by LDN and DM in the presence of BMP4 (0.5 ng/ml) (Figs. 3.6 - 3.9). To confirm 
that this effect was by BMP antagonism, Western blotting for Smad 1/5/8 phosphorylation 
was performed at the same time-point (i.e. day 6). The presence of BMP4 induced strong 
phosphorylation of Smad 1/5 /8 (lane 10, Fig. 3.17 (a), (b)), and this was inhibited by noggin 
treatment to a level that was similar to that of cultures differentiated in CDM alone (lane 1 
and lane 9, Fig. 3.17 (a), (b)). LDN and DM reduced Smad 1/5/8 phosphorylation in a 
dose-dependent manner (land 3-5 and lane 6-8, Fig. 3.17 (a), (b)). These observations 
indicate that that LDN and DM antagonise the BMP4 signal through reducing Smad1/5/8 
phosphorylation.  
Both LDN (0.1 μM) and DM (0.5 μM) treatments showed very similar levels of pSmad 
1/5/8 inhibition (lane 4 and 7, Fig. 3.17 (a), (b). However the treatment with LDN (0.1 μM) 
induced much stronger expression of Sox1/GFP than DM (0.5 μM) treatment (Figs 3.6 and 
3.7), suggesting that the level of pSmad 1/5/8 inhibition alone did not determine the level of 
Sox1/GFP expression. 
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(a) 
 
 (b) 
 
Figure 3.17 Western blotting of 46C cells treated with LDN, DM, noggin and BMP4 on 
day 6 of neural differentiation 
(a) 46C cells were differentiated with LDN (0.01 μM, 0.1 μM, 0.25 μM) and DM (0.25 μM, 0.5 
μM, 0.75 μM) for 6 days. Protein was extracted and phosphorylation of Smad 1/5/8 was 
detected by Western blotting. Ethanol (0.1 %) was used as a vehicle control for LDN and 
DM. Noggin (150 ng/ml) was used as a positive control for phosphorylated Smad 1/5/8 
inhibition. All samples contained BMP4 (0.5 ng/ml) except CDM. Equal loading was 
confirmed by β-actin.  
(b) Band intensity of phosporylated Smad1/5/8 was quantified by QuantiScan and was 
expressed as a value relative to β-actin expression (n=1). 
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3.2.9 Effect of DM, LDN and noggin on the metabolic activity  
Although DM and LDN enhanced the expression of Sox1/GFP and Pax6 and nestin (Fig. 
3.7-3.14), fewer colonies were found at higher doses of LDN and DM when observed under 
the microscope. Therefore, this raised the question as to whether the treatments with LDN, 
DM or noggin also had effects on cell vitality. To do this, Wst-1 mitochondrial activity assay 
was performed to study potential differences in the metabolic rate of cells cultured with 
increasing concentrations of DM (0.25 μM to 0.75 μM) and LDN (0.01 μM to 0.25 μM). The 
assay works by measuring the amount of formazan produced by cellular enzymes which 
cleave tetrazolium salts in Wst-1 reagent. The amount of formazan produced is directly 
related to the overall activity of mitochondrial dehydrogenases, which in turn correlates to 
the number of metabolically active cells in the culture. 
The absorbance measurements for all treatments measured on day 4 were similar and 
no significant differences were found (Krustal-Wallis test, P = 0.384). On day 6, significant 
differences were found across all samples (one-way ANOVA test, F8,18 = 66.52, P < 0.001). The 
metabolic activity was reduced in a dose-dependent manner for DM and LDN treatments, 
showing that increasing doses of LDN and DM decreased the metabolic activity of the 
cultures. Significant differences were found between the highest dose and lowest dose of 
LDN (0.01 μM and 0.25 μM) and DM (0.25 μM and 0.75 μM) (Tukey-Kramer test, P < 0.05). 
This suggested that the metabolic rate and, consequently, the health of the cultures were 
adversely affected by LDN and DM at higher doses but not at the lower doses. Therefore, the 
selection of a dose of these compounds for use in differentiation experiments will reflect a 
compromise between the effectiveness of blockade of BMP signalling and the maintenance 
of healthy cell cultures (Fig. 3.18).  
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(a)  
 
(b) 
 
Figure 3.18  Wst-1 mitochondrial activity assay for DM, LDN and noggin treated 
samples on day 4 and day 6 of neural differentiation 
 46C cells were treated with LDN (0.01 μM, 0.1 μM, 0.25 μM), DM (0.25 μM, 0.5 μM, 
 0.75 μM) and noggin (150 ng/ml). Ethanol (0.1 %) was used as a vehicle control for LDN 
 and  DM. Cells were differentiated on 96-well plates. The plates were measured at 
 450 nm normalised absorbance measurements at 590 nm after 2 hours of incubation at 
 37°C with the Wst-1 reagent. No BMP4 was added in any treatment.  
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(a) The graph illustrates the mean absorbance on day 4 of neural differentiation for 
each treatment. Bars represent the mean ± S.D. of three independent experiments. 
(Krustal-Wallis test, P = 0.384) 
(b) The graph illustrates the mean absorbance on day 6 of neural differentiation for 
each treatment. Bars represent the mean ± S.D. of three independent experiments. 
Significant post-hoc differences are indicated with brackets. (Tukey-Kramer test, *P 
< 0.05) 
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3.3 Discussion 
The use of recombinant noggin in inducing the neural differentiation of cell cultures has 
been shown to enhance neural conversion of ES cells (Tropepe et al., 2001, Okada et al., 
2008, Okada et al., 2004, Wu et al., 2012) but with limitations because they have a short 
shelf-life and have batch-to-batch variation and thus the results might not be always be 
reproducible (Burton et al., 2010). This study therefore looked at whether LDN and DM 
could be used as a replacement of recombinant noggin in neural differentiation protocols 
because they are more stable and cost-effective and therefore can be scaled up effectively 
for large scale analysis such as drug screening studies.  
To investigate the effect of LDN and DM on neural induction of ES cells, 46C Sox1-GRP 
reporter ES cell line was used to provide assay for neural induction, in particular using flow 
cytometry analysis to quantify the percentages of cells expressing GFP under different 
culture treatment regimes. Surprisingly, over 90% of ESC-derived neural progenitor cells 
expressed Sox1/GFP using CDM as the base differentiation medium in the absence of LDN or 
DM treatments on day 4 and day 6 of differentiation (Figs. 3.5 and 3.6). Lower percentages 
of Sox1/GFP expressing cells (60%) were reported by Ying et al.'s study, which describes the 
first monolayer differentiation protocol. The discrepancy between the findings herein and 
those of Ying et al's might be due to differences in protocol design. In Ying's protocol, ES 
cells were plated directly in N2B27 medium, whereas in this study, ES cells were plated in ES 
medium overnight before differentiation was initiated by changing the medium to CDM. 
Plating ES cells in ES medium overnight probably produced more optimal cell densities for 
more effective neural conversion to occur. As revealed by other studies (Watanabe et al., 
2005, Tropepe et al., 2001), cell plating densities had a significant effect on the expression of 
Sox1/GFP on day 4 and day 6 of differentiation. An important factor that regulates 
differentiation decision between cells is Notch signalling (Lai, 2004). Moderately activated 
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Notch signalling synchronises the timing of neural induction, homogenizes the level of Sox1 
expression between cells and amplifies Sox1 expression (Lowell et al., 2006). It would be 
valuable to find out whether Sox1 expression found at different cell-plating densities is 
associated with Notch signalling. The activity of Notch can be detected by generating a 
reporter cell line for RBPJK protein (which is activated by Notch intracellular domain upon 
ligand binding (Lai, 2004)) to measure Notch activity at different cell plating densities.  
Although it has been shown that noggin treatment can increase the number of neural 
colonies (Tropepe et al., 2001), this study showed that a high percentage of Sox1-positive 
cells (>90%) was generated on day 4 and day 6 of differentiation in CDM alone and that DM 
or LDN treatment did not produce any significant increase in Sox1-positive cells (Fig. 3.5 and 
3.6). This raised the question of whether exogenous BMP inhibition is necessary to induce 
neural differentiation. In fact, certain in vitro studies have demonstrated that blocking BMP 
signalling did not enhance neural conversion. Ying et al. showed that noggin treatment did 
not increase the level of Sox1/GFP expression in adherent monolayer cultures (Ying et al., 
2003b). Kawasaki's study on stromal cell-induced neural differentiation showed that 
blocking BMP signalling using BMPR-Fc receptobody can reverse the inhibitory effect of 
BMP4 but had no significant effect on the generation of β-III-tubulin positive colonies 
(Kawasaki et al., 2000).  Furthermore, Smuckler showed that single ES cell differentiated in 
PBS alone expressed nestin and Sox1 after 4 hours, although nutritive factors were needed 
for long-term maintenance of neural cultures (Smukler et al., 2006). All this evidence 
suggested that it might be possible that the high percentage of Sox1/GFP expression found 
in this study was due to endogenous expression of BMP inhibitors in subpopulations of cells. 
Therefore it would be worthwhile to find out the expression of BMPs and BMP inhibitors 
(chordin, follistatin and noggin) of neural progenitors from day 0 to day 6 of differentiation 
in order to assess the importance of BMP inhibition in neural differentiation.  
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The first evidence that suggested DM and LDN can enhance neural differentiation was 
that they induced higher intensity of Sox1/GFP expression than CDM alone. However, since 
the levels of Sox1/GFP induction were already high in CDM alone, it was difficult to make 
accurate comparisons of the effects of LDN, DM and noggin. Therefore in order to make 
these such comparisons on the level of Sox1/GFP induction, neural induction in the base 
medium CDM was first suppressed by treatment with a low dose of BMP4, thus providing a 
more sensitive and direct assay to measure the potency of BMP antagonism to the different 
agents for Sox1/GFP induction. In the presence of BMP4 (0.5 ng/ml), LDN was more effective 
than DM in overcoming the BMP4 suppression of neural induction as assessed by induction 
of Sox1/GFP expression. DM induced higher expression of Sox1/GFP than the vehicle control 
(ethanol 0.1%) but the response was slower than LDN (Figs. 3.8 and 3.9). The difference in 
the response rate could be due to the difference in chemical groups found in LDN and DM 
and will require some structure-activity studies to confirm. 
In examining the expression of the neural markers Pax6 and nestin, using RT-PCR and 
immunocytochemistry, noggin led to greater expression than did CDM control. The results 
obtained from LDN- and DM-treated samples were less conclusive and would require further 
work to confirm. The data obtained from RT-PCR nevertheless appeared to show that both 
LDN (0.25 μM) and DM (0.5 μM) treatments induced at least a comparable if not higher level 
of nestin and Pax6 expression than the vehicle control (Figs. 3.13 and 3.16). These data are 
consistent with a DM study carried out in human ES cells and human iPS cells. In human ES 
cells, expressions of Pax6, Sox1 and nestin showed dose-dependent response to DM through 
downregulation of Smad1/5/8 expression. The level of increase was even greater than 
noggin treatment alone (Kim et al., 2010). A surprising result in this study was that noggin 
appeared to induce a higher level of p75 expression. This would suggest an additional effect 
on promoting neural crest development, however, it is well-established in the 
developmental biology literature that BMP antagonism acts to suppress neural crest 
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development (Kanzler et al., 2000, Okada et al., 2008). Therefore, further studies are 
required to confirm the observation.  
Compared to noggin, both DM and LDN had relatively little effect on the expression of 
the neural crest markers Sox9 and p75 and also the epithelial marker CK18. Differing doses 
of both compounds were not observed to result in wide variation in neural 
marker-expression. The vehicle treatment (ethanol 0.1%) seemed to be able to enhance the 
expression of Pax6 and nestin, which makes it difficult to determine whether LDN and DM 
have any additional effect in enhancing the expression of the early neural markers. In 
addition, the vehicle treatment also increased the level of Smad1/5/8 phosphorylation in 
DM-treated undifferentiated cells (Fig. 3.17) and increased the mitochondrial activity on day 
6 of differentiation (Fig. 3.18). The fact that the effect of vehicle control was detected only in 
some experiments suggests that certain steps involved in neural specification might be more 
sensitive to ethanol. These observation could probably be explained by a recent study which 
showed that exposing mouse ES cells at 25 nM to 100 nM of ethanol resulted in an increase 
in Oct4/Sox2 ratio in a dose-dependent manner during the first 4 days of RA-directed neural 
differentiation (Ogony et al., 2013). The change in stoichiometry of Oct4 and Sox2 was 
reported to be able to divert ES cells from neuroetodermal lineage to mesoendodermal 
lineage (Thomson et al., 2011). As a result cells expressed less -III-tubulin on day 6 of 
differentiation (Ogony et al., 2013). And this suggested that ethanol might have an effect on 
lineage specification through altering the balance of lineage specifiers. 
The use of small molecules for inducing neural progenitors from ES cells can be 
hindered by its off-target effects. One known off-target effect for DM is 5' AMP-activated 
protein kinase (AMPK) inhibition (Zhou et al., 2001). AMPK plays a key role in energy 
consumption, including the regulation fatty acid oxidation and glucose transport (Hardie and 
Carling, 1997, Merrill et al., 1997, Hayashi et al., 1998). A study of AMPK activity in 
transgenic mice that had kinase dead (KD) mutation of the α2 catalytic subunit of AMPK in 
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the heart reveals that the loss of AMPK activity is associated with an inability to augment 
glucose uptake and glycolysis with an increase in apoptotic activity (increased caspase-3 
activity and TUNEL staining) during low-flow ischemia (Russell et al., 2004). Data from the 
Wst-1 mitochondrial activity assays showed that the metabolic activity of NPCs was reduced 
with increasing doses of DM and LDN. Whether this observation had any association with 
AMPK inhibition remains unclear, and requires more studies to clarify. Examination of the 
effect of DM and LDN on the AMPK pathway will give more information about how AMPK 
might be associated with the metabolic activity in LDN and DM treatments and allow better 
strategies for neural differentiation to be designed.  
The data in this study indicated that both LDN and DM inhibited Smad1/5/8 
phosphorylation in undifferentiated ES cells and neural progenitor cells in a dose-dependent 
manner (Figs 3.1, 3.2, 3.16), and this was in accordance with previous studies that first 
describe DM and LDN as BMP inhibitors (Yu et al., 2008, Cuny et al., 2008). However, the DM 
and LDN do not always have the same effect even though they are structurally similar. For 
instance, DM but not LDN induced the formation of neurite outgrowth through ErK1/2 
activation in PC12 cells, a rat cell line isolated from an adrenal medullary 
pheochromocytoma and used as a model to study neuronal differentiation and neurite 
outgrowth (Vaudry et al., 2002, Kudo et al., 2011). The exact mechanism of how DM activate 
Erk1/2 was unclear but the action is cell type specific because Erk1/2 was not activated in 
C2C12 cells (murine mesenchymal cell line) (Boergermann et al., 2010). On the other hand, 
Erk1/2 is a key regulator of cell proliferation through induction of positive regulators of the 
cell cycle (Meloche and Pouyssegur, 2007, Cargnello and Roux, 2011). Thus it would be of 
interest to test whether DM or LDN treatment had any effect on Erk1/2 activation because 
this could explain the reduction in metabolic activity of DM-treated samples analysed by the 
Wst-1 mitochondrial assay (Fig. 3.18).  
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Data presented here suggests that LDN is more effective than DM and has a similar 
effect to recombinant noggin in inducing neural differentiation in mouse ES cultures. The 
reduction of the metabolic activity of DM and LDN was less pronounced at lower doses. 
Therefore, one possible way to obtain more neural colonies is to use lower doses of DM and 
LDN accompanied by recombinant noggin. The delayed action of DM in inducing Sox1/GFP 
expression suggests that it might be possible to retain more colonies by exposing them to 
recombinant noggin for a short period initially, followed by DM exposure. More specific 
small molecules that target the BMP-mediated Smad pathway will need to be developed in 
future in order to restore the metabolic activity of cells treated with small molecules. 
 
3.4 Conclusion  
In summary, 46C cells underwent neural differentiation when plated at low density and 
expressed early neural markers including Sox1, nestin and Pax6. Although the expression of 
the neural markers was further enhanced by LDN, DM and noggin, partly due to BMP 
inhibition, the metabolic activity was reduced by LDN and DM in a dose-dependent manner. 
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CHAPTER 4: 
DEFINING TEMPORAL RESPONSIVENESS OF NEURAL 
PROGENITORS TO THE CAUDALIZING ACTION OF RETINOIC 
ACID SIGNALLING
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4.1 Introduction 
Neural progenitor cells (NPCs) are competent to differentiate into a vast number of 
neurons and glia. Their potential for differentiating into different neuronal subtypes, 
therefore, brings with it hopes for the treatment of a number of neurological disorders by 
stem cell replacement therapy. The identity of neuronal subtype generated from NPCs is 
determined by the regional identities of the NPCs. A key element of regional specification is 
temporal regulation: this appeared to govern the developmental potential of NPCs (Allen, 
2008). This chapter looks at how the regional specification of NPCs is temporally regulated 
by retinoic acid (RA), an important regulator for the regional patterning of the neural tube in 
vivo (Maden, 2002). 
A number of in vivo studies have shown that the effect of RA on neural patterning is 
stage-specific. RA administration at mid-late streak stage (7.2-7.4 days post coitum (dpc) 
mice resulted in severe brain malformation including truncation of the brain and molecular 
alterations such as the repression of forebrain markers, Otx2, Emx2, Emx1 and Dlx1. The 
effect was stage-specific because if RA was administered 6-10 hr earlier or later, the 
expression of the forebrain markers was preserved, and less severe brain malformation was 
found (Simeone et al., 1995, Avantaggiato et al., 1996). This suggested that forebrain 
patterning undergoes a critical period of RA exposure and brain formation can be affected 
by the level of RA (Luo et al., 2004). The correct level of RA in the anterior region appears to 
be controlled by RA catabolizing enzyme Cyp26a1, which is expressed transiently at the 
anterior epiblast at E7 (Fujii et al., 1997, MacLean et al., 2001). RA administration to 
Cyp26a1-/- embryos caused severe head truncation between E7.5-E8.5, and a more severe 
effect was found if RA was supplemented between E6.5-E7.5. This also adds further proof 
that the effect of RA is stage-specific (Ribes et al., 2007). 
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RA activity is detected as early as in the epiblast stage (Ribes et al., 2009), and has been 
reported to regulate neural patterning in a region-specific manner (Rhinn and Dolle, 2012). 
Within the hindbrain, loss-of-function mutants in RA synthesizing enzyme Raldh2 displayed a 
loss of posterior rhombomeres (r5-7) in the hindbrain and expansion of more anterior ones 
(r2-4) (Niederreither et al., 2000, White et al., 2000). Several studies have also reported the 
role of dynamic expression RA catabolizing enzymes Cyp26s in establishing specific 
rhombomeric territories by modulating the RA gradient or periods of RA exposure (Gavalas, 
2002, Sirbu et al., 2005, Hernandez et al., 2007, Maves and Kimmel, 2005, White et al., 2007) 
(see section 1.6.3.3). 
The effect of RA on forebrain development is somewhat less conclusive compared to 
that of hindbrain development. Niederreither et al. showed that the forebrain development 
was normal in Raldh2-/- embryos because the expression of forebrain marker (Otx2) was not 
affected (Niederreither et al., 1999), whereas a recent transcriptomic analysis of Raldh2-/- 
embryos reported that expression of forebrain marker Emx2 and Foxg1 was downregulated 
due to RA deficiency (Paschaki et al., 2013). The role of forebrain development appears to be 
evident because RA activity was detected in the telencephalon between E9.5 to E14.5 
examined by RARE-LacZ transgene (Dolle et al., 2010). Disruption of RA signalling by blocking 
the RAR receptor resulted in the misspecification of Nkx2.1 MGE progenitors and caused 
them to initiate LGE-specific neuronal differentiation (Rajaii et al., 2008). A number of 
studies analysing the effect of RA on forebrain development brought to light the importance 
of RA in regulating neurogenesis in the LGE (Molotkova et al., 2007). The LGE is more 
competent to respond to RA signalling than the MGE or the cortex, as revealed by higher 
expression of cellular retinol binding protein (CRBP) at E12.5 (Toresson 1999), and Raldh3 at 
E11 (Li et al., 2000, Luo et al., 2004). Enhanced RA signalling in the LGE promoted striatal 
neuronal differentiation, an effect that was not found in MGE cultures (Toresson et al., 
1999). In summary, RA is involved in regulating forebrain and hindbrain development as 
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shown by the expression of RA receptors, RA synthesizing enzymes (Raldhs) and RA 
catabolizing cytocrhome P450 (CYP26s) enzymes in both regions. However, the exact 
mechanisms and requirements for RA to generate region-specific responses remain unclear.  
In vitro, RA regulates caudalization in early ES cells-derived NPCs in a 
concentration-dependent manner (Okada et al., 2004, Okada et al., 2008, Irioka et al., 2005), 
but relatively little is known about the effect of RA on the expression of forebrain markers in 
ES cell-derived NPCs. It is known that ES cell-derived NPCs display temporal restriction in cell 
fate specification (Bouhon et al., 2006). The experiments presented in this chapter aimed to 
determine how the changing temporal windows of competence and responsiveness to RA 
can affect the regional specification of NPCs. To investigate this, ES cells were differentiated 
in the presence of FGF2 for 20 days and RA treatment was initiated at regular intervals. 
Against this background the expression of early forebrain markers, including that of the early 
telencephalic marker Foxg1 (Xuan et al., 1995), was determined. The cell line Foxg1Z (a gift 
from J. Quinn and D. Price) was generated by replacing most of the coding sequence of 
Foxg1, which is contained in a single exon, with LacZ and a neomycin cassette. They were 
used for most experiments here as a convenient tool for determining Foxg1 expression using 
X-gal staining and the Beta-Glo assay to detect Foxg1 driven β-galactosidase expression.   
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4.2 Results 
4.2.1 The characterization of Foxg1Z cells 
It has been shown that FGF2 upregulated rostral gene expression (Bouhon et al., 2006), 
and exposure of ESC-derived NPCs to RA promotes caudalization and suppresses rostral gene 
expression (Wichterle et al., 2002). Therefore, the first investigation examined whether 
Foxg1 and the lacZ gene are co-expressed in response to morphogens in Foxg1Z cells. Foxg1Z 
cells were differentiated for 8 days with FGF2 in the presence or absence of RA. Fluorescent 
immunocytochemistry was performed to examine the expression of Foxg1 and 
β-galactocidase (expressed by the LacZ gene) of Foxg1Z cells.  
Merged images (images C and C') illustrate that the lacZ reporter and wildtype Foxg1 
alleles were co-expressed in response to FGF2. This indicated that Foxg1Z cells responded to 
FGF2 signalling by expressing Foxg1. Furthermore, this experiment demonstrated that when 
Foxg1Z cells were differentiated in the presence of RA (1 M), only very weak expression of 
Foxg1 and β-galactocidase was detectable, thus indicating that RA treatment for 8 days of 
differentiation inhibited the expression of Foxg1 (Images E-G, E'-G') (Fig. 4.1). 
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Figure 4.1 Fluorescent immunocytochemistry analysis of RA treated Foxg1Z cells on 
day 8 of neural differentiation 
 Foxg1Z and β-galactosidase expression was analysed by fluorescent 
immunocytochemistry on day 8 of differentiation. FGF2 (20 ng/ml) was added from day 4 to 
day 8, and cells were fixed and triple-labelled for β-galactosidase (green), Foxg1 (red) and 
Hoechst (blue). Scale bars for x10 images = 100 μm; Scale bars for X40 images = 25 μm. 
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4.2.2 Investigation of the effect of RA on Foxg1/LacZ expression in early and 
late neural cell cultures 
The last section revealed that the expression of Foxg1/LacZ was strongly reduced after 
incubating cells with RA (1 M) for 8 days (Fig. 4.1). The next step was to investigate 
whether there would be a change in Foxg1 expression when RA was added at different time 
points. If cells displayed a change in responsiveness to RA, it would be possible that cells 
might respond to RA by downregulating the expression of hindbrain markers. To investigate 
this, Foxg1Z cells were maintained in chemically defined medium (CDM) for differentiation 
for 20 days. FGF2 was added on day 4 to induce Foxg1 expression and to maintain long-term 
propagation of neural stem cells (Tropepe et al., 2001, Lee et al., 2000, Okabe et al., 1996). 
FGF2 was added from day 4 and not from day 0 because previously generated data showed 
that Foxg1Z gave the highest Foxg1 expression on day 8 of differentiation (Precious, 2009) – 
a phenomenon which could be explained by an in vivo finding that neural progenitor cells do 
not acquire responsiveness to FGF2 before E8.5 (Hitoshi et al., 2004). Starting at day 6 of 
differentiation, Foxg1Z cells were dissociated into single cells and plated onto 
poly-L-ornithine coated-tissue culture plastic plates every 4 days thererafter. RA (1 M) was 
added at 4-day intervals during the course of differentiation and analyses were carried out 
on day 8 and day 20 of differentiation. These two time points were chosen because the 
Bouhon et al. study made it clear that early neural progenitor cells (day 8 cultures) 
responded to the caudalizing signal RA by displaying differential patterning responses at day 
8 and day 20 (Bouhon et al., 2006). A schematic illustration of the differentiation strategy is 
shown in Fig. 4.2.  
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Figure 4.2 Schematic representation of the differentiation protocol used in this study 
 Foxg1Z cells were differentiated in CDM on gelatin-coated plates for the first 6 days of 
differentiation and dissociated into single cells and replated onto poly-L-ornithine-coated 
plates every 4 days. FGF2 (20 ng/ml) was added from day 4 to day 20. RA (1 M) was added 
starting at 4-day intervals from day 0 to day 20 and analyses were carried out on day 8 and 
day 20 of differentiation. 
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4.2.3 X-gal and Beta-Glo analysis of Foxg1/LacZ expression in early and late 
neural cultures 
The time-window within a 20-day period in which RA had an effect on Foxg1/LacZ 
expression was examined using 5-Bromo-4-chloro-3-indolyl galactopyranoside (X-gal) 
staining. X-gal staining measures the activity of beta-galactosidase (encoded by the LacZ 
gene), This cleaves the β-glycosidic bond in X-gal and gives 5,5'-dibromo-4,4'-dichloro-indigo 
yielding a blue product. Foxg1/LacZ expression was also quantified using a Beta-Glo assay. 
To perform the Beta-Glo analysis, Foxg1Z cells were analysed by both the Beta-Glo assay and 
the Wst-1 assay, and the readings obtained by Beta-Glo assay were normalised by Wst-1 
assay. The Beta-Glo assay works by measuring luminescence produced by β-galactosidase 
which catalyses luciferin-galactoside substrate in the Beta-Glo reagent to produce 
oxyluciferin. However, the oxyluciferin produced can be misrepresented by the number of 
metabolically active cells presented because a higher reading can be obtained if more 
metabolically active cells are present in the sample. To control for this, the number of 
metabolically active cells was measured by Wst-1 mitochondrial activity assay. This gives 
readings about the overall metabolic activities of each measured samples.  
On day 8, X-gal staining made it clear that the number of Foxg1/LacZ positive cells was 
highest in the absence of RA (image A, Fig. 4.3 (a)). Almost no Foxg1/LacZ positive cells were 
found if RA was added on day 0 and only a small number of Foxg1/LacZ positive cells were 
found when RA was added on day 4 (Images B and C, Fig. 4.3 (a)). Similar results were 
obtained with the Beta-Glo analysis. That showed that Foxg1/Z cells grown in the control 
sample (without RA) had the highest Foxg1/LacZ expression. Adding RA (1 M) on day 0 and 
day 4 strongly reduced Foxg1/LacZ expression (Fig. 4.3 (b)), indicating that early neural 
cultures responded to RA primarily by reducing Foxg1 expression.  
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On day 20, through X-gal analysis, it was seen that the number of Foxg1/LacZ positive 
cells was relatively similar across all samples, and the day 20 control sample appeared to 
have a much lower number of Foxg1/LacZ positive cells than the day 8 control sample 
(Image D, Fig. 4.4 (a)). Adding RA at day 0 gave almost no positive Foxg1/LacZ cells (Image E, 
Fig. 4.4 (a)). Beta-Glo analysis showed that the expression of Foxg1/LacZ was increased 
gradually until day 12 and to a level that was comparable to the control sample (Fig. 4.4 (b)), 
implying that the inhibition of Foxg1 expression by RA was gradually reduced when RA was 
added at later time points.  
In summary, the optimal time point for RA caudalization appears to be at day 0. After 
this point a diminishing number of cells appear to be receptive to RA signalling (Fig. 4.4 (b)). 
Although there was no substantial difference between day 0 and day 4 RA additions when 
Foxg1/LacZ expression was sampled at day 8, Day 0 RA addition was much more effective 
than day 4 RA addition at reducing Foxg1/LacZ expression when sampled at day 20. At day 
16, RA addition also reduced Foxg1/LacZ expression at day 20, indicating that there might be 
a second time window at which the cells are receptive to caudalization by RA. However, 
whether NPCs at day 8 are the same as NPCs at day 16 is questionable and the conclusions 
drawn from time window experiments must be interpreted with this caveat.  
 
  Chapter 4   
 145 
 
(a) 
 
(b) 
 
Figure 4.3 Expression of Foxg1/LacZ analysed by Beta-Glo assay and X-gal staining of 
Foxg1Z cells with RA (1 μM) added at day 0 and day 4 
 Foxg1Z cells were differentiated in CDM with RA (1 μM) added on day 0 and day 4. FGF2 
(20 ng/ml) was added from day 4 to day 8. The expression of LacZ/Foxg1 positive cells was 
detected by X-gal staining and quantified by Beta-Glo assay on day 8. Bars represent the 
mean of triplicates of one experiment. Scale bars = 100 μm. 
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(a) 
 
(b) 
 
Figure 4.4 Expression of Foxg1/LacZ analysed by Beta-Glo assay and X-gal staining of 
Foxg1Z cells with RA (1 μM) added at day 0, 4, 8, 12 and 16 
 Foxg1Z cells were differentiated in CDM with RA (1 M) added at every 4-day interval 
from day 0 to day 20. FGF2 (20 ng/ml) was added from day 4 to day 20. The expression of 
LacZ/Foxg1 positive cells was detected by X-gal staining and quantified by Beta-Glo assay on 
day 20. Bars represent the mean of triplicates of one experiment. Scale bars = 100 μm. 
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4.2.4 Effect of RA on anteroposterior patterning of early and late NPCs 
The number Foxg1/LacZ-expressing cells was affected by the timing of RA addition and 
also the duration of RA exposure (Figs. 4.3 and 4.4). The changes in Foxg1/LacZ expression in 
response to RA suggested that other positional markers might also show differences in 
expression in early and late cultures. To gain further insight into how RA regulated the 
specification of rostrocaudal and dorsoventral positional identity in early and late neural 
cultures, RT-PCR and fluorescence immunocytochemistry of regionally specific markers were 
performed on the day 8 and day 20 cultures.  
Foxg1 expression was strongly suppressed by day 0 RA addition but gradually increased 
when RA was added from day 4 onwards in early (day 8) and late (day 20) neural cell 
cultures. This clearly suggests that the optimal time window for caudalization by RA is 
between day 0 and day 4. LacZ expression also took place, controlled as it is by Foxg1 
promoter. The data showed that the expression of LacZ corresponded well with Foxg1 
expression in RT-PCR analysis (Fig. 4.5 (a), (b)).  
The expression pattern of the protein in question was studied by fluorescence 
immunocytochemistry. Cells were considered to be immuno-positive if Foxg1 expression 
overlapped the nuclear stain. The immunocytochemistry data presented in this chapter 
brings to light an interesting possible trend in the way protein expression might be affected 
by time and RA treatment. Though their reliability would be enhanced by further work, two 
independent experiments yielded interesting results. Significant differences were found in 
Foxg1 expression across all samples (Krustal-Wallis test, P = 0.002). As expected, RA reduced 
Foxg1 expression significantly in early and late cultures (Mann-Whitney U test, P < 0.05). It 
appeared that the difference between the control sample and samples that were treated 
with RA gradually became less pronounced in late cultures. By the time RA was added on 
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day 16 in late cultures, the expression level of Foxg1 was about half that which was observed 
in the control sample in late culture (Fig. 4.6).  
RT-PCR analysis of hindbrain marker HoxB3 (Manzanares et al., 1999) in early neural 
cultures (day 8) showed that the expression was strongly induced by RA. In late neural 
cultures, strong HoxB3 expression was found when RA was added on day 0, day 4 and day 8 
and was gradually diminished when RA was added from day 12 onwards, a time point that 
coincided with an increased expression of Foxg1/LacZ (Fig. 4.5). Immunocytochemistry 
shows similar results for another hindbrain marker, HoxB4, expressed in the caudal 
hindbrain and spinal cord (Nordström et al., 2006). Both early and late NPCs responded to 
early RA treatment by increasing HoxB4 expression significantly (Tukey Kamer test, P < 0.05). 
The HoxB4 expression appeared to be sustained with late RA treatment. It could be assumed 
that this was because HoxB4 contains RA response element (RARE) in their promoters 
(Gould et al., 1998) (Fig. 4.7). 
Combining the results obtained by RT-PCR and immunocytochemistry shows that NPCs' 
competence to respond to RA regional identity cues is restricted temporally. Early RA 
treatment resulted in strong expression of HoxB3 and HoxB4 and weak expression of Foxg1 
in early NPCs; late RA treatment, however, resulted in a weaker upregulation of HoxB3. Late 
RA treatment also gradually increased the expression of Foxg1 in late NPCs, and the effect 
appeared to be significant (the difference between the expression level of Foxg1 when RA 
was added on day 0 and when it was added on day 16 in late NPCs was significant 
(Mann-Whitney U test, P < 0.05). Thus, the window of NPCs’ competence to respond to the 
caudalizing signal can be said to occur early, most likely between day 0 and day 4. 
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(a) 
 
 (b) 
 
Figure 4.5 RT-PCR analysis of RA treated samples on day 8 and day 20 of neural 
differentiation 
(a) Expression of Foxg1, LacZ, En2, HoxB3 was analysed by RT-PCR. RA (1 M) was added at 
every 4-day interval from day 0 to day 20. FGF2 (20 ng/ml) was added from day 4 to day 
20 in all samples. Control samples (C) contain FGF2 and with no RA. RNA was collected on 
day 8 and day 20 of neural differentiation. Total RNA from the forebrain, midbrain and 
hindbrain from E12.5 mouse embryo was used as a positive control. Representative of 
two independent experiments was shown. 
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(b) Band intensity of PCR products of Foxg1, LacZ, Emx2, En2 and HoxB4 was quantified by 
Gel Doc 2000 and was expressed as arbitrary relative values obtained for GAPDH. Bars 
represent the mean of two independent experiments. 
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  Chapter 4   
 152 
 
(b) 
 
 
Figure 4.6 Immunocytochemistry analysis of Foxg1 expression of Foxg1Z cells on day 
8 and day 20 of differentiation 
(a) Foxg1 expression was analysed by fluorescent immunocytochemistry. Foxg1Z cells were 
treated with RA (1 μM) added on day 0, day 8 and day 16. They were fixed with 4% PFA 
on day 8 and day 20, double-labelled for Foxg1 (red) and Hoechst nuclear stain (blue). 
Representative of two independent experiments was shown. Scale bars for x10 images = 
100 μm; Scale bars for x40 images = 25 μm  
(b) Foxg1 immuno-positive cells on day 8 and day 20 were counted and were represented as 
percentage of total Hoechst cells. Bars represent the mean of the numbers obtained by 
counting four random fields of two different coverslips from two independent 
experiments. Significant post-hoc difference is indicated with bracket. (Mann-Whitney U 
test, *P < 0.05) 
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(b) 
 
 
Figure 4.7 Immunocytochemistry analysis of HoxB4 expression of Foxg1Z cells on day 
8 and day 20 of differentiation 
(a) HoxB4 expression was analysed by fluorescent immunocytochemistry. Foxg1Z cells were 
treated with RA (1 μM) added on day 0, day 8 and day 16. They were fixed with 4% PFA 
on day 8 and day 20, double-labelled for HoxB4 (green) and Hoechst nuclear stain (blue). 
Representative of two independent experiments was shown. Scale bars for x10 images = 
100 μm; Scale bars for x40 images = 25 μm  
(b) HoxB4 immuno-positive cells on day 8 and day 20 were counted and were represented as 
percentage of total Hoechst cells. Bars represent the mean of the numbers obtained by 
counting four random fields of two different coverslips from two independent 
experiments. Significant post-hoc difference is indicated with bracket. (Tukey-Kramer test, 
*P < 0.05) 
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4.2.5 Effect of RA on dorsoventral patterning of early and late NPCs 
The change in the expression of rostral and caudal markers in late NPCs suggested that 
the expression of dorsal telencephalic and ventral telencephalic markers might be different 
in late NPCs. To test this, the expression of dorsal telencephalic and ventral telencephalic 
markers in early and late neural cultures was analysed by RT-PCR and immunocytochemistry. 
The expression of the dorsal telencaphalic population can be distinguished by the expression 
of Emx2 (Suda et al., 2010, Gulisano et al., 1996, Simeone et al., 1992), Ngn2 (Imayoshi et al., 
2008) and Pax6 (Carney et al., 2009, Stoykova and Gruss, 1994), while the ventral 
telencephalic population can be distinguished by the expression of Mash1 (Casarosa et al., 
1999, Long et al., 2009). 
Pax6 expression is found in mitotically active progenitors of the dorsal telencephalon  
(Puelles et al., 1999). RT-PCR analysis showed that the expression of Pax6 was relatively 
weak across all samples and therefore it is difficult to draw any conclusion from it. Although 
no significant difference was found in the number of Pax6-immunopositive cells in both early 
and late cultures (one-way ANOVA test, F5,18 = 1.92, P = 0.141), it appeared that the 
expression was reduced slightly by RA treatment in late NPCs (Fig. 4.8, Fig. 4.9). Another 
dorsal marker Emx2, reported to be downregulated in Raldh2-/- mutants (Paschaki et al., 
2013), was induced by RA when added on day 0 in both early and late cultures but its 
expression was downregulated by RA in late cultures by later RA treatments (Fig. 4.8). 
Analysis of these two dorsal markers suggests that late RA treatment antagonises the 
dorsalization in late, but not early NPCs cultures. 
Ngn2 and Mash1 are responsible for patterning and regulating neurogenesis in the 
dorsal and ventral telencephalon respectively (Nieto et al., 2001, Fode et al., 2000). Both 
markers were induced by RA in early NPCs but only Mash1 in late NPCs when RA was added 
on day 0. Liao et al. showed that ventral telencephalon is more responsive to RA signalling 
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than dorsal telencephalon (Liao et al., 2005b), and this probably could explain the strong 
Mash1 expression induced by RA at day 0 in late culture. However, the expression weakened 
when RA was added at later time points. Analysis of Mash1 suggests that early RA treatment 
ventralizes NPCs cultures and here the initial time window for ventralization appeared later 
(which contrasts with the Emx2 data). From this data, it appears that the time window for 
ventralization occurs at a later time point than the time window for caudalization, as Mash1 
expression was only induced in late cultures (Fig. 4.8). 
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(a) 
 
(b) 
 
Figure 4.8 RT-PCR analysis of RA treated Foxg1Z cells on day 8 and day 20 of neural 
differentiation 
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(a) Expression of Pax6, Ngn2, Emx2, Mash1 and nestin was analysed by RT-PCR. RA (1 M) 
was added at every 4-day interval from day 0 to day 20. FGF2 (20 ng/ml) was added from 
day 4 to day 20. Control samples (C) contain FGF2 and with no RA. RNA was collected on 
day 8 and day 20 of neural differentiation. Total RNA from the forebrain, midbrain and 
hindbrain from E12.5 mouse embryo was used as a positive control. Representative of 
two independent experiments was shown. 
(b) Band intensity of PCR product of Pax6, nestin, Ngn2, Tbr1 and Mash1 was quantified by 
Gel Doc 2000 and was expressed as arbitrary relative values obtained for GAPDH. Bars 
represent the mean of two independent experiments. 
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(a) 
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(b)  
 
Figure 4.9 Immunocytochemistry analysis of Pax6 expression on day 8 and day 20 of 
differentiation 
(a) Pax6 expression was analysed by fluorescent immunocytochemistry. Foxg1Z cells were 
treated with RA (1 μM) added on day 0, day 8 and day 16. They were fixed with 4% PFA 
on day 8 and day 20, double-labelled for Pax6 (green) and Hoechst nuclear stain (blue), 
Representative of two independent experiments was shown. Scale bars for x10 images = 
100 μm; Scale bars for x40 images = 25 μm. 
(b) Pax6 immuno-positive cells on day 8 and day 20 were counted and were represented as a 
percentage of total Hoechst cells. Bars represent the mean of the numbers obtained by 
counting four random fields of two different coverslips from two independent 
experiments. (One-way ANOVA test, P = 0.141) 
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4.2.6 Expression of glial and early neuronal markers in early and late neural 
cultures 
To determine whether the progenitor population was maintained in the NPC cultures 
over the 20 day period (and therefore whether the cells receiving early RA and late RA are 
NPCs, not differentiated NPCs), the expression of markers for progenitors and differentiated 
cells was investigated. Nestin is an intermediate filament gene that is expressed by neural 
stem cells (Lendahl et al., 1990). Nestin expression appeared to be increased by RA 
treatment, but the expression was similar in both early and late cultures. 
Immunocytochemistry analysis confirms this, suggesting that the number of neural 
precursor cells had not decreased in late cultures (Fig. 4.10). Tbr1 is expressed in cortical 
postmitotic cells (Bulfone et al., 1995, Englund et al., 2005). The expression of Tbr1 was very 
weak across all samples, indicating that the majority of cells had not undergone neuronal 
differentiation (Fig. 4.8).  
The change in responsiveness to RA could be due to the presence of more mature 
phenotypes owing to spontaneous differentiation such as β-III-tubulin and GFAP even 
though NPCs were propagated in the presence FGF2. To investigate this, early and late NPCs 
were immunostained with early neuronal marker β-III-tubulin and the results show that, in 
early cultures, weak expression of β-III-tubulin was found. The expression of β-III-tubulin was 
weak across all samples, except when RA addition on day 8 in late cultures appeared to 
produce a significant increase in the expression of β-III-tubulin. However, the expression 
decreased significantly when RA was added on day 16 (Mann-Whitney U test, P < 0.05) (Fig. 
4.11).  
Bouhon et al. demonstrated that late neural cultures express Olig2, Mash1 and EGFR but 
do not express Ngn1/2, a phenotypic profile that is similar to putative radial glia (Bouhon et 
al., 2006). To find out whether late cultures of this study displayed a higher gliogenic 
potential, immunocytochemistry analysis of GFAP was performed. Fig 4.12 illustrates how 
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only very weak GFAP expression was found in early neural cultures and that the expression 
increased significantly in late cultures (Tukey-Kamer test, P < 0.05) (Fig. 4.12). 
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 (a) 
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 (b) 
 
Figure 4.10 Immunocytochemistry of nestin expression on day 8 and day 20 of 
differentiation 
(a) Nestin expression was analysed by fluorescent immunocytochemistry. Foxg1Z cells were 
treated with RA (1 μM) added on day 0, day 8 and day 16. They were fixed with 4% PFA 
on day 8 and day 20, and double-labelled for nestin (green) and Hoechst nuclear stain 
(blue), Representative of two independent experiments was depicted. Scale bars for x10 
images = 100 μm; Scale bars for x40 images = 25 μm 
(b) Nestin immuno-positive cells on day 8 and day 20 were counted and were represented as 
a percentage of total Hoechst cells. Bars represent the mean of the numbers obtained by 
counting four random fields of two different coverslips from two independent 
experiments. Significant post-hoc difference is indicated with bracket. (two sample t-test, 
*P < 0.05)  
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(a) 
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 (b) 
 
Figure 4.11 Immunocytochemistry analysis of β-III-tubulin expression on day 8 and day 
20 of differentiation 
(a) β-III-tubulin expression was analysed by fluorescent immunocytochemistry. Foxg1Z cells 
were treated with RA (1 μM) added on day 0, day 8 and day 16. They were fixed with 4% 
PFA on day 8 and day 20, double-labelled for β-III-tubulin (red) and Hoechst nuclear stain 
(blue), Representative of two independent experiments was shown. Scale bars for x10 
images = 100 μm; Scale bars for x40 images = 25 μm 
(b) β-III-tubulin immuno-positive cells on day 8 and day 20 were counted and were 
represented as a percentage of total Hoechst cells. Bars represent the mean of the 
numbers obtained by counting two random fields of four different coverslips from two 
independent experiments. (Mann-Whitley U test, *P < 0.05) 
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 (a)  
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(b) 
 
Figure 4.12 Immunocytochemistry analysis of GFAP expression on day 8 and day 20 of 
differentiation 
(a) GFAP expression was analysed by fluorescent immunocytochemistry. Foxg1Z cells were 
treated with RA (1 μM) added on day 0, day 8 and day 16. They were fixed with 4% PFA 
on day 8 and day 20, double-labelled for GFAP (red) and Hoechst nuclear stain (blue), 
Representative of two independent experiments was shown. Scale bars for x10 images = 
100 μm; Scale bars for x40 images = 25 μm 
(b) GFAP immuno-positive cells on day 8 and day 20 were counted and were represented as 
a percentage of total Hoechst cells. Bars represent the mean of the numbers obtained by 
counting four random fields of two different coverslips from two independent 
experiments. Significant post-hoc difference is indicated with bracket. (Tukey-Kramer test, 
*P < 0.05)  
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4.3 Discussion 
During embryogenesis, RA is involved in regulating patterning along the AP and DV 
axes and subsequently the development of forebrain, hindbrain and the spinal cord (Wilson 
and Maden, 2005, Maden, 2006, Rhinn and Dolle, 2012). However, how such tissue-specific 
responses were regulated remained poorly understood. ES cells can be patterned 
appropriately in response to the right combination of morphogens (Smith, 2001). However, 
such observation can only be found in early, not late NPCs. This suggested that regional 
specification in NPCs is regulated by the temporal change in responsiveness to RA (Bouhon 
et al., 2006). In order to gain full control over the generation of specific neural and neuronal 
subtypes from ES cells, it was necessary to understand how cells respond to patterning cues 
over time. This chapter sets out data describing how the temporal change in competence to 
respond to RA can affect the expression profile of positional markers.  
The results in this study showed that the positional identities of ESC-derived NPCs were 
specified temporally. Adding RA at early time points (day 0 and day 4) generated cells with 
hindbrain character as confirmed by strong HoxB3 and HoxB4 expression in RT-PCR and 
immunocytochemistry analysis (Fig. 4.5, 4.6). This observation was consistent with Irioka et 
al.’s finding that suppression of forebrain gene expression happened in a narrow period 
during an early phase of differentiation (between day 0 to day 4) in vitro. It was also 
consistent with Okada et al.’s study that Hox genes were induced by RA in ES cell culture in 
early neural cultures (day 4 and day 6) (Irioka et al., 2005, Okada et al., 2004).  
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A loss of regional specification was found in late cultures when late NPCs were treated 
with RA between day 16 to day 20. The expression of all the positional markers tested 
(Foxg1, HoxB3, En2, Emx2) except those that contain RARE in their promoters (HoxB4 (Gould 
et al., 1998) and Pax6 (Enwright and Grainger, 2000)) was weak. This is in accordance with 
Bouhon et al.’s study which shows that late NPCs were unable to acquire anterocaudal or 
dorsoventral identities in response to late addition of morphogens (Bouhon et al., 2006).  
It was observed that different markers had different RA response windows before NPCs 
lost the competence to be patterned by RA. For instance, in late cultures, the expression of 
Emx2, Mash1 can only be found with early treatment of RA (day 0) in late culture, but the 
expression of HoxB3 can be still be induced by RA up to day 8 in late culture (Fig. 4.5 and 4.7). 
This suggests that NPCs had a wider window of competence to respond to RA induced 
hindbrain cues. The expression of Foxg1 in late NPCs gradually increased with later periods 
of RA treatment to a level that was similar to the control as revealed by Beta-Glo analysis or 
even greater than the control as revealed by RT-PCR analysis (low at RA on day 0 to 4 
compared to higher at RA on day 4 to day 12). This indicated that late RA treatment might 
be needed to sustain Foxg1 expression as a number of in vivo studies have reported that RA 
is essential for ventral forebrain development and that the effect of RA on forebrain 
development occurs at later time points (Rajaii et al., 2008, Liao et al., 2005b, Liao et al., 
2008). It would be interesting to examine the expression of another ventral forebrain marker, 
Gsh2, which is required for retinoid production in the LGE (Waclaw et al., 2004) to 
determine whether RA is required for the late expression of ventral forebrain markers.  
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This study also examined whether the change in responsiveness to RA in late neural 
progenitor cells was due to NPCs having committed to become neuronal or glial cells. In 
early cultures, on average about 15% of the cells treated with or without RA expressed 
β-III-tubulin, while in late cultures, on average about 40% of β-III-tubulin-expressing cells 
were found when RA was added at day 8 (Figs. 4.11, 4.12). Although the expression of 
β-III-tubulin was detected in early and late cultures - probably due to spontaneous 
differentiation as cells were cultured in the presence of FGF2, which maintains cells as 
neural progenitors (Tropepe et al., 2001, Lee et al., 2000, Okabe et al., 1996) - the 
comparatively slight increase in β-III-tubulin-expressing cells can probably be explained by a 
finding that demonstrates that RA treatment speeded up the differentiation process. Cells 
treated with RA (0.5 μM) from day 4 to 8 in embryoid bodies generated a higher percentage 
of β-III-tubulin-expressing cells at earlier time points and had fewer precursor cells with 
lower BrdU incorporation, suggesting that RA treatment can induce an earlier cell-cycle exit 
and result in neuronal differentiation (Kim et al., 2009). However, considering that nestin 
expression was found in late NPCs and the expression of Tbr1 was relatively weak across all 
samples (Fig. 4.8 and 4.10), it seemed unlikely that the change in responsiveness was the 
result of late NPCs having undergone differentiation.  
One important question to ask regarding the weak expression of positional markers 
(Foxg1, HoxB3, HoxB4,, Emx2, Pax6, Ngn2 and Mash1) with RA treatment between day 16 to 
day 20 (Figs. 4.5-4.9) is whether these NPCs had lost the competence to respond to RA. This 
can be answered by examining the expression of RA receptors (RARα, β, γ and RXRα, β, γ). If 
they were present in response to RA treatment, then it could affirmed that cells still retain 
the ability to respond to RA signalling (Waclaw et al., 2004). However, the presence of RA 
signalling machinery such as RA receptors cannot reveal the level of retinoid present in the 
system. Even though 1 μM of RA was added at every 4-day interval, it is unclear whether late 
NPCs would respond to the RA treatments by changing the expression of RA catabolizing 
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enzyme Cyp26s. In vivo, temporal expression of Cyp26a1 is involved in regulating the 
responsiveness of RA in hindbrain patterning (White et al., 2007, Hernandez et al., 2007, 
Sirbu et al., 2005). Therefore, it would be of interest to examine the expression of Cyp26s in 
early and late neural cultures to determine whether the level of RA has a role in determining 
the expression of positional markers. 
The change in responsiveness to RA in late cultures could be due to increased repressor 
activity as a result of more corepressors being recruited by the retinoid receptors. In an 
independent cell-based study, retinoid receptors acted as repressors by recruiting 
corepressors in the absence of ligands and as activators by recruiting coactivators when 
ligands were present (Xu et al., 1999, Glass and Rosenfeld, 2000). Co-activators and 
co-repressors are proteins that interact with nuclear receptors to regulate gene transcription 
(Glass and Rosenfeld, 2000). Co-activators for retinoid receptors include steroid receptor 
coactivator-1 (SRC-1) and P300/CBP-associated factor (P/CAF) (Glass and Rosenfeld, 2000). 
Co-repressors include the nuclear receptor corepressor (N-CoR) and the silencing-mediator 
of retinoid and thyroid hormone receptors (SMRT) (Chen and Evans, 1995, Kurokawa et al., 
1995, Burke and Baniahmad, 2000). All the four co-activators and co-repressors were 
expressed at similar levels in the cerebral cortex, the LGE and the MGE in the absence of 
retinol, but regional differences in repressor activity were found in the telencephalon where 
repressor activity is higher in the cerebral cortex than in LGE and MGE in the presence of 
retinol (Liao et al., 2005b). It is possible that the repressor activity is higher in late NPCs 
when they failed to be patterned by RA. This could be examined in future experiments by 
comparing the expression of co-repressors and co-activators of RA receptors between early 
and late NPCs. 
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4.4 Conclusion 
In summary, data presented in this chapter has brought us to a more precise 
understanding of the effect of RA addition on the acquisition of the regional identities of ES 
cell-derived NPCs. According to the data presented in this chapter, the most effective time 
window for RA to caudalize NPCs cultures was between day 0 to day 4 in both early and late 
cultures. The optimal time point for RA treatment to ventralize NPCs appeared to be at day 0 
in late cultures as the induction of ventral forebrain marker can only be found at that time 
point. RA treatment induced dorsalization in early cultures but not in late cultures. The 
expression of the tested positional markers was weak with RA treatment between day 16 to 
day 20 in late cultures. Although conclusive evidence is lacking here, it could well be 
assumed that it is during this period that late NPCs might have lost the competence to 
respond to RA signalling.  
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CHAPTER 5: 
INVESTIGATION OF THE RELATIONSHIP BETWEEN SOX1 
EXPRESSION AND REGIONAL SPECIFICATION IN RESPONSE TO 
MORPHOGENS 
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5.1 Introduction 
The previous chapter and Bouhon et al.'s study showed that early ES cell-derived 
neural progenitor cells (NPC)s were able to respond to RA by expressing caudal markers and 
a number of other forebrain markers, but the expression of these markers was gradually 
reduced in late NPCs. This indicated that late NPCs might have a reduced responsiveness to 
morphogens (Bouhon et al., 2006). As the neurogenic potential of NPCs depends to a certain 
extent on their competence to respond to morphogens (Gabay et al., 2003, Plachta et al., 
2004), this chapter therefore investigates whether the competency to respond to 
morphogen is related to Sox1 expression. 
Sox1 is one of the earliest markers expressed by ES cells-derived NPCs (Ying et al., 
2003b, Bouhon et al., 2005). It is a HMG-box transcription factor and belongs to the B1 
subgroup of Sox gene family, which includes Sox1, Sox2 and Sox3. Each Sox protein regulates 
a unique repertoire of genes and plays an important role in the determination of cell fate. It 
exhibits a domain which is involved in silencing developmental genes in undifferentiated ES 
cells. The domain is resolved upon differentiation and triggers the activation of 
lineage-related genes (Kamachi et al., 2000). During neural development, different classes of 
Sox transcription factors are expressed during neurogenesis and they play important roles in 
coordinating specific gene expression from early pluripotent stem cell stages to neuronal 
maturation (Bergsland et al., 2011). SoxB1 proteins are expressed by neural progenitors and 
SoxC proteins mostly found in post-mitotic neurons (Bergsland et al., 2006, Bylund et al., 
2003). Genome wide study of SoxB1 and SoxC proteins revealed that Sox2, Sox3 and Sox11 
(belong to SoxC proteins) sequentially bind to a common set of neural genes in mouse ES 
cells. Sox2 preselects neural lineage-specific genes that will be bound by Sox3 in neural 
progenitor cells. Neuronal genes that are associated with Sox3 are resolved from bivalent 
chromatin to a permissive monovalent state upon the binding of Sox11. Sox3 competes for 
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the binding sites with Sox11 in order to prevent premature Sox11-induced neuronal gene 
expression. This indicated the importance of SoxB1 proteins in maintaining neural 
progenitor properties (Bergsland et al., 2011). Moreover, induced expression of Sox1 in P19 
embryonal carcinoma cells substituted the requirement of retinoic acid to initiate neural 
differentiation (Pevny et al., 1998). All of this evidence indicated that Sox1 plays a key role in 
neural commitment. 
In mouse, Sox1 is one of the earliest neural markers expressed in ectodermal cells that 
are committed to neural cell fate. It is first expressed in neural precursor cells at 7.5 days 
post coitum (dpc) in the anterior half of late-streak embryo and is maintained in all 
neuroepithelial cells along the anteroposterior axis until the neural plate bends and fuses to 
form a neural tube (9.0-9.5 dpc). Downregulation of Sox1 expression is found along the 
dorsoventral axis and eventually Sox1 expression is restricted to the ventricular zone at 13.5 
dpc. This suggested that Sox1 expression is associated with the acquisition of neural fate 
within the embryonic neural tube but is downregulated when neuroepithelial cells leave the 
proliferative state and undergo neuronal and glial differentiation (Pevny et al., 1998). The 
downregulation of Sox1 expression is also found in neural cultures. Conti et al. showed that 
Sox1 expression is lost after 5 passages In neural stem cells either in the presence of FGF2 
alone or with FGF2 and EGF (Conti et al., 2005). 
The downregulation of Sox1 found in both in vivo and in vitro studies and also its role in 
determining neural commitment suggested that it might be possible that Sox1 was involved 
in the change in responsiveness of NPCs to morphogens, and consequently led to the loss of 
regional specification in late NPCs. To investigate this, ES cells-derived NSCs were exposed to 
RA and sonic hedgehog (Shh) because both morphogens play important roles in regulating 
AP and DV patterning during the development of the nervous system (Wilson and Maden, 
2005). 
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RA signalling plays an important role in patterning the hindbrain (Gavalas, 2002, Sirbu 
et al., 2005). The vertebrate hindbrain is arranged as neuroepithelial compartments called 
‘rhombomere’ (r). The identity of rhombomeres is partly conferred by the expression of 
Homeobox (Hox) genes, which are regulated by RA (Glover et al., 2006). Therefore, any 
change in competence to respond to RA can be reflected by the change in Hox gene 
expression.  
Hedgehog (Hh) signalling plays an essential role in regulating ventral patterning in the 
telencephalon (Ericson et al., 1995). Shh (the vertebrate homolog of Hh) is transduced 
through the transmembrane receptors patched (Ptc1) and smoothened (Smo). The inhibition 
of Smo by Ptc1 is relieved by Shh, and this allows the transcription of target genes through 
the Gli transcription factors (Ingham and McMahon, 2001). Three Gli proteins have been 
identified in vertebrates. Within the telencephalon, Gli2 and Gli3 function as transcriptional 
repressors in the absence of Hh ligands and as activators when Hh ligands are present. Hh 
ligands inhibit the repressor form by stopping the proteolytic processing near the DNA 
binding domain (Pan et al., 2006). Gli1 does not contain any repressor domain and functions 
as a strong transcriptional activator (Bai and Joyner, 2001, von Mering and Basler, 1999). 
Misexpression of Shh can result in the induction of ventral forebrain markers in the dorsal 
forebrain (Rallu et al., 2002). 
To understand the expression of Sox1 on the acquisition of positional markers, 
previously described 46C ES cell line was used in this study. The open reading frame of Sox1 
in 46C cells has been replaced with the coding sequence of GFP and an internal ribosome 
entry site (IRES)-linked puromycin resistance gene (Ying et al., 2003b), and this enables easy 
visualization and identification of Sox1/GFP expression by fluorescence microscopy and 
using flow cytometry. Furthermore, cells can also be sorted into Sox1/GFP positive and 
negative populations using fluorescence activated cell sorting (FACS) to examine the effect 
of Sox1 on cell fate specification. Knowledge of neural fate specification over time in 
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response to patterning cues is useful because it enables better strategies to be developed in 
order to systematically manipulate the cell fate of ES cells-derived NPCs.  
  Chapter 5   
 179 
 
5.2 Results 
5.2.1 Sox1/GFP expression of 46C cells over time 
According to Conti et al. ’s study, 46C cells express Sox1 temporarily and the expression 
is lost after 5 passages using the monolayer protocol described by Ying et al. (Ying et al., 
2003b). They show characteristics for neural stem cells because they express RC2 and nestin 
and are competent for astrocyte and neuronal differentiation (Conti et al., 2005). To find out 
whether ESC-derived NPCs in early (day 8) and late neural cultures (day 20) had different 
Sox1 expression, cells were differentiated for 20 days using the same differentiation 
protocol described in section 4.3.2 (Fig. 4.2) but with no RA added. Since this study deals 
with the investigation of the effect of Sox1 expression on neural patterning and not neuronal 
differentiation, ES cells-derived NPCs were cultured in the presence of FGF2 because it has 
been shown that NPCs can be expanded in FGF2 (Tropepe et al., 2001). 
To visualise GFP expression, 46C cells were observed under the fluorescence 
microscope. Fluorescent images showed that Sox1/GFP expression gradually decreased from 
day 10 to day 18 but it appeared that a considerable number of cells were still Sox1/GFP 
positive on day 18 (Fig. 5.1a).  
To quantify the expression of Sox1/GFP over time, cells were analysed by flow 
cytometry. All data were gated and analysed as described in section 2.1.7. Foxg1 cells were 
differentiated in CDM, the base medium used for differentiation, and were used as the 
negative control of Sox1/GFP expression for flow cytometry analysis. Differentiated Foxg1Z 
cells (a Foxg1-LacZ reporter cell line) were used instead of undifferentiated 46C ES cells 
because the distribution of fluorescence intensity of differentiated Foxg1Z cells changed 
slightly from day 6 to day 18 (Fig. 5.1 (b)).  
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The geometric mean fluorescence intensity (MFI) and the percentage of Sox1/GFP 
expressing cells of 46C cells from day 6 to day 18 were presented in Figs. 5.1(c) and (d). 
Significant differences were found in the percentage of Sox1/GFP expressing cells over 18 
days of differentiation overall (one-way ANOVA test, F3,8 = 443.57, P < 0.001), and the 
percentage of Sox1/GFP expressing cells on day 18 was significantly lower than other 
time-points (Tukey-Kamer test, P < 0.05). Significant differences were also found in the mean 
MFI values of Sox1/GFP expressing cells over 18 days of differentiation (one-way ANOVA test, 
F3,8 = 35.29, P < 0.001). The mean MFI values on day 14 and day 18 were significantly 
different from day 6; and the MFI values on day 14 and day 18 were significantly different 
from day 10 (Tukey-Kamer test, P < 0.05). Interestingly, the histogram of day 18 appeared to 
display two populations of Sox1/GFP positive cells with different fluorescence intensity, and 
in this case, only the population with the higher fluorescence intensity was considered to be 
Sox1/GFP positive. It was unclear whether there would be a further change in the population 
of Sox1/GFP positive cells if cells were cultured for a longer period, but the significant 
decrease in the percentage of Sox1/GFP expressing cells for the first 18 days enabled further 
investigation of the effect of the change in Sox1/GFP intensity over time in determining the 
change in responsiveness to morphogenic cues in late cultures.  
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(a) 
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(b)  
 
 
(c) 
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(d) 
 
Figure 5.1 Flow cytometry analysis of Sox1 expression over time 
(a) 46C cells were differentiated in CDM, FGF2 (20 ng/ml) was added from day 4 to day 18. 
Bright field and fluorescent pictures of one representative sample on day 10, day 14 and 
day 18 of neural differentiation are shown. Scale bar = 100 μm  
(b) 46C cells were dissociated and measured by flow cytometry on day 6, day 10, day 14 and 
day 18 for Sox1/GFP expression. Cells were gated in G1, excluding clumped cells and 
debris. The percentage of cells included in the G1 gate is shown on the SSC/FSC plots. The 
fluorescent intensity of gated control samples (differentiated Foxg1 cells) (red line) and 
differentiated samples (blue line) is shown on the histograms. The bimodal distribution on 
day 18 is divided into subpopulation 1 and 2. Tables show the percentage of Sox1/GFP 
expression, the geometric mean (geo. mean) fluorescence value and MFI ratio of each 
sample acquired. The highlighted regions (in green) indicate the samples represented in 
the SSC/FSC plots and the histograms. 
(c) The graph illustrates the mean percentage of Sox1/GFP expressing cells on day 6, day 10, 
day 14 and day 18 of neural differentiation. Bars represent the mean ± S.D. of three 
independent experiments. Significant post-hoc differences are indicated with an asterisk. 
(Tukey-Kramer test, *P < 0.05). 
(d) The graph illustrates the mean MFI ratio of Sox1/GFP expressing cells on day 6, day 10, 
day 14 and day 18 of neural differentiation. Bars represent the mean ± S.D. of three 
independent experiments. Significant post-hoc differences are indicated with brackets. 
(Tukey-Kramer test, *P < 0.05) 
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5.2.2 Analysis of Sox1/GFP positive and negative populations treated with RA 
and purmorphamine on day 8 and day 20 of neural differentiation 
 The previous section shows that the intensity of Sox1/GFP expression in the absence of 
any morphogens decreased significantly over 18 days. To find out whether the 
responsiveness to morphogens was affected by the decrease in the percentage of Sox1/GFP 
positive cells, 46C cells were differentiated for 20 days and RA (1 M) was added from day 4 
to day 8, when the expression of HoxB3 was strongest; or from day 16 to day 20, when the 
expression of HoxB3 was weakest according to the results obtained by RT-PCR analysis in 
section 4.3.4 (Fig. 4.5), and also according to the results from Bouhon et al.'s study which 
shows that early NPCs can be patterned systematically for the first 4-8 days of cultures while 
late NPCs were non-responsive to morphogens between day 16 to day 20 and resulted in a 
loss of regional specification (Bouhon et al., 2006). The effect of Hh signalling on ventral 
telencephalic expression in early and late neural cultures was studied using a Shh agonist 
purmorphamine (PM). It was discovered by Wu and co-workers by running a screen of a 
heterocycle combinatorial library consisting of roughly 50 000 compounds for small 
molecules that induce the expression of ALP, a marker for osteogenesis. PM produced a 
significant increase in ALP expression and showed minor toxicity (Wu et al., 2002). Further 
investigation into this compound indicated that it acts as an agonist for the Hh signalling 
pathway and increases expression of patched (Ptc) and Gli (Wu et al., 2004). It targets Hh 
receptor Smoothened (Sinha and Chen, 2006) and has been shown to ventralize 
diencephalic progenitors in serum-free culture conditions (Wataya et al., 2008) (Fig. 5.2).  
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Figure 5.2 Schematic representation of the differentiation protocol used in this study 
 46C cells were differentiated in CDM for 20 days. FGF2 (20 ng/ml) was added from day 4 
to day 20. RA (1 M) and PM (0.25 M) was added from day 4 to day 8 and day 16 to day 20. 
GFP positive and negative populations were sorted by FACS on day 8 and day 20 of 
differentiation and gene expression was analysed by RT-PCR. ES cells were differentiated on 
gelatin-coated plates for the first 6 days of differentiation and dissociated into single cells and 
replated onto poly-L-ornithine-coated plates every 4 days. 
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The effect of RA and PM on Sox1/GFP expression in 46C cells in early and late neural 
cultures was examined by fluorescence microscopy and flow cytometry. Fluorescent images 
of Sox1/GFP showed that more cells expressed GFP in early cultures than in late cultures. It 
appeared that PM treatment generated more GFP positive cells than CDM and RA 
treatments in both early and late cultures (Fig. 5.3 (a)).   
 To understand whether the responsiveness to morphogenic cues was determined by 
Sox1 expression, 46C cells were sorted by FACS into Sox1/GFP positive and Sox1/GFP 
negative populations. In early cultures (day 8), the positive and negative populations were 
defined by placing a delineator at the limit of the control sample fluorescence (between 
0.5% to 1%) and cells that were found above this level were sorted as GFP positive. For late 
cultures (day 20), the delineator was placed at the limit of the negative populations, even 
though they did not overlap with the negative control samples. In the case of PM treatment 
where three populations were generated according to the histogram on day 20 (Fig. 5.3 (b)), 
only the population with the highest GFP intensity was being sorted as GFP positive. RNA 
was extracted from the GFP positive and GFP negative populations and was then analysed 
by RT-PCR.  
HoxB3 is upregulated in r5 of the hindbrain specifically (Manzanares et al., 1999) and 
its expression is regulated by RA signalling (Niederreither et al., 2000). Fig. 5.4 showed that 
HoxB3 expression was strongly induced by RA treatment in early cultures (day 8) but not in 
late cultures (day 20) in both Sox1/GFP positive and negative populations. Nkx2.1 is a 
responsive gene of Shh and is expressed exclusively in the MGE and is required in the 
specification of MGE-derived neurons (Sussel et al., 1999, Butt et al., 2008). Similarly to 
HoxB3 expression, it was only induced in early cultures.  
Interestingly, neither Sox1/GFP positive nor negative populations were permissive for 
HoxB3 and Nkx2.1 expression on day 20. As the expression pattern was very similar in the 
Sox1/GFP positive and Sox/GFP negative population in both early and late cultures, this 
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suggests that the loss of expression of the positional markers in late cultures was not due to 
a decline in Sox1 progenitor population, and hence the responsiveness to morphogenic cues 
in neural cultures was not associated with Sox1 expression. 
The downregulation of HoxB3 and Nkx2.1 expression in late cultures could be due to an 
inactivation of Hh signalling. Therefore Ptc1 expression in early and late cultures was 
examined because it is a direct target of active Hh signalling (Marigo and Tabin, 1996). 
RT-PCR analysis showed that Ptc1 expression was induced by PM in both Sox1/GFP positive 
and negative populations and in both early and late neural cultures. This suggested that the 
lack of Nkx2.1 expression in late neural progenitors was not due to downregulation of Shh 
signalling per se. This showed that even though the positional identities were lost in late 
cultures, late NPCs were responsive to Shh signal.  
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(a) 
 
 (b)   
 
(c)  
Day of sorting CDM PM (0.25 μM) RA (1 μM) 
Day 8 82.30 91.50 77.00 
Day 20 26.00 33.40 24.90 
Table 5.1 Percentage of GFP/Sox1 positive cells sorted 
 
Figure 5.3 FACS sorting of Sox1/GFP positive and negative populations on day 8 and day 20 
of neural differentiation 
(a) 46C were differentiated in CDM and treated with PM (0.25 μM) and RA (1 μM). Bright 
field and fluorescent pictures of 46C cells on day 8 and day 20 of neural differentiation 
are shown. Scale bar = 100 μm 
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(b) 46C cells were dissociated into single cells and sorted for Sox1/GFP expression by FACS on 
day 8 and day 20 of neural differentiation. Cells were gated in G1, excluding clumped cells 
and debris. The percentage of cells included in the P1 gate is shown on the SSC/FSC plots. 
The fluorescent intensity of differentiated Foxg1 cells (negative control for GFP 
expression) (red line) and differentiated 46C cells (blue line) is shown on the histograms. 
Populations of cells being sorted into Sox1/GFP positive and negative are shown on the 
histograms.    
(c) The table shows the percentage of Sox1/GFP positive and negative cells sorted on day 8 
and day 20 of differentiation. 
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(a) 
 
(b) 
 
 
Figure 5.4 RT-PCR analysis of PM and RA treated sample on day 8 and day 20 of 
differentiation 
 Cells were treated with either RA (1 μM) or PM (0.25 μM) in the presence of FGF2 (20 
ng/ml) added from day 4 and day 20. No RA or PM was added in CDM control (C). Sox1/GFP 
positive and negative populations of 46C cells were sorted on day 8 and day 20 by FACS. 
Expression of HoxB3, Nkx2.1 and Ptc1 were analysed by RT-PCR. Forebrain, midbrain and 
hindbrain were taken from E12.5 mouse embryo. 
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5.3 Discussion 
It was observed that temporal difference in responsiveness to RA was found in early and 
late neural cultures (chapter 4). Late NPCs seemed to lose the ability to respond to RA, as 
reflected by a reduced caudalizing effect of RA and the lack of expression of a number of 
forebrain markers. Therefore, the question addressed by the present study was whether the 
change in responsiveness was due to a change in Sox1 expression over time, and if it was, 
whether it had any relation to the difference in responsiveness to patterning cues in early 
and late neural cultures.  
The first investigation was to examine the percentage and intensity of Sox1/GFP 
expressing cells over time. The high percentage (nearly 100%) of Sox1/GFP expressing cells 
was maintained for the first 14 days of differentiation and decreased substantially on day 18. 
This observation appeared to be similar to Conti et al.'s study that Sox1/GFP expression was 
downregulated after 5 passages. Even though the images obtained from fluorescence 
microscopy clearly showed that the intensity of Sox1/GFP expressing cells decreased from 
day 10 to day 18, the intensity of Sox1/GFP expressing-cells obtained from flow cytometry 
analysis seemed to vary over time. The discrepancy could be due to the way cells were gated 
in the flow cytometry analysis because the data obtained can be easily affected by the 
negative control and also how the voltages were adjusted. Nevertheless, the data presented 
were the best possible representation of Sox1/GFP expression of 46C cells over time using 
flowjo as an analytical tool.  
The next question addressed was whether Sox1 expression determines the 
responsiveness to patterning cues in early and late cultures. To investigate this, early and 
late NPCs were sorted into Sox1/GFP positive and Sox1/GFP negative populations using FACS. 
Contrary to the hypothesis that the expression of positional markers can be rescued in the 
Sox1/GFP positive population in late culture, the results showed that both the Sox1/GFP 
positive and Sox1/GFP negative populations responded to RA and PM by expressing HoxB3 
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and Nkx2.1 respectively in early cultures but not in late cultures. The expression pattern 
revealed by RT-PCR analysis (Fig. 5.4) showed that Sox1 did not seem to have any effect on 
the acquisition of positional markers. This was surprising considering the importance of 
SoxB1 proteins in regulating neural commitment. A recent study showed that SoxB1 proteins 
regulate neural-specific response by binding directly to the cis-regulatory modules (CRM) of 
morphogen-mediatory transcription factors (Oosterveen et al., 2013). CRM are stretches of 
DNA where a number of transcription factors can bind and regulate the expression of other 
genes (Davidson, 2010). The authors discovered that class II genes expressed in the ventral 
neural tube (Nkx2.2, Nkx6.1, Nkx6.2 and Olig2) can be induced in the limb bud by forced 
expression of both SoxB1 and Smo, but not SoxB1 or Smo alone. Similar responses were 
observed for other target genes induced by BMP and RA signalling. Interestingly, the 
expression of Sox1 was a lot weaker than Sox3 in the limb bud, suggesting Sox1 might not be 
the only factor that determined neural specification in NPCs (Oosterveen et al., 2013). Sox1 
was shown to play a role in directing cells towards a neural fate. This was based on the 
evidence that induced expression of Sox1 in P19 embryonal carcinoma cells obviated the 
requirement for RA to initiate neural differentiation (Pevny et al., 1998). However, another 
study suggested that while Sox1 played some part in determining neuroectodermal fate it 
was not necessarily the only factor involved because the action of Sox1 can be overridden by 
the presence of serum (Zhao et al., 2004). It would be of interest to perform CHIP analysis to 
find out whether SoxB1 binds to the Sox-binding sites of the CRM of lineage markers in early 
and late markers to find out the role of Sox1 in determining the responsiveness to 
morphogens in vitro.   
The responsiveness to morphogens can be determined by the signal transduction 
machinery. In the case of Hh signalling, the competence of neural progenitor cells to 
respond to Shh is regulated by the Gli family of transcriptional regulators, Gli1, Gli2 and Gli3 
and their expression is under temporal control. In vivo study showed that during the later 
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stages of telencephalic development (after E12), Gli3 plays a less important role in regulating 
competence to Hh signalling because Nkx2.1 expression can be maintained by Shh in a Gli3 
independent manner, indicating that there is a temporal change in requirement for Gli 
activity (Gulacsi and Anderson, 2006). Since it was reported that the maintenance of target 
genes requires a different threshold of Gli activity (Dessaud et al., 2010), it would be useful 
to study the expression Gli proteins in early and late cultures. Other candidates for 
investigation would include Fused and Cos2 , which are part of a cytoplasmic protein 
complex and are both phosphorylated in response to active Hh signalling (Robbins et al., 
1997). In addition, Cos2 was reported to accumulate in cells that were responsive to Hh 
signalling in Drosophila embryos (Sisson et al., 1997). 
 
5.4 Conclusion 
 The overall finding in this chapter, therefore, is that that both Sox1/GFP positive and 
negative cells responded to RA and PM by expressing HoxB3 and Nkx2.1 respectively in early 
but not in late cultures, indicating that HoxB3 and Nkx2.1 expression was not dependent on 
Sox1 expression. Cells were responsive to PM in late cultures even though Nkx2.1 expression 
was downregulated because Ptc1 was being induced by PM in both early and late cultures, 
indicating that late neural cultures were responsive to Hh signalling.  
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CHAPTER 6: 
GENERAL DISCUSSION 
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To devise appropriate strategies for producing specific neural and neuronal subtypes 
from ES cells, we have to understand how ES cells respond to developmental cues in 
acquiring neural character. At present, the mechanisms for regional specification in response 
to morphogens as regulated in vitro are not entirely clear. This study addressed this by 
looking at the effectiveness of using BMP inhibitors in inducing neural differentiation in ES 
cells and also how the lineage specification of neural progenitor cells was regulated 
temporally. Knowledge about lineage specification is vital for making progress with using ES 
cells for cell replacement therapies and drug screen studies.   
 
6.1 BMP inhibition in neural induction of ES cells 
Chapter 3 originally sought to explore the effect of BMP inhibition on the generation of 
neural progenitors from ES cells using newly-discovered chemical inhibitors. Such chemical 
inhibitors are stable and cost-effective and therefore provide useful alternatives to the use 
of recombinant proteins such as noggin in cell differentiation protocols and for tranference 
into processes which are Good Manufacturing Practice (GMP) compliant. However, the 
results showed that ES cells differentiated in CDM alone generated a high percentage of 
Sox1-expressing cells (>90%) on day 4 and day 6 of differentiation (Fig. 3.3). A high 
percentage of Sox1 expression is desirable because Sox1-positive cells have the potential for 
differentiating into functional neurons that respond to various neurotransmitters in a 
manner that was similar to primary central neurons (Lang et al., 2004). Owing to the high 
percentage of Sox1-expressing cells generated by cells cultured in CDM alone, it was difficult 
to assess the effects of DM or LDN treatment on Sox1/GFP expression. Cells differentiated in 
CDM alone expressed early neural markers (nestin and Pax6), and the presence of LDN, DM 
and noggin treatments can only enhance the expression of neural markers slightly (Fig. 
3.13-3.16). This suggests that exogenous BMP inhibition might not be essential for mouse ES 
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cells neural induction. This was also observed in a recent in vitro study showing that noggin 
treatment could only produce a marginal increase of neural progenitors (Bertacchi et al., 
2013). Examination of noggin null mutants has revealed that noggin is not essential for the 
formation of neural tissue but is required for the ventral development in the posterior 
neural tube (McMahon et al., 1998). Noggin and chordin double-mutants displayed reduced 
forebrain development and did not express anterior marker Six3 (Bachiller et al., 2000). 
Therefore it seems that BMP inhibition might have a stronger influence on regional 
specification in NPCs than on the neural conversion of ES cells. ES cells differentiated in CDM 
alone expressed midbrain markers (Otx2 and Irx3). In the presence of noggin, cells 
preferentially expressed telencephalic markers (Foxg1, Tbr1 and Emx2), and downregulated 
midbrain and hindbrain markers (Bertacchi et al., 2013). It would be useful to examine the 
effect of DM or LDN treatments and of another newly-discovered BMP inhibitor, DMH1 (Ao 
et al., 2012), on regional patterning of neural progenitors in future studies. 
 
6.2 Change in responsiveness in neural progenitor cells 
Chapter 4 of this study revealed that late ES cell-derived neural progenitor cells (NPCs) 
appeared to have a tendency to be more gliogenic as more GFAP-positive cells were found in 
late NPCs than early NPCs (Fig. 4.12). The underlying mechanisms that lead to the change in 
response in late NPCs was not entirely clear but data from several studies suggests that this 
could be due a progressive change in responsiveness to FGF2 and EGF2 found in NPCs in vivo 
and in vitro (Ciccolini, 2001, Tropepe et al., 1999). Both FGF2 and EGF are required for 
long-term propagation of ES cell-derived neural stem cells (Conti et al., 2005), but only 
primary neurospheres (generated by differentiating ES cells for 8 days) and secondary 
neurospheres (generated by dissociating primary neurospheres) had high expression of 
FGFR1 and FGFR2. In contrast, the expression of EGFR was low in primary neuropheres but 
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increased dramatically in secondary neurospheres. Furthermore, both primary and 
secondary neurospheres can be generated effectively in the presence of FGF2 alone, but the 
generation of tertiary neurospheres (generated by dissociating primary neurospheres) 
required EGF (Okada et al., 2008). In vivo, FGF-responsive neural stem cells are found as 
early as E8.5 in the anterior neural plate (Tropepe et al., 1999), and FGF2 is required to 
maintain neural stem cell populations in the neurogenic adult subventricular zone (SVZ) 
(García-González et al., 2010). EGF responsiveness is not acquired until EGF receptors are 
expressed at mid gestation (Tropepe et al., 1999). As a result of the differential expression of 
FGF and EGF receptors in neural stem cells, early NPCs (E8.5 to E11.5) found in the CNS that 
are FGF-responsive and not EGF-responsive have the potential to generate early-born 
neurons such as forebrain cholinergic and midbrain dopaminergic neurons; in contrast, late 
NPCs (E11.5 onwards) in the CNS are EGF-responsive and have gliogenic potential and 
cannot generate early-born neurons (Qian et al., 2000, Temple, 2001, Tropepe et al., 1999). 
Recent study revealed that the responsiveness to EGF in gliogenic NPCs is dependent on the 
expression of tenascin C (Tnc) (Karus et al., 2011), which is an extracellular matrix 
glycoprotein expressed by NPCs in the brain (von Holst et al., 2007) and the spinal cord 
(Karus et al., 2011). Tnc knockout mutants had a reduced number of EGF-responsive 
neurospheres and lower expression of EGFR in the spinal cord than wild-type between E15.5 
to E18.5 (Karus et al., 2011). Furthermore, the change in responsiveness to EGF also led to 
an increased expression of neural patterning genes including Nkx6.1 and Nkx2.2 in the 
Tnc-deficient spinal cord, and caused an upregulation of Sulf1, which is a downstream target 
of Nkx2.2 (Genethliou et al., 2009) and has been shown to inhibit FGF signalling (Otsuki et al., 
2010). Further work is needed to establish whether late NPCs in this study are more 
responsive to EGF than early NPCs and to establish whether the temporal change in 
responsiveness to FGF and EGF is related to the patterning-responsiveness potential of NPCs 
in vitro.  
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Thus, temporal change in the competence of cells to respond to morphogens partly 
accounts for the irreversible progression of NPCs from being neurogenic to gliogenic. But it is 
also required for the proper development of the telencephalon. The sequential appearance 
of the MGE followed by the LGE is the result of progressive changes in the competence of 
telencephalic cells to respond to Shh signalling. This is based on the finding that blocking Shh 
activity between E9.5 to E10.5 in telencephalic explants reduced the expression of Dlx2 
(expressed in the LGE) but did not affect the expression of Nkx2.1 (expressed in the MGE). In 
contrast, between E10.5 to E11.5, recombinant Shh induced the expression of Dlx2 but not 
Nkx2.1 in telencephalic explants even at the highest concentration examined (960nM) 
(Kohtz et al., 1998). This, therefore, indicates that early Shh signalling induces E9.5 
telencephalon to take the form of MGE while late Shh signalling induces E10.5-E11.5 
telencephalon to become LGE. Beyond E11.5, telencephalic explants are unable to be 
ventralized by Shh (Kohtz et al., 1998). While the underlying mechanism for the temporal 
change in responsiveness was not entirely clear, it can be construed that competence to 
respond to Shh in the MGE is partly regulated by Nkx2.1 (Butt et al., 2008). After the MGE is 
formed (E10.5), the expression of Shh target genes Gli1 (Lee et al., 1997) and Nkx6.2 
(Stenman et al., 2003) is found in areas that are away from high Shh expression (Xu et al., 
2005). Conditional knockout of Nkx2.1 results in upregulation of the Shh target gene Gli1 
and Nkx6.2 in the MGE (Butt et al., 2008). Therefore, although Nkx2.1 expression is 
dependent on Shh signalling during MGE development (Sussel et al., 1999), removing Nkx2.1 
after the MGE is formed seems to enable MGE progenitors to acquire competence to 
respond to Shh signalling (Sousa and Fishell, 2010). Whether or not other transcription 
factors have similar effects on regulating competence to respond to morphogens in vitro 
awaits further enquiry.  
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For different regions of the central nervous system to be properly developed, having 
temporal limits on the responsiveness to patterning cues is necessary to prevent unwanted 
secondary patterning of NPCs (Allen, 2008). An example can be found in the specification of 
the hindbrain rhombomere boundaries, which have an RA dependency that is lost from an 
anterior-to-posterior sequence as development proceeds (Dupe and Lumsden, 2001). 
Chapter 5 of this study showed that even though positional markers expression was not 
induced by Shh in late NPCs, cells were nevertheless still responsive to Hh signalling because 
Shh target gene Ptc1 expression was found to be in equal measure in both early and late 
cultures. The transition from being competent to incompetent in the process of inducing 
positional information was not due to a reduction of neural progenitors, because the 
expression of nestin in late cultures was similar to early cultures (Fig. 4.8). Consistent results 
are found in telencephalic explant study which shows that both early (E11.5) and late (E12.5) 
explant cultures had comparable levels of nestin expression, even though telencephalon has 
lost its capacity for expressing patterning genes in response to Shh after E12.5. This indicates 
that the loss of competence was not due to progenitors having withdrawn from the cell 
cycle (Kohtz et al., 1998), and suggests that late Shh signalling is involved in maintaining 
neural progenitor population. Hence, removing Hh signalling from E12.5 onwards leads to a 
reduction in the number of progenitors found in the postnatal SVZ while the regional 
patterning within the telencephalon is maintained (Machold et al., 2003). In the context of 
embryonic development, the change in the function of imposing positional identities in NPCs 
by morphogens has the benefit of allowing a small number of signalling pathways to be 
reused for other developmental processes such as regulation of progenitor cell number in 
the adult hippocampus (Lai et al., 2003).  
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NPCs expanded for a prolonged period in cultures have not only a reduced patterning 
response, but also reduced survivability when transplanted into rat neonatal hippocampus. 
Zietlow et al. found that early passage foetal -derived human progenitors (expanded in vitro 
for 2 weeks) survive up to 12 weeks in the recipient brain whereas late passage foetal 
derived human progenitors (expanded in vitro for 20 weeks) initially form healthy-looking 
grafts but these grafts disappear after 4 weeks. Zietlow et al. argued that the reduced 
survivability of late passage cells was not due to an ageing of neural progenitors because 
they expressed NS cell markers (Sox2, nestin) and were able to give rise to GFAP- and 
β-III-tubulin-positive cells. However, they also reported that the percentage of 
β-III-tubulin-positive cells obtained from spontaneous differentiation decreases from 27.7% 
to 5.8% from early to late passage cells (Zietlow et al., 2012), suggesting that cells became 
less neurogenic (more gliogenic) over time. Further research to deepen understanding of the 
developmental potential of these temporally-restricted NS cells is required if they are to be 
utilised in transplantation studies. 
 
6.3 Regulation of neural patterning by co-repressor  
Experimentation carried out in the course of this study has only investigated the effect 
of extracellular factors on the regional specification of ES cell-derived NPCs: it did not 
examine the epigenetic mechanisms. Previous study has shown that both class I and II 
homeodomain proteins in the ventral neural tube can act as repressors by relying on the Eh1 
domain to recruit Gro/TLE co-repressor to establish the correct positioning of the 
homeodomains. Therefore, misexpression of class II protein Nkx6.1 in the dorsal region of 
the neural tube caused the repression of class I protein Dbx2 (Muhr et al., 2001). Many 
homeodomain proteins involved in AP and DV patterning, such as the Msx and Gbx proteins, 
contain Eh1 domain (Smith and Jaynes, 1996), indicating the importance of the role of 
Gro/TLE in setting the correct spatial patterns. In the case of homeodomain proteins (such as 
  Chapter 6   
 201 
 
Pax6 and Irx3), which do not contain the Eh1 domain, repression of homeodomain proteins 
was believed to be mediated through the activation of intermediary repressor proteins 
(Muhr et al., 2001).  
Since neural patterning of the ventral tube relies on some homeodomain proteins that 
function as repressors by recruiting Gro/TLE (Muhr et al., 2001), it would be of interest to 
find out if the expression of Grg5 in early and late cultures inhibits the activity of Gro/TLE 
(Roose et al., 1998).  In vivo, ectopic expression of Grg5 reduced the ability of Nkx6.1 to 
repress Dbx2 expression, causing dorsal expansion of the domain of Nkx6.1. Similar results 
were obtained in another pair of class I/II proteins Pax6 and Nkx2.2, indicating that the 
reduction in Gro/TLE activity caused by Grg5 can deregulate the positioning of the 
homeodomain proteins (Muhr et al., 2001). The change in positional response was not 
associated with the change in responsiveness to Shh signal of ventral progenitor cells as the 
expression of Shh and Ptc1 was unaffected by the ectopic expression of Grg5. Another 
interesting gene to examine in relation to changes in responsiveness in late cultures would 
be the Gro/TLE gene Grg4 because it shows a spatial change in expression during embryonic 
development. In chick, It is uniformly expressed in the neural plate and neural tube fold 
(stage 10), but is expressed at a higher level in the ventral region after neural tube closure 
(stage 15), suggesting that Grg4 might be involved in regulating ventral patterning response 
(Muhr et al., 2001).  
 
6.4 Transferability of mouse ES works to human ES works   
One of the reasons for studying the neural differentiation of mouse ES cells is because 
they can be used as informative models for human ES and iPS cells differentiation, even 
though there are differences in growth factor requirements in human and mouse models. 
For instance, the pluripotency of mouse ES cells is dependent on the synergistic effects of 
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BMP and LIF (Ying et al., 2003a). In contrast, human ES and iPS cells rely on the synergistic 
effect of TGFβ (mediated through Smad 2/3 activation) and FGF signals to suppress BMP 
signalling in order to regulate the expression of Nanog and therefore to maintain 
pluripotency (Vallier et al., 2005, Xu et al., 2008, Vallier et al., 2009). Human ES cells 
differentiate into extracellular trophoblast (Xu et al., 2002, Amita et al., 2013), mesoderm 
(Laflamme et al., 2007) and endoderm (D'Amour et al., 2005) in response to active BMP 
signalling. Therefore, the dual inhibition of Smad signalling using noggin (which prevents the 
phosphorylation of Smad1/5/8) and SB431542 (which prevents the activation of Smad2/3) 
enhances neural induction in human ES cell cultures yielding a high percentage of 
neuroepithelial cells that can potentially be differentiated into motoneurons and 
dopaminergic neurons (Chambers et al., 2009). Furthermore, even though human ES cells 
express gp130 receptors and respond to LIF by inducing STAT3 phosphorylation and 
translocation to the nucleus, LIF itself cannot sustain the self-renewal of human ES Cells 
(Daheron et al., 2004). However, once human ES cells are converted to neural progenitors, 
LIF can significantly enhance their in vitro survival by reducing caspase-mediated apoptosis 
and also promote their differentiation (Majumder et al., 2012). Previous study has shown 
that the same neural differentiation protocol that is used to generate mouse ES cell-derived 
neural stem cells can be also be used to generate β-III-tubulin positive-neurons and GFAP 
positive-cells from human ES cells, though not as effectively as is the case in mouse cells. 
Therefore species-specific requirements need to be met in order to achieve more efficient 
neural induction and differentiation of human ES cells (Conti et al., 2005). 
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6.5 Experimental limitation of this study: Heterogeneity in cell cultures 
Discrepancies between studies using culture systems are inevitable because different 
cell lines and differentiation media are used. Different cell lines derived from mouse strains 
with dissimilar genetic backgrounds might produce variation in the pattern of gene 
expression. Some genes might be more susceptible to certain components of the 
differentiation media. These two factors might not contribute to any detectable disparity at 
an early stage but might produce more significant differences in phenotypic response at a 
later stage (Stojkovic et al., 2004). Therefore, it is necessary to study findings reported by a 
variety of neural differentiation approaches carefully, noting the similarities and 
dissimilarities between each system.  
Even when the same neural differentiation protocol is used, discrepancies can be 
observed between each experimental setup because heterogeneity exists within ES cell 
cultures, and it is difficult to identify responsive cells (Parmar and Li, 2007). Pluripotency 
factors are heterogeneously expressed in ES cell cultures as revealed by a 10-fold variation in 
the expression of Oct4 and Sox2 between individual ES cells (Tang et al., 2010). Furthermore, 
the level of Nanog expression fluctuates in each individual ES cell (Chambers et al., 2007) , 
and the fluctuating levels of Nanog can have an effect on the differentiation potential of ES 
cells (Abranches et al., 2013). The population of ES cells with low Nanog expression had a 
higher degree of readiness for differentiation (indicated by a higher expression of FGF5 
(ectoderm), T-brachyury (mesoderm) and Gata6 (endoderm)) than a population of ES cells 
with high Nanog expression (Abranches et al., 2013). Considering that pluripotency factors 
are also lineage specifiers (Loh and Lim, 2011, Thomson et al., 2011), it is unsurprising that 
the uneven expression and fluctuations in the expression of pluripotency factors of ES cells 
might account for the differential developmental potential between cultures. In addition, 
some of the transcription factors that confer positional information are not entirely copied 
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by ES cell-derived cultures and this might also affect competence in the generation of 
site-specific neurons (Conti and Cattaneo, 2010). Furthermore, each individual ES cell 
possesses a unique collection of histone modifications that have different kinetics and 
stoichiometries in lineage-control gene loci, and hence will also influence lineage decision 
(Gan et al., 2007). 
  Chapter 6   
 205 
 
6.6 Conclusion 
Recent progress made in the neural differentiation of ES cells has proved extremely 
promising. The use of ES cells-derived NPCs as a source of specific neurons for clinical 
applications opens up wide-ranging possibilities. This study has demonstrated that a high 
percentage of Sox1-positive neural progenitors was generated from ES cells in CDM alone 
and that the effect was slightly enhanced by the introduction of BMP inhibitors. Although 
newly-discovered BMP inhibitors can potentially be used as a replacement of recombinant 
noggin, it is necessary to consider their off-target effects.  
This study has also shown that regional specification of ES cell-derived neural 
progenitors is determined by the temporal change in competence to respond to 
morphogens. In vivo, the dynamic change in temporal competence to morphogens is 
essential for regulating the correct specification of different organs and tissues (Sousa and 
Fishell, 2010). However, in vitro this seems to contribute to the gradual loss in regional 
identities of ES cell-derived NPCs over time, indicating that the patterning response given by 
NPCs is restricted temporally.  
Though a better understanding of the underlying mechanism for the loss of patterning 
response in late NPCs is vital to further progress, it remains, at present, elusive. However, 
the temporal change in responsiveness to morphogens can partly explain how the 
patterning and growth of different tissues during embryonic development relies on the 
redeployment of only a small number of signalling pathways. Although SoxB1 proteins have 
been shown to regulate neural specific response in vivo (Oosterveen et al., 2013), this study 
indicates that the loss of regionalisation in late NPCs was not due to the downregulation of 
Sox1 expression.  
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The findings submitted in this study suggest that further work is needed to reach an 
understanding of this temporal change in responsiveness. Such a step would greatly increase 
the developmental potential of ES cell-derived NPCs. Their therapeutic application is 
dependent on the extent to which our knowledge of NPC patterning responses is such that 
they can be predicted and manipulated comprehensively and accurately. 
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